Critical Role of Transcription Cofactor PC4 in Mammals by Li, Na
 
    
 
Dissertation zur Erlangung des Doktorgrades 
der Fakultät für Chemie und Pharmazie 
der Ludwig-Maximilians-Universität München 
 
Critical Role of Transcription Cofactor PC4 
in Mammals  
 
 
 
 
 
 
 
 
 
 
 
Na Li 
aus 
Henan, China 
2010 
 

 

 
Erklärung  
Diese Dissertation wurde im Sinne von §13 Abs. 3 bzw. 4 der 
Promotionsordnung vom 29. Januar 1998 von Herrn Prof. Dr. Meisterernst 
betreut. 
 
 
Ehrenwörtliche Versicherung 
Diese Dissertation wurde selbständig und ohne unerlaubte Hilfe erarbeitet.  
 
 
 
München, am 11.01.2010 
 
                                                                                             __________ 
                              Na Li 
 
 
 
Dissertation eingereicht am: 11.01.2010 
1. Gutachter: Prof. Dr. Meisterernst 
2. Gutachter: Prof. Dr. Wolf 
Mündliche Prüfung am: 15.03.2010 
 
 
  

 
ACKNOWLEDGEMENTS 

I am very grateful to Prof. Dr. Michael Meisterernst for giving me the opportunity to 
work with him and for guiding me in the field of transcription. I am thankful for his 
constant support and guidance throughout my work. 
 
I am grateful to Prof. Dr. Eckhard Wolf for taking the part of referee. 
 
I am thankful to all the current and former lab members, especially, Ulrike Niehues for 
taking care of mice and all the technical help. 
I would like to thank former member Dr. Wera Roth who was initially involved in 
designing the conditional knockout-targeting vector for this project and also for 
constant guidance.  
I thank former member Gertraud Stelzer for making a lot of contribution to generating 
the constitutive knockout mouse model. 
Many thanks to Dr. Thomas Albert for the critical comments on this manuscript.  
I enjoyed all the scientific and non-scientific discussions with my friends Ming, 
Tasneem and Caroline and thank them for the pleasant atmosphere in the lab. 
 
I am grateful to all the collaborators who contributed to this work,  
Prof. Dr. Hans R. Schöler, who provided me the opportunity to work in his lab and 
utilize the facilities at the Max PIanck Institute for Molecular Biomedicine, and Dr. 
Guangming Wu from his lab, who helped me to generate knockout ES cell lines and 
also taught me many techniques related to this work. 
Prof. Dr. Jörn Walter and Mark Wossidlo, who helped in mouse zygotes 
immunostaining. 
Prof. Dr. Heinrich Leonhardt and Dr. Ursula Zimber-Strobl, who gave me a lot of 
invaluable help and advice. 
 
Finally, I would like to thank my husband and my family for their love, support and all 
the encouragement throughout these years. 

  

 
SUMMARY 

PC4 is a small protein with unique DNA-binding properties that affects transcription 
and has presumptive roles in DNA repair and genome stability. It was originally 
isolated from a cofactor fraction termed the ‘‘upstream stimulatory activity’’ (USA) of 
HeLa cell nuclear extracts. The cofactor has been shown to broadly enhance RNA 
polymerase II-driven gene transcription in the presence of activators (e.g., hormone 
receptors, viral activators, cell-specific and ubiquitous activators). Although such data 
imply that PC4 is a very important factor in vivo, human tumor cell lines with PC4 
knockdowns are without obvious phenotypes. To further study the in vivo role of PC4, 
we constructed constitutive and conditional knockout mouse models as well as 
knockout embryonic stem cells. Mammalian PC4 is here shown to be an essential 
factor during early embryogenesis. PC4
-/- embryos develop normally until E5.5, but 
then degenerated around E7.5. PC4 knockout ES cell lines were generated from PC4-/- 
blastocysts (E3.5), which develop normally from 2-cell stage embryos. All PC4 
knockout ES cell lines displayed a severe proliferation deficit phenotype, which could 
be partially rescued by re-expression of human PC4. The reduced proliferation was 
not due to an increase in cell apoptosis. Occasionally, PC4 knockout ES cells undergo 
tetraploidy apparently as a survival mechanism to circumvent the loss of PC4. 
Knocking down PC4 in mouse embryonic fibroblasts also resulted in reduced 
proliferation rates. These data indicate that PC4 is important for cell proliferation in 
embryos. Moreover, in vitro embryoid body formation and in vivo teratoma formation 
assays provided preliminary evidence for an important role of PC4 in differentiation. 
Differentiated ES cells displayed alterations in germ-layer specific gene expression, 
that are in agreement with morphological abnormalities observed in histological 
analyses of PC4
-/- embryos at E6.5 and E7.5. Thus, depletion of PC4 results in 
reduced proliferation and impaired differentiation, the consequence of which appears 
to be of gastrulation arrest in early embryos.   
In an attempt to understand the underlying mechanisms of this phenotype, differential 
gene expression in ES knockout and wild-type cells was studied. Microarray and qRT-
PCR analyses revealed more than 2 fold alterations in expression of many genes in 
knockout ES cells as compared with wild-type cells. These include enhanced 
expression of p21, Rb1, and Ddit4l, and lower expression of Sfmbt2, Tdrd12, and 
Dppa3, suggesting a specific direct or indirect physiological role of the cofactor. 
  
Nevertheless, the previously proposed role of PC4 in p53 expression and function was 
not confirmed using the knockout model. Taken together, this work represents the first 
description of the physiological functions of PC4 during mammalian embryogenesis. 
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1. INTRODUCTION 
1.1 The process of gene expression 
The genome of an organism has been called “the blueprint for life”. Through the 
process of gene expression, the master plan is realized. During this process, genetic 
information is transferred from deoxyribonucleic acid (DNA) to ribonucleic acid (RNA) 
(transcription) and then from RNA to protein (translation) to bring the genome to life. 
These two processes, transcription and translation, are physically separated in 
eukaryotes by a membrane that surrounds the nucleus; transcription occurs in the 
nucleus, whereas translation is a cytoplasmic event. 
Transcription of protein-coding genes is a highly coordinated process mediated, in 
eukaryotes, by RNA polymerase II (Pol II), which is aided in its function by other 
factors, termed general transcription factors (GTFs), including TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF, and TFIIH (Table 1). For most genes, transcription is initiated once the 
preinitiation complex (PIC) is formed. The sequential PIC assembly process begins 
with the recruitment of TFIID to the core promoter, followed by the entry of TFIIA and 
TFIIB that help stabilize promoter-bound TFIID, and then the recruitment of Pol 
II/TFIIF. After formation of a stable TFIID-TFIIA-TFIIB-Pol II/TFIIF-promoter complex, 
TFIIE is then recruited, followed by TFIIH (Orphanides et al. 1996). In addition to this 
sequential assembly pathway, the PIC can also be formed by the Pol II holoenzyme 
pathway, whereby the Pol II holoenzyme associates with TFIID and TFIIA. The human 
Pol II holoenzyme complex contains Pol II, TFIIB, TFIIE, TFIIF, TFIIH, GCN5 histone 
acetyltransferase, SWI/SNF chromatin remodeling factor, and SRBs (suppressors of 
RNA polymerase B mutations) (Kim et al. 1994; Koleske and Young 1994), but is 
devoid of TFIID and TFIIA (Wu and Chiang 1998; Wu et al. 1999a). As soon as the 
nascent RNA is transcribed, it is modified by the addition of a “cap” structure at its 5’ 
end. The capping process protects the new transcript from attack by nucleases as well 
as serves as a platform for binding proteins that will export the mature mRNA. During 
transcription elongation, Pol II moves 5’ to 3’ along the gene sequence and extends 
the transcript. Both coding sequences (exons) and non-coding sequences (introns) of 
the gene are transcribed into pre-mRNA. Introns are then removed from pre-mRNA via 
splicing. Upon reaching the end of a gene, Pol II stops transcription (“termination”), the 
newly synthesized RNA is cleaved (“cleavage”), and a polyadenosine [poly (A)] tail is 
added to the 3’ end of the transcript (“polyadenylation”). The diverse steps of gene 
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expression are considered to be physically and functionally connected to each other 
(Orphanides and Reinberg 2002). 
 
Table 1: Human general transcription factors (GTFs) (Thomas and Chiang 2006) 
Factor Protein composition Function 
TFIIA p35 (), p19 (), and p12 
() 
Antirepressor; stabilizes TBP-TATA complex; coactivator 
TFIIB p33 Start site selection; stabilizes TBP-TATA complex; Pol 
II/TFIIF recruitment 
TFIID TBP+TAFs (TAF1-
TAF14) 
Core promoter-binding factor 
Coactivator 
Protein kinase 
Ubiquitin-activating/conjugating activity 
Histone acetyltransferase 
TFIIE p56 () and p34 () Recruits TFIIH 
Facilitates formation of an initiation-competent Pol II 
Involved in promoter clearance 
TFIIF RAP30 and RAP74 Binds Pol II and facilitates Pol II recruitment to the 
promoter 
Recruits TFIIE and TFIIH 
Functions with TFIIB and Pol II in start site selection 
Facilitates Pol II promoter escape 
Enhances the efficiency of Pol II elongation 
TFIIH P89/XPB, p80/XPD, p62, 
p52, p44, p40/CDK7, 
p38/Cyclin H, p34, 
p32/MAT1, and p8/TFB5 
ATPase activity for transcription initiation and promoter 
clearance 
Helicase activity for promoter opening 
Transcription-coupled nucleotide excision repair 
Kinase activity for phosphorylating Pol II CTD 
E3 ubiquitin ligase activity 
 
1.1.1 Promoter structure of protein-coding genes 
Protein-coding genes contain DNA elements that are recognized by transcription 
factors and the transcription machinery. Promoters harbor core promoter elements and 
distal regulatory elements. Core promoter elements define the site for proper assembly 
and orientation of the PIC, and include the TATA box, the initiator (Inr), the 
downstream promoter element (DPE), the motif ten element (MTE), the downstream 
core element (DCE), the upstream TFIIB-recognition element (BREu), and the 
downstream TFIIB-recognition element (BREd) (Figure 1). The TATA box is an A/T-rich 
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sequence located approximately 25 to 30 nucleotides upstream of the transcription 
start site, and is recognized by the TATA-binding protein (TBP). The Inr contains a 
pyrimidine-rich sequence surrounding the transcription start site (Smale and Kadonaga 
2003), and is capable of directing accurate transcription initiation. The third core 
element, DPE, is located about 28 to 34 nucleotides downstream of the start site and 
functions together with Inr as a binding site for the general transcription factor TFIID at 
TATA-less promoters. Alternatively, DPE can restore the core promoter activity if a 
TATA-dependent promoter is inactivated. The MTE and DCE are also situated, along 
with the DPE, downstream of the transcription start site. MTE functions in conjunction 
with the Inr to enhance Pol II-mediated transcription, whereas DCE binds the TAF1 
component of TFIID to establish downstream promoter-regulated transcription. 
Furthermore, BRE
u (Lagrange et al. 1998; Qureshi and Jackson 1998), located 
immediately upstream of the TATA element, and BREd, located downstream of the 
TATA box (Deng and Roberts 2005), help orient the directionality of the PIC. 
Distal regulatory elements are gene-specific sequences that control the rate of 
transcription initiation by binding the transcription factor to affect the basic apparatus, 
which includes the upstream activation sequence (UAS), enhancer, locus control 
region (LCR), upstream repression sequence (URS), silencer, insulator, and S/MAR. 
The UAS is recognized by activators to influence transcription from nearby start sites. 
Similarly, enhancers can regulate transcription, but this influence is independent of 
their orientation and distance from the core promoter. The LCR enhances the 
expression of linked genes to physiological levels in a tissue-specific manner (e.g., cis-
independent) at the gene’s integration site. LCR activation results in chromatin 
opening, suppression of position effects, and large distance gene activation. The URS 
is bound by sequence-specific repressors to inhibit transcription by interfering with 
activator binding, preventing recruitment of the transcription apparatus, and modifying 
chromatin structure. Silencers are sequence elements that can repress promoter 
activity in an orientation- and position-independent manner. Insulators are regulatory 
elements that can shelter genes from inappropriate regulatory interaction (Brasset and 
Vaury 2005). They are able to block interaction of enhancer to promoter and prevent 
the spread of repressive chromatin, like barriers. S/MARs are sequences by which 
chromatin loops attach to the nuclear scaffold and matrix. The S/MARs remodel the 
chromatin loop domains to move the gene near to the nuclear matrix so as to access 
the transcription machinery, thereby initiating transcription and replication (Heng et al. 
2004).  
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Figure 1: Core promoter elements and their recognition by TFIID (TBP and 
TAFs) and TFIIB (Thomas and Chiang 2006). 
 
1.1.2Eukaryotic RNA polymerases 
Three eukaryotic RNA polymerases (Pol I, II, and III, respectively) were first identified 
by Roeder and Rutter (Roeder and Rutter 1969), based on the chromatographic 
fractionation of sea urchin embryo nuclei on a DEAE-Sephadex column. Pol I came off 
the column first at the lowest salt concentration, whereas Pol III eluted at the highest 
salt concentration. Moreover, these polymerases are also responsible for the 
transcription of different classes of RNA, and they can be distinguished biochemically 
according to their sensitivity to -amanitin (Table 2). In rapidly growing cells, Pol I and 
III can contribute up to 80% of all nuclear transcription.  
Pol II comprises 12 subunits (Rpb1-12) that are highly conserved among eukaryotes, 
while Pol I and III possess 14 and 17 subunits, respectively. Five subunits, Rpb5, 6, 8, 
10, and 12, are common to all three RNA polymerases, whereas the Rpb1, 2, 3, and 
11 subunits of Pol II are homologous to subunits of Pol I and Pol III (Cramer et al. 
2000; Asturias 2004; Cramer 2004). A unique feature of the largest Pol II subunit is the 
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presence of tandem repeats of a heptapeptide sequence at its carboxy-terminus, 
known as the carboxy-terminal domain (CTD). The CTD has the consensus sequence 
Tyr-Ser-Pro-Thr-Ser-Pro-Ser that is highly conserved among eukaryotic organisms. 
Moreover, it contains binding sites for proteins that regulate processes such as 
transcriptional initiation, elongation, termination, and mRNA processing (Palancade 
and Bensaude 2003). Phosphorylation of the CTD regulates the activity of Pol II. 
During initiation, Pol II carries an unphosphorylated CTD, while elongating polymerase 
molecules contain phosphorylated CTDs. The switch in CTD phosphorylation between 
initiation and elongation seems to cause Pol II to switch cofactors (Meinhart et al. 
2005). Several kinases have the potential to phosphorylate the CTD of Pol II in vitro. 
Most CTD kinases belong to the class of cell-cycle-dependent kinases (CDKs) and 
require a cyclin as cofactor for full activation; they include the cyclin-dependent kinase 
7 (CDK7) associated with TFIIH (Feaver et al. 1991); CDK8 found in the general 
cofactor, Mediator; and CDK9 present in the positive transcription elongation factor b 
(P-TEFb). There are five potential phosphorylation sites in the CTD consensus 
sequence. It has also been established that Pol II can be phosphorylated at Ser2, -5 
and -7 of the heptarepeat. Ser5 phosphorylation occurs in promoter-proximal regions, 
and leads to recruitment of the capping enzyme. Ser2 phosphorylation predominates 
in regions that are more distal from the promoter, and triggers binding of the 3’-RNA 
processing machinery. Phosphorylation of Ser7 facilitates snRNA gene expression 
(Egloff et al. 2007), but the restriction of Ser7 epitopes to the Linker-proximal region 
limits CTD phosphorylation patterns and is a requirement for optimal gene expression 
(Chapman et al. 2007).  
 
Table 2: Eukaryotic RNA polymerases  
Type Genes     Transcripts Localization 
Response to -
amanitin 
Pol I class I 18S-, 5.8S- 28S-rRNA nucleoli none 
Pol II class II pre-mRNA, snRNA nucleoplasm strong, KD=10
-8
 M 
Pol III class III tRNA, 5S-rRNA, snRNA  nucleoplasm weak, KD=10
-6
 M 
 
Pol I, Pol II, and Pol III: the three DNA-dependent RNA polymerases; rRNA: ribosomal 
RNA; mRNA: messenger RNA; snRNA: small nuclear RNA, tRNA: transfer RNA. 
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1.1.3 Transcription coactivators 
The transcription coactivators are distinct from the GTFs in that they are dispensable 
for basal-level transcription and distinct from activators in that most do not directly bind 
DNA and none appears to bind DNA in a sequence-dependent manner. They are 
required for transcription activation and some act as a bridge to accumulate the gene-
specific activators to their target sequence [TFIIA, TAFs found in TFIID, USA factors, 
and SRB/Mediator (Myers and Kornberg 2000; Kornberg and Lorch 2002; Bjorklund 
and Gustafsson 2004; Blazek et al. 2005)], while some interact with nucleosomes, 
promoting chromatin modification (histone acetyltransferases), or chromatin 
remodeling (SWI/SNF remodeling complex). 
USA factors include both positive and negative effectors of transcription, and interact 
with the PIC to repress transcription in the absence of activators or to stimulate 
transcription in the presence of activators (Meisterernst et al. 1991). At least six 
positive cofactors were discovered in the human USA fraction: PC1 [later identified as 
the poly(ADPribose) polymerase, PARP] (Meisterernst et al. 1997); PC2 (the smaller 
form of human Mediator complexes) (Malik et al. 2000); PC3/Dr2, which is the 
topoisomerase I and functions in both repression of basal transcription and stimulation 
of activated transcription (Kretzschmar et al. 1993; Merino et al. 1993); PC4; PC5, 
which coactivates the transcription regulated by upstream stimulatory factor 1 (USF1) 
in a reconstituted, class II gene transcription system (Halle et al. 1995); and PC6 
(Mittler et al. 2003). Among all the positive cofactors, PC4 was the first to be cloned, 
and it will be discussed below in detail. The negative cofactors include NC1/HMG1 and 
NC2. NC1 represses basal transcription via binding to the TBP-DNA complex, and is 
competed by binding of TFIIA to the same complex (Meisterernst and Roeder 1991). 
NC2 is a heterodimer consisting of two subunits, NC2 and NC2, also called DRAP1 
and DR1, respectively, (Goppelt and Meisterernst 1996; Goppelt et al. 1996; 
Mermelstein et al. 1996) and inhibits transcription initiation by Pol II (Meisterernst and 
Roeder 1991; Inostroza et al. 1992; Albert et al. 2007; Schluesche et al. 2007). 
1.2 Transcription cofactor PC4 
PC4 was originally purified from the USA fraction as a positive general transcription 
cofactor that could increase GAL4-AH dependent transcription in conjunction with 
other general transcription factors (Kretzschmar et al. 1994). PC4 is composed of 127 
residues, with a so-called SEAC domain (serine/acidic residue-rich, spanning amino 
acids 7 to 22, aa 7-22) followed by a lysine-rich motif (aa 23-41) in the N-terminal 
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region and a DNA-binding region at the C-terminal domain (PC4-CTD, aa 63-127). A 
comparison of human, mouse, and rat homologues indicate that full-length PC4 is 
highly conserved (Figure 2). The yeast homolog SUB1 and PC4 are conserved in the 
PC4-CTD (Henry et al. 1996). PC4 not only facilitates Pol II-regulated transcription by 
interacting with the acidic activation domain of different activators and GTFs, but also 
plays a role in mRNA processing, viral DNA replication, DNA repair, and tumor 
repression (Kannan and Tainsky 1999). Apart from its role in Pol II transcription, SUB1 
was implicated in Pol III transcription by its interactions with components of the Pol III 
transcription system, and presence on Pol III-transcribed genes. 
1.2.1 Purification and cloning of PC4 (p15) and SUB1 
In 1994, the laboratories of Meisterernst and Roeder simultaneously purified a new 
transcription factor from the P11 0.85 M KCl (USA) fraction of HeLa cell nuclear 
extracts, called PC4 or p15, which is able to enhance activator-dependent transcription 
(Ge and Roeder 1994; Kretzschmar et al. 1994). PC4 (p15) turned out to be a novel 
cofactor with a smaller native size of 50-100 kDa on sizing columns. In contrast to 
TAFs, PC4 does not tightly associate with TFIID, and can be separated from it at 
moderate ionic strength. Subsequent to the purification of PC4,  
SUB1, the yeast homolog, was isolated as a suppressor of the cold sensitive TFIIB 
mutant and as a transcription stimulator by two different groups in 1996 (Henry et al. 
1996; Knaus et al. 1996). Its N-terminal third shows strong similarity to a 73-residue 
region encompassing the majority of the 127-amino acid mammalian co-activator PC4 
(48% identity, 70% similarity) (Figure 2).  
1.2.2 PC4 stimulates activator-dependent transcription and functions as a 
general repressor  
1.2.2.1 PC4 stimulates and represses basal transcription 
In the absence of a transcriptional activator, high concentrations of PC4 were 
demonstrated to inhibit basal transcription in a system reconstituted with only TBP, 
TFIIB, TFIIF and Pol II (Malik et al. 1998), while low concentrations stimulated 
transcription. When TFIID (TBP + TAFIIs) was substituted for TBP, or when the 
amounts of TFIID, TAFIIs, TFIIH, and a preassembled Pol II holoenzyme were 
increased, PC4 repression was alleviated (Malik et al. 1998; Wu and Chiang 1998; Wu 
et al. 1998). Kornberg and colleagues suggested that the yeast PC4 (SUB1/TSP1) 
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exerts positive effects on basal transcription in the presence of Mediator and TFIIH 
(Henry et al. 1996). In Schizosaccharomyces pombe, PC4 was shown to stimulate 
 
Figure 2: PC4-CTD is highly conserved from yeast to human. 
Homologs of PC4 are aligned using ClustalW. Organism names are indicated at left, and amino 
acid residues are indicated at right. Identical (*) and similar (.) residues are identified below. 
 
basal transcription from both TATA-containing and TATA-less promoters. The 
stimulation of basal transcription with TATA-containing templates is dependent on 
Mediator and TFIIA, but not TAFs (Contreras-Levicoy et al. 2008). Because human 
PC4 was observed to interact with multiple components of PIC, including TFIIA, 
TFIID,TFIIH, and Pol II (Ge and Roeder 1994; Kretzschmar et al. 1994; Kaiser et al. 
1995; Malik et al. 1998; Fukuda et al. 2004), the Sc. pombe PC4 was also tested for its 
interaction with GTFs and found to interact with TFIIA, TFIIB, TBP, TFIIH, and the Pol 
II holoenzyme (Contreras-Levicoy et al. 2008). The highly conserved interaction of 
PC4 and components of the transcription machinery play a critical role in regulating 
promoter activity. 
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1.2.2.2 PC4 functions as a coactivator 
1.2.2.2.1 PC4 stimulates activator-dependent transcription 
To elucidate the relationship between the various PC4 domains and their coactivator 
activities, many PC4-deletion mutants, including both N-terminal (p15[1-87], p15[22-
127]), and C-terminal (p15[88-127], p15[62-127]) mutants (Kretzschmar et al. 1994). 
These studies demonstrated that the amino-terminal portion is critical for PC4 cofactor 
activity and double-stranded DNA (dsDNA) binding, the C-terminal domain is important 
for single-stranded DNA (ssDNA) binding, and amino acids 61-87 are critical for 
interaction with both dsDNA and ssDNA (Kretzschmar et al. 1994). The relevance of 
dsDNA binding activity for cofactor activity was tested in a promoter-competent assay, 
which showed that PC4 binds to the promoter, thereby stabilizing the TFIID-TFIIA (DA) 
complex during PIC formation (Kaiser et al. 1995). Consequently, the activator and 
PC4 initiate stimulation of transcription during DA complex formation. Moreover, 
Roeder et al. (Malik et al. 1998) provided another dynamic model for PC4 coactivator 
function. In this model, activator-mediated recruitment of TFIIH to a TAF-containing 
PIC is stabilized by PC4 via its interaction with components of the transcription 
machinery. However, the resulting complex cannot initiate transcription unless a 
mechanism such as phosphorylation of PC4 by TAFII250 or TFIIH dislodges PC4 
and/or an ATP-hydrolysis-dependent TFIIH helicase activity frees the Pol II. 
1.2.2.2.2 Activators require PC4 to activate transcription 
In addition to its role as a coactivator with GAL-VP16 (Ge and Roeder 1994; 
Kretzschmar et al. 1994), PC4 was also shown to stimulate transcription in vitro with 
diverse other activators, including NF-B, Sp1 (Guermah et al. 1998), thyroid hormone 
receptor (Fondell et al. 1999), octamer transcription factor A-B (Luo et al. 1998), and 
BRCA-1 (Haile and Parvin 1999), presumably by facilitating assembly of the 
preinitiation complex through bridging between activators and the general 
transcriptional machinery (Ge and Roeder 1994; Kaiser et al. 1995).  
Alternatively, it was demonstrated that human PC4 stimulates activated transcription 
by GAL4-VP16 at the level of preinitiation complex assembly, promoter opening, 
promoter escape, elongation, and reinitiation (Fukuda et al. 2004). Further studies also 
demonstrated the importance of PC4 for transcriptional activation by AP-2 (Kannan 
and Tainsky 1999), hepatocyte nuclear factor IV- (HNF-4) (Guo et al. 2007), and the 
HIV transcriptional transactivator (Tat) (Holloway et al. 2000) in vivo. Among these 
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factors, PC4 was found to physically interact with Tat and AP-2 via its C-terminal 
domain (Zhong et al. 2003). All the activators regulated by PC4 were summarized in 
table 3. 
 
Table 3: Coactivators that cooperate with PC4  
Activators 
Physical 
interaction with 
the following 
domains of PC4 
Functional consequences References 
Ap-2 CTD domain 
PC4 is critical for AP-2 transcriptional 
interference by which ras transform cells, and 
PC4-expression ras cells were highly growth 
suppressed. 
(Kannan and 
Tainsky 1999; 
Zhong et al. 
2003) 
BRCA1 N/A 
PC4 facilitates transcriptional activation by GAL4-
BRCA1. 
(Haile and 
Parvin 1999) 
GAL4-AH N/A 
PC4 enhances transcription activated by GAL4-
AH. 
(Kretzschmar et 
al. 1994) 
GAL-VP16 
Coactivator 
domain (aa 22-91) 
PC4 facilitates the assembly of the preinitiation 
complex (PIC) and stimulates promoter escape in 
response to GAL-VP16. 
(Ge and Roeder 
1994; 
Kretzschmar et 
al. 1994; 
Fukuda et al. 
2004) 
HNF4 CTD domain 
The presence of the inflammatory-redox state 
enhances PC4-HNF4 binding to upregulate 
transcription of target hepatocyte genes, such as 
iNOS. 
(Guo et al. 
2007) 
OCA-B Full length 
PC4 as an essential component of USA acts 
synergistically with PC2, to support the function of 
Oct1/ OCA-B in a reconstituted transcription 
system. 
(Luo et al. 1998) 
Rel/NF-B 
and Sp1 
N/A 
PC4 together with PC2 could synergistically 
facilitate activation by both activators. 
(Guermah et al. 
1998) 
Tat Lysine-rich motif 
PC4 is involved in linking Tat to the basal 
transcription machinery and enhances Tat-
mediated activation. 
(Holloway et al. 
2000) 
Thyroid 
hormone 
receptor 
N/A 
PC4 and PC2 synergistically mediate thyroid 
receptor-dependent transcription activation in vitro 
system. 
(Fondell et al. 
1999) 
VP16 Full length 
PC4 markedly enhances activation by acidic 
activation domain of VP16. 
(Ge and Roeder 
1994)
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1.2.2.3 Structure analysis of PC4  
X-ray crystallography identified a novel dimeric fold located within the PC4-CTD 
(Figure 3), spanning aa 63-127 (Brandsen et al. 1997) that provides a novel binding 
motif for two antiparallel ssDNA strands and heteroduplex nucleotides. The affinity for 
ssDNA that can fold into two antiparallel strands is indeed very high, exceeding that for 
dsDNA at least 100 times (Werten et al. 1998a). The -sheets and loops that form the 
two quarterpipe structures are flexible in the absence of ssDNA, which is significantly 
reduced upon ssDNA binding (Werten et al. 1999). The evolutionary conservation 
suggests a critical role of the ssDNA fold in the cellular function of PC4. The ssDNA 
fold is composed of a ß-ridge region, two flanking antiparallel channels formed by the 
ß2 and ß3 strands, and a ß2-ß3 loop (Figure 3). It was expected that both Trp89 
 
Figure 3: Structure of PC4-CTD dimer. 
(A) Fold of the PC4-CTD dimer. Monomers of the PC4-CTD dimer were shown blue and pink. 
Indicated are the ß-ridge formed by residues 87-101(Brandsen et al. 1997). (B) Interaction 
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model of PC4-CTD with ssDNA (Werten and Moras 2006). (C) Interaction model of PC4-CTD 
with VP16 (an activator) (Jonker et al. 2005).  
 
(located in the -ridge) and the 2-3 loop (connecting -strands 2 and 3) would be 
particularly important for the interaction with ssDNA (Figure 3). A PC4 mutant, in which 
Trp89 was replaced by Ala (W89A), and a triple mutant, in which the Phe residue and 
both of the Lys residues of the 2-3-loop were replaced by Ala and Gly, respectively 
(F77A/K78G/K80G, 2-3), were constructed to study PC4 coactivator and repressor 
activity (Werten et al. 1998b). These mutants lost the ability to repress transcription. 
Combining these results with those of the N-terminal mutants depleted of PC4 cofactor 
function, leads to the conclusion that PC4 interaction with unpaired DNA during 
opening of the promoter is not required for its co-activator function in vitro. Its 
interaction with dsDNA may also provide a second mode of repression. Furthermore, 
PC4 at very low concentrations can antagonize binding of heteroduplex by Pol II. 
 
 
Figure 4: Model for the roles of PC4 in the regulation of transcription from non-
promoter and promoter regions.  
(A) PC4 binds to dsDNA and ssDNA regions and prevents the binding of Pol II to ssDNA 
regions by direct competition. PC4 bound to dsDNA regions may also serve as a reservoir for 
PC4 recruited to ssDNA regions. (B) PC4 binds dsDNA regions and prevents the binding of Pol 
II to DNA by restricting the formation of transient ssDNA regions. (C) The PIC (dotted line) 
containing TFIIH can initiate transcription from the promoter DNA that is bound by PC4. (D) The 
PIC, whose TFIIH activity is repressed, fails to initiate transcription from the promoter DNA that 
is bound by PC4 (Fukuda et al. 2003).  
 
This novel role of PC4 reveals a mechanism for repressing non-promoter regions and 
unpaired DNA generated by DNA damage. TFIIH-binding and PC4-CTD 
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phosphorylation might attenuate this inhibitory activity (Werten et al. 1998b). The 
mechanism for alleviating PC4-mediated transcription repression was investigated in 
more detail with purified recombinant protein (Fukuda et al. 2003). A transcription 
assay showed that PC4-repression was restored by adding TFIIH and ATP, which is 
required for ß- bond hydrolysis. The ERCC3 helicase activity, but not CDK7 kinase, 
counteracted PC4-regulated repression. In light of these studies, PC4 represses 
promoter-independent transcription in both ‘direct’ and ‘indirect’ ways (Figure 4). 
1.2.2.4 Phosphorylation of PC4 negatively regulates its coactivation 
function and DNA binding activities 
In the N-terminus region of PC4 there are two SEAC motifs (one major motif aa 7 to 21 
and one minor motif aa 50 to 63) flanking a lysine-rich region (aa 23-41). 
Phosphorylation of the SEAC domain inhibits the PC4-coactivation function (Ge et al. 
1994; Kretzschmar et al. 1994). Protein interaction studies (Ge et al. 1994) and in vitro 
transcription assays (Kretzschmar et al. 1994) demonstrated that only the 
nonphosphorylated form of PC4 stimulates TAF-dependent activator functions. Casein 
kinase II (CKII) and protein kinases phosphorylate PC4 in vitro, but in vivo, 
hyperphosphoration of PC4 is meditated mainly by CKII (Ge et al. 1994). 
Phosphorylated PC4 was also detected in PIC, and both TFIIH and TAFII250, the 
largest subunit of TFIID, can phosphorylate PC4 (Malik et al. 1998). PC4 also 
competitively inhibits the TFIIH-Cdk7 enzyme subcomplex-mediated phosphorylation 
of the Pol II CTD, but does not inhibit phosphorylation of other substrates of the same 
kinases. Phosphorylated PC4 is devoid of kinase inhibitory activity, and mutations in 
its lysine-rich domain abolish its inhibitory ability (Schang et al. 2000).  
As there are many serines in the N-terminal region to act as potential phosphorylation 
sites, gradual phosphorylation occurs and phosphorylation status differentially 
influences the various biochemical functions (Jonker et al. 2006). For example, ssDNA 
binding activity is slightly enhanced by phosphorylation of one serine residue without 
augmentation by further phosphorylation, whereas, dsDNA binding decreases with 
gradual phosphorylation, and the presence of at least two phosphoserines decreases 
DNA-unwinding activity and abrogates binding to the activator. Compared with 
negative regulation of PC4 activity by phosphorylation, acetylation positively stimulates 
PC4 DNA binding activity. It is reported that p300 can acetylate PC4 specifically, and 
that phosphorylation of PC4 by CKII inhibits the p300-mediated acetylation (Kumar et 
al. 2001).  
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1.2.3 PC4 and DPE, promoter escape  
A study of downstream promoter element (DPE)-dependent transcription 
demonstrated that PC4 and CKII were required to establish DPE-specific transcription 
(Lewis et al. 2005). However, in the same study, depletion of PC4 with an anti-PC4 
antibody in nuclear extracts increased spurious initiation rather than specific promoter-
dependent transcription. And a chromatin immunoprecipitation (ChIP) assay showed 
that PC4 and CKII were present in IRF-1 and TAF7 promoters. CKII was shown by the 
same group to eliminate DCE-dependent transcription and to phosphorylate the HMG 
box of TAF1, thereby converting TFIID from DCE-specific recognition to a DPE-
specific recognition function. However, as PC4 is also a popular target of CKII in vivo, 
does phosphorylated PC4 repress DPE-specific transcription?  
1.2.4 PC4 has a role in viral replication 
The trimeric, ssDNA-binding protein HSSB plays important roles in the replication of 
simian virus 40 (SV40) DNA (Matsumoto et al. 1990; Murakami et al. 1992). Because 
PC4 harbors ssDNA-binding activity, it can form a PC4-HSSB-ssDNA complex and 
replace HSSB for unwinding of the SV40 origin by T-antigen. PC4 has been shown to 
inhibit RNA primer synthesis and DNA elongation carried out by pol . By contrast, 
PC4 inhibits SV40 DNA replication in the presence of low concentrations of HSSB, but 
activates it under high HSSB concentrations (Pan et al. 1996). Another report also 
showed that PC4 functionally interacts with Rep in 293-31 cells to regulate adeno-
associated virus replication (Weger et al. 1999). 
1.2.5 PC4 participates in DNA repair process 
A study from Michael Volkert’s lab demonstrated that PC4 was also a suppressor of 
oxidative mutagenesis in E. coli and yeast, and that it could revert an oxidative mutate 
phenotype in a DNA repair-deficient E. coli strain, possibly by physically interacting 
with Rad2, the homolog of human endonuclease XPG that functions in multiple DNA 
repair pathways in mammals (Wang et al. 2004). This report implies that apart from 
the many different roles of PC4 described so far, PC4 may take part in the DNA repair 
process. Work on human and mouse cells in our laboratory showed that endogenous 
PC4 accumulates at DNA damage sites introduced by either chemical agents or laser 
microirradiation (Mortusewicz et al. 2008). In addition, rapid recruitment of PC4 to 
laser-induced DNA damage sites was independent of poly (ADP-ribosylation) and 
H2AX, but dependent on its single strand binding capacity. Therefore, PC4 might play 
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a role in the early response to DNA damage by recognizing ssDNA to facilitate or 
repress subsequent DNA repair steps. This repair role of PC4 was also confirmed by 
data showing that PC4 can activate nonhomologous end joining and double-strand 
break repair (Batta et al. 2009). 
1.2.6 PC4 and p53 
The highly abundant, non-histone, chromatin protein, HMGB-1, is reported to be a 
unique activator of p53-mediated DNA binding and transcription activation (Jayaraman 
et al. 1998). Likewise, it was shown that PC4, which displays significant functional 
homology to HMGB-1, enhanced the DNA binding of p53 to its cognate sites by direct 
interaction with p53 in vitro and in vivo (Banerjee et al. 2004). Furthermore, the same 
study showed that p53-dependent apoptosis was enhanced by PC4; thereby, 
establishing the first physiological role of PC4. On the other hand, they also reported 
that p53 regulated PC4 expression by directly binding to the PC4 promoter region. 
Further evidence of the relationship between p53 and PC4 was provided by showing 
that PC4 was over expressed in a p53-dependent way upon genotoxic insult (Kishore 
et al. 2007). The interaction of different PC4 truncation mutants with p53 implied that 
aa 62 to 87 of the PC4 DNA-binding domain were essential for p53 interaction and 
activation. Furthermore, this protein-protein interaction, together with PC4 DNA 
bending activity, is responsible for p53 activation. Phosphorylation of PC4 abolishes its 
ability to activate p53 binding to its cognate sites, whereas acetylation of PC4 
facilitates this function (Batta and Kundu 2007). Recently, it was shown by NMR 
spectroscopy that the p53 TAD domain interacts with the PC4 C-terminal DNA-binding 
domain, confirming that PC4 directly interacts with p53 (Rajagopalan et al. 2009). 
Taken together, these data suggest that p53 is a potential target gene of PC4; of note, 
however, these data were not confirmed independently, and they were not proven in 
mammalian model. 
1.2.7 Yeast SUB1  
1.2.7.1 Transcription functions of SUB1 
The yeast homologue of PC4, SUB1/TSP1, is not essential for cell growth on medium 
containing galactose or lactate when it’s coding sequence is entirely deleted, however, 
it is essential for viability in the presence of TFIIB mutations (Knaus et al. 1996). SUB1 
also functions as a coactivator for the GCN4 and HAP proteins in vivo and specifically 
inhibits the formation of TBP-TFIIB-promoter complexes in vitro (Knaus et al. 1996). 
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Phosphorylated form of SUB1/TSP1 does not bind to TFIIB and interacts less tightly 
with GAL4-VP16, and dephosphorylated recombinant SUB1/TSP1 binds strongly to 
single-strand DNA (Henry et al. 1996). Additionally, SUB1 was found to interact 
physically and genetically with the polyadenylation factor CstF64/Rna15p (in yeast) 
(Calvo and Manley 2001). Deletion and over-expression of SUB1 in yeast suppressed 
or enhanced, respectively, growth and termination defects in an Rna15 mutant strain, 
suggesting that transcription is linked to RNA polyadenylation and termination, and 
that PC4 has anti-termination activity. In yeast, in the presence of SSU72, another 
component of the cleavage/polyadenylation factor (CPF), SUB1 did not bind to the 
Pta1 of CPF, indicating that SUB1 plays a role in the 3’-end processing of RNA (Wu et 
al. 1999b; He et al. 2003). Furthermore, SUB1 and Rna15 are recruited to promoters 
and remain chromatin-associated during transcription elongation. Additionally, SUB1 
function is connected to Pol II CTD phosphorylation. By accumulating FCP1 
(phosphatase in yeast) to the CTD, PC4 dephosphorylates Pol II and facilitates 
elongation (Calvo and Manley 2005). 
1.2.7.2 SUB1 functions in Pol III transcription 
Apart from its role in Pol II transcription regulation, PC4 is also involved in Pol III 
transcription both in vitro and in vivo. In 1998, PC4 was found in the holo TFIIIC 
complex and to enhance interaction of TFIIIC with downstream promoters and 
termination sequences. Additionally, PC4 promoted multiple-round transcriptions by 
Pol III from preformed preinitiation complexes (Wang and Roeder 1998). Eleven years 
later, Manley’s group not only confirmed the function of PC4 (SUB1) in Pol III-
dependent transcription, but also showed the underlying mechanism (Rosonina et al. 
2009). They found that SUB1 rapidly associated with osmoresponse gene promoters 
upon osmotic shock. SUB1 was present at Pol III-transcribed genes, such as SNR52 
(snoRNA), SNR6 (U6 snRNA), SUP56 (tRNA), and 5S (rDNA) and at constitutively 
expressed Pol II-transcribed genes, such as RPP2B (ribosomal protein gene) and 
HHT1 (histone H3 gene), but was not detected at inactive genes. SUB1 deletion 
suppressed Pol II and Pol III recruitment to their transcribed genes without affecting 
TBP occupancy. During conditions of stress, such as exposure to NaCl, SUB1 was 
predominately recruited to stress response genes by temporarily evacuating 
constitutively transcribed Pol II and III genes due to reduced availability of the 
polymerases (Rosonina et al. 2009). Almost at the same time, Acker’s group 
confirmed the presence of SUB1 on all Pol III-transcribed genes by genome-wide 
mapping (Tavenet et al. 2009). They also reported that in a reconstituted Pol III 
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assembly of TFIIIC-TFIIIB-DNA through protein-protein interactions with basal factors -
Bdp1 (a component of TFIIIB) as well as with 138 and 95 (2 subunits of TFIIIC). 
Because Pol III transcription reinitiation accounts for a large number of noncoding 
RNAs, they tested the activity of SUB1 in transcription reinitiation. The data indicated 
that SUB1 played a critical role in stimulating transcription reinitiation. Although 
deletion of SUB1 in yeast did not affect the growth rates of exponentially growing cells 
or of steady state levels of Pol III, Pol III transcription was decreased and TFIIIB 
occupancy was reduced in Pol III-transcribed genes (Tavenet et al. 2009). Together, 
these two reports present a consistent issue: SUB1 directly regulate Pol III 
transcription. However, these two studies also present a contradictory issue: does 
SUB1 deletion affect TFIIIB occupancy at Pol III-transcribed genes? Therefore, further 
investigations are necessary to determine by which molecular mechanisms Pol III 
transcription is regulated by SUB1 under different conditions and whether PC4 is 
important for Pol III transcription in mammalian cells. 
1.3 Mouse embryonic stem cells: vehicles for creating mutant mice 
Two laboratories first succeeded in isolating the cell lines from the cultured early 
mouse embryos, that proved pluripotent (Evans and Kaufman 1981; Martin 1981). 
These cells, derived from the inner cell mass (ICM) of blastocysts, named embryonic 
stem (ES) cells, are able to generate all tissues including the germ line after 
microinjection into blastocysts, initially giving birth to chimeras. ES cells can be 
genetically modified in vitro via transfection with target vector carrying a mutation. As a 
consequence, mutant mouse models could be constructed. It is helpful if the genetic 
background of ES cells is different from the host blastocysts. Male ES cells are 
preferred because of the efficient incorporation of XY cells into XX host embryos. This 
causes phenotypic sex conversion to yield male animals. Generally, ES cells can be 
derived from 129/sv, C57BL/6J, Balb/c and so on. However, the ES cells from 129/sv 
strain proved to be efficient in germ line transmission, and hence are often used to 
produce knockout mice. 129/sv ES cells encode brown coat color because they are 
A/A (A is the gene affecting hair color.  An agouti mouse is described as ‘‘brownish-
gray’’ with alleles A/A. Non-agouti mice contain the alleles a/a.). The C57BL/6J host 
embryos give rise to completely plain black coat color because they are non-agouti 
(a/a). Hence, if the chimeras are male and mostly brown, the chances are good that 
the ES cells also generated germ line cells. To test the percentage of germ line 
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transmission, chimeras are bread to non-agouti mice (C57BL/6J), and agouti offspring 
(A/a) must arise from ES cell-derived gametes. 
ES cell-growth requires a monolayer of inactivated MEFs. These provide critical 
factors that promote self-renewal and suppress differentiation. In addition, Leukemia 
Inhibitory Factor (LIF) is needed to maintain mouse ES cells in a pluripotent state. LIF 
is a soluble glycoprotein of the interleukin (IL)-6 families of cytokines. It acts via a 
membrane bound gp130 signaling complex to regulate a variety of cell functions 
through signal transduction and activation of transcription (STAT) signaling.  
ES cells are different from embryonic carcinoma (EC) cells, which originate from 
malignant teratocarcinomas. EC cells have extensive differentiation potential leading 
to formation of three germ layers. But they showed chromosomal aberrations and 
could not form viable mice. Moreover, mouse embryonic germ (EG) cell lines, which 
are originated from primordial germ cells, unlike ES cells, retain the capacity to erase 
gene imprinting. Some experiments suggest that ES cells closely resemble cells from 
the primitive ectoderm, which are known as epiblast or embryonic ectoderm (Brook 
and Gardner 1997).  
1.3.1 Targeting constructs for the generation of knockout mice 
Targeting constructs carry homologous isogenic DNA (ideally between 5-8kb split 
between upstream and downstream arms), a positive selectable marker whose 
expression is driven by a promoter active in ES cells and a negative selectable marker 
to screen for recombination and against random integration events of the vector.  
1.3.1.1 Positive selection for vector incorporation 
Neomycin phosphotransferase (neo) gene expression cassette, which mediates 
resistance to G418, is often used to select ES cell clones carrying the targeting vector. 
Alternatively, are the puromycin resistance gene (puro), the hygromycin resistance 
gene (hygro) and the hypoxanthine phosphor-ribosyltransferase (hrpt). Problems could 
arise from the fact that the selectable marker gene with its associated promoter may 
influence the expression of neighboring genes, especially in multigene cluster (Pham 
et al. 1996). Secondly, presence of the resistant gene could affect the level of the gene 
targeted resulting a hypomorphic phenotype (Zhou et al. 2008). Hypomorphic alleles in 
the extreme situation may be lethal for the mutant mice. On the other hand such a 
scenario may be used for the biological analysis. To avoid the negative effect, the 
selectable marker can be removed by using the Cre/LoxP or FLP/FRT technology.  
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1.3.1.2 Negative selection against random integration events 
Random integration of the targeting vector usually occurs during positive selection. To 
select for the homologous recombination event, a negative selection is applied to 
remove ES cell clones that have randomly incorporated the targeting vector. The 
method of choice is expression of the herpes simplex virus (HSV) thymidine kinase (tk) 
gene. HSV-tk is usually positioned on the vector outside of the homology region. ES 
cells are then cultured with Ganciclovir. Cells expressing the tk gene become sensitive 
to drug treatment and will be eliminated. An alternative negative selection gene, 
diphtheria toxin A-chain (DT-A) which kills cells in the absence of drug addition can 
also be used. 
1.3.1.3 Reporters 
LacZ (ß-galactosidase gene from E.coli) and GFP (Green Fluorescent Protein gene) 
are used as reporters for gene expression and exon disruption. LacZ has been ideally 
used in gene trap construct as a tool to identify and disrupt active genes, for example 
via IRES (internal ribosome entry site) to be connected with a splice acceptor.  
1.3.1.4 Site specific recombinases 
Site-specific recombinases catalyze the recombination between two consensus DNA 
sequences. If these sites are designed in the target locus and the recombinases are 
expressed in the same cell, site-specific recombination may be induced resulting in 
gain function or loss of function. These strategies are standard tools for targeted 
mutations in cells and mice. For example, Cre recombinase of the bacteriophage P1 
and FLP recombinase from yeast (Saccharomyces cerevisia) are popular instruments 
in recombinant mouse technology. Both belong to the  integrase superfamily and 
share an overall structure of recognition sites in which an eight base pair (bp) 
asymmetric core sequence is flanked by two inverted or repeated 13bp palindromic 
sequences. The 34bp consensus recombination sites of Cre and FLP are called loxP 
and FRT respectively, and have a defined polarity. Consequently, the relative 
orientation of target sites with respect to one another determines the outcome of 
recombination: Cre and FLP recombinases excise the sequence between two directly 
repeated recombination sites. Two sites in opposing direction cause DNA inversion on 
chromosomes. Recombinase can also exchange chromosome area. Many variant 
targets sites for Cre and FLP were created, which include spacer variants and 
inverted-repeat variants. The mutation targeting sites for Cre and FLP could increase 
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the efficiency of recombination, and protect gene expression from excising by 
heterotypic target sites instead of homotypic. This strategy is the basis for RMCE 
(recombinase-mediated cassette exchange) and FLEx switch (invert the orientation of 
genes) (Bode et al. 2000; Schnutgen et al. 2003). Expression of recombinases may be 
regulated at the translation and transcription level. Furthermore, recombinase estrogen 
receptor fusion proteins have been created rendering the enzyme accessible to rapid 
induction by hormones. Relatedly, conditional expression of Cre under the Mx1 gene 
has been reported (Kuhn et al. 1995). And tetracycline response system could activate 
or repress recombinase expression to control the sites specific recombination.  
1.3.2 Constitutive knockout versus conditional knockout 
The conventional gene targeting strategy generates null allele in mice for the target 
gene. Usually, the genes as a whole or at least an essential part of it are removed. 
This procedure provides information about the earliest essential role of the target gene 
during development. To study the multiple roles of a target gene in different tissues at 
different development stages, conditionally switching on or off recombinase genes 
using tissue specific promoters has been employed. These methods provide means to 
bypass the early embryonic lethality. Conditional null alleles are usually generated by 
two loxP sites introduced in the same orientation into non-coding regions flanking the 
critical protein coding exons. Meanwhile, a conditional knockout can be converted to a 
constitutive knockout model, which is carried out by crossing with recombinase 
‘deleter’ mice, a strain that expresses the relevant recombinase in whole tissues 
including germ cells (Schwenk et al. 1995; Rodriguez et al. 2000).  Although the 
conditional knockout strategy is a better way to identify the gene function in vivo, a 
tissue-specifically expressed recombinase may not completely delete the target gene, 
which can compromise the analysis of the lose of function in the tissues. 
1.4 Mouse development 
1.4.1 Ovulation and fertilization 
Luteinizing hormone stimulates oocytes to undergo nuclear maturation by setting first 
meiotic division. After finishing the first meiosis and polar body formation, the oocytes 
are arrested at the metaphase of second meiosis (MII) and released from the ovary 
into oviduct for fertilization. Completion of second meiotic division and extrusion 
second polar body are triggered by fertilization, then female and male pronuclei form. 
When both pronuclei migrate to the center of zygote, visible nucleoli form and DNA 
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duplication starts. Fertilization also induces demethylation of DNA to erase epigenetic 
information for establishing a pluripotent state. 
1.4.2 Embryonic development 
Mouse embryogenesis is a coordinated process. Cleavage and blastulation is the first 
event, which is followed by implantation, gastrulation, organogenesis, and fetal growth. 
During this process, the embryo development can be staged according to the days 
post coitum (dpc). Since mating usually takes place around midnight during the dark 
cycle (7 pm to 5 am) (vaginal plugs were checked in the morning), at this point, the 
embryos are staged as half-day post coitum [(0.5 dpc, embryo stage (E0.5)]. There are 
further criteria to distinguish stages of embryo development. For example, cell and 
somite number are commonly used to classify stages. Different stages have specific 
characters. Briefly, at the 2-cell stage (1.5 dpc, E1.5), the zygotic genome is activated. 
Up to the early 8-cell stage (uncompacted morula, 2.5 dpc, E2.5), the blastomeres in 
an embryo are regarded as equipotent; as the compaction and cavitation proceed, a 
blastocyst is formed (3.5 dpc, E3.5, 16-40 cells); after hatching from the zona 
pellucida, the blastocyst is ready for implantation in the uterus (4.5 dpc, E4.5); with the 
implantation proceeding, trophoblast, primitive endoderm and ectoderm (epiblast) are 
formed (5.5 dpc, E5.5); at 6.5 dpc, gastrulation begins and results in the formation of a 
multilayered, three-chambered conceptus; amnion is formed at 7.5 dpc (E7.5); at 8.0 
dpc (E8.0), somites begin to develop until 11 dpc (E11.0); most  organs are generated 
till 14 dpc (E14.0); from 14 dpc to 19 dpc (E19.0), fetal growth is increased twice in 
size.  
During the early mouse embryo development, the cell growth in different stages is fast 
and not uniform. Prior to E6.5, the mean cell cycle time of mouse embryo is 11.5 and 
9.1 hours in E5.5 and E6.0, respectively. Once gastrulation starts at E6.5, the primitive 
streak is formed and the cell cycle is decreased to 4.4 hours. A region called 
‘proliferative zone’, constituting 10% of the whole epiblast, proliferates fast and the 
average cell cycle time is only 2 hours versus 6.5 hours for other epiblast regions. This 
short cell cycle time facilitates rapid increase of cell numbers during embryo 
gastrulation. 
1.4.3 Differentiation of tissue lineages in early embryo 
In the blastocyst stage, two distinct lineages are generated: the outer epithelial 
trophectoderm (TE) and inside inner cell mass (ICM) (Figure 5). After implantation, TE 
can develop into the mural trophectoderm and the polar trophectoderm. The mural 
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trophectoderm is derived from the cells surround the blastocyst cavity without 
contacting the ICM, while the polar trophectoderm is derived from cells in close 
proximity to the ICM. The mural trophectoderm differentiates into the post-mitotic 
primary trophoblast giant cells (TGCs), which carry up to a thousand copies haploid of 
DNA in one cell. Some TGCs migrate into the antimesometrial portion of the 
implantation chamber and surround the future parietal yolk sac. On the other hand, the 
polar trophectoderm spreads in several directions, and finally forms the 
extraembryonic ectoderm of pregastrula and ectoplacental cone. Cdx2, a homeobox 
transcription factor, is essential for maintaining trophectoderm identity, which is the 
precursor to all trophoblast cell subtypes (Kunath et al. 2004). FGF4 produced by ICM 
interacts with Fgfr2, which is the receptor of FGF4 and is specifically expressed in 
trophectoderm and extraembryonic ectoderm, to promote the trophoblast proliferation. 
This conclusion is based on FGF4 requirement for the establishment of trophoblast 
stem cells (TSCs) (Tanaka et al. 1998) from blastocysts or E6.5 extraembryonic 
ectoderm (Simmons and Cross 2005). At E6.5, TSCs potential is maintained in the 
extraembryonic ectoderm by FGF4 signaling pathway through Fgfr2 to sustain Err2, 
Eomes, and Cdx2 expression and suppress Mash2 expression. However, the TSCs 
potential will lose at approximately E8.5-E8.75, because of occlusion of the 
ectoplacental cavity. 
After formation of the trophectoderm lineage, another epithelial layer, primitive 
endoderm, appears on the free surface of ICM, which contacts with blastocyst cavity. 
In parallel, the remaining core of ICM organizes into primitive ectoderm, which is also 
known as the epiblast. Primitive endoderm gives rise to visceral endoderm and parietal 
endoderm during differentiation. The epiblast is pluripotent and gives rise to the 
embryonic ectoderm, definitive endoderm, embryonic mesoderm, and extraembryonic 
mesoderm (Figure 6). Oct4 is expressed in the epiblast cells in the blastocyst and in 
early gastrulation stages, but disappears as the definitive germ layers form. A tight 
control of Oct4 levels is important for cell fate allocation in blastocysts. For example, it 
was reported that depletion of Oct4 in ES cells resulted in differentiation of ES cells 
into trophectoderm, while two-fold increase in Oct4 expression causes ES cells to 
adopt a visceral endoderm and mesoderm fate (Niwa et al. 2000). 
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Figure 5: Differentiation of tissue lineage from early embryos.  
(A) The differentiation of trophectoderm (gray), ICM (blue), and primitive endoderm (brown) of 
E4.75 embryo to the extraembryonic and embryonic tissues of E7.5 embryo (germ layer tissues 
are color-coded, see key). (B) Colonies of embryonic and trophectodermal stem cells (white 
arrows) derived from the ICM and extraembryonic ectoderm, respectively (Loebel et al. 2003). 
 
 
Figure 6: Cell lineage relationships in the early mouse embryo (Lu et al. 2001). 
A 
B 
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1.4.4 Gastrulation 
Gastrulation is a pivotal step to generate a blueprint for the subsequent 
morphogenesis of the embryo. The characterization of gastrulation includes formation 
of the primitive streak, allocation of germ-layer precursors, and morphogenetic cells 
and tissue movement. The primitive streak is a prerequisite to set anterior-posterior 
axis for directing future embryo development. The formation of the germ layers 
requires movement of the progenitor cells from the epiblast through the primitive 
streak, to either emerge as a new mesoderm layer or be incorporated as definitive 
endoderm into the pre-existing visceral-endoderm layer. It has been reported that the 
deployment of different levels of nodal and WNT signaling in the primitive streak 
determine the formation of different population for mesoderm and endoderm cells 
(Tam and Loebel 2007). In addition, TGFB-related factor, activin A, can also support 
endodermal marker gene activation. It is further demonstrated that interactions 
between extra-embryonic and embryonic tissues are crucial for lineage specification 
and embryonic patterning to build the mouse gastrula, and these interactions are 
mediated by WNT and TGF signaling (Tam et al. 2006). 
1.5 Aims and scope of this work 
The objective of this work was to characterize the in vivo function of transcription 
cofactor PC4. To address this question, a conditional PC4 mouse model was 
generated. From this mouse strain, a null functional PC4 mouse strain was derived to 
investigate its generic role in all tissues. Furthermore, in order to disclose the 
underlying mechanism of the phenotype, PC4 knockout embryonic stem cell lines 
were derived as a cellular model.  
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and biochemicals 
Acetic Acid (analytical grade, 100%) Roth 
Acrylamide solution 30% (Rotiphorese Gel A) Roth 
Agarose Roth 
Ammonium persulfate (APS) Merck, Roth 
Ammonium sulphate Merck 
Aprotinin Sigma 
Ampicillin Roth 
Bacto Agar Difco 
Bacto Trypton Difco 
Bacto Yeast Extract Difco 
Benzamidin Sigma 
Bisacrylamide solution 2% (Rotiphorese Gel B) Roth 
Boric Acid Roth 
Bradford reagent Bio-Rad 
Bromophenol Blue Sigma 
Bovine Serum Albumin (BSA) (10 mg/ml) NEB 
Colcemid Sigma 
Coomassie brilliant blue R-250 Sigma 
DAPI (4’,6-diamidino-2-phenylindole) Sigma 
Denhardt’s Invitrogen 
Dextransulphate Amersham  
Diethylpyrocarbonate (DEPC) Sigma             
Dimethylsulfoxide (DMSO) (cell culture grade, 99.7%) Sigma 
Dithiothreitol (DTT) Roth 
DMEM medium Gibco 
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dNTPs MBI, Roche 
Ethanol (EtOH, analytical grade, 99.8%) Merck 
Ethidium bromide (10 mg/mL) Sigma 
Ethylendiamintetraacetate disodium salt (EDTA) Merck 
Ethylene Glycol Tetraacetic acid (EGTA) Merck 
Fetal Bovine Serum (FBS) Invitrogen 
Formamide Fluka 
Gancyclovir Sigma 
Gelatin solution Sigma 
Geneticin G-418 sulphate PAA 
Glucose Merck 
Glycerol (analytical grade, 99.5%) Roth 
Glycine Roth 
Hepes Biomol 
Histogel mounting medium Linaris 
Isopropanol Merck 
Leupeptin Roche 
Leukaemia inhibitory factor (LIF) ESGRO Chemicon  
International                            
Mineral oil Sigma 
Mitomycin C Sigma 
Magnesiumchloride Merck 
2-Mercaptoethanol Invitrogen 
Methanol (analytical grade, 99.9%) Merck, Roth 
Milk powder Roth 
N-Lauroylsarcosine Sigma 
Nocodazole Sigma 
NP40 (IGEPAL CA630) Sigma 
Paraffin Fisher Scientific 
Paraformaldehyde (PFA) Fluka 
Penicillin-Streptomycin Invitrogen 
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Pepstatin Sigma 
Phenol Clorophorm Isoamyl alcohol 25/24/1 Roth 
Phenylmethylsulphonylfluoride (PMSF) (biochemistry grade, 
99%) 
Roth 
Polyvinylpyrrolidone Sigma 
Ponceau S Sigma 
Potassium chloride Sigma 
Potassium hydroxide Roth 
Sodium azide Sigma 
Sodium carbonate Merck 
Sodium chloride Merck, Roth 
Sodium citrate Merck 
Sodiumdodecylsulphate (SDS) Merck, Roth 
Sodium hydroxide Merck 
Spermidine Sigma 
Sucrose Roth 
Tetramethylethylendiamine (TEMED) Sigma, Roth 
Top agar Sigma 
Tris(hydroxidmethyl)-aminomethan (Tris) Sigma 
Triton X-100 Sigma 
Trypsin-EDTA (0.05%) Invitrogen 
Trypsin (0.25%) Invitrogen 
TWEEN 20 Sigma 
Xylene Merck 
 
2.1.2 Additional material 
Disposable plastic material Greiner, Nunc,Falcon 
DNA maxi and midi preps kit Qiagen, NucleoBond 
ECL detection system Perkin Elmer 
Film X-OMAT BioMax Kodak 
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Megaprime DNA labelling system Kit Amersham 
Membrane Hybond-N Amersham 
MicroSpin colums G25 Amersham 
Miniprep Kit Amersham 
Nitrocellulose membrane Bio-Rad 
Power SYBR Green PCR Kit Applied Biosystem 
RNeasy Kit Qiagen  
Sterile flter (0.22/0.45 μm) Roth 
ThermoScript™ RT-PCR system Kit Invitrogen 
Whatman 3MM Paper Whatman 
 
2.1.3 Instruments 
Acrylamide gel electrophoresis Bio-Rad 
Agarose gel electrophoresis Bio-Rad 
Autoradiography cassette Amersham, Kodak 
Camera C-5060, wide zooms, 
Olympus 
Centrifuges Avanti, Beckman; Multifuge 
3SR+, Heraeus; Centrifuge 
5418, 5415R, Eppendorf 
Confocal light microscope TCS SP2 Leica 
Developing machine Curix60 Agfa 
Electroblot, semi-dry Bio-Rad 
Electroporator Gene Pulser II Bio-Rad 
Geiger counter LB122 Berthold 
Heating block Eppendorf 
Homogenizer Douncer, Wheaton 
Incubator WJ311, Forma Scientific; 
Unequip, Unitherm; B6200, 
Heraeus; MCO-18AIC, 
SANYO 
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Inverted microscope SZ61, Olympus; ECLIPSE 
TE-2000U, Nikon; Axiovert 
200 M, Zeiss; Light 
microscope Axiovert 25, Zeiss 
NanoDrop spetrophotometer Thermo Fisher Scientific 
PCR-Thermocycler GeneAmp 5700 Applied Biosystem 
StepOnePlus™ Real-Time PCR System Applied Biosystem 
Thermomixer compact Eppendorf  
pH-Meter Calimatic 760, Knick 
Photometer GeneQuant Pro Amersham 
Rotors JA10, JA25-50, SW41, 
SW28,Beckman 
UV–Illuminator Bachofer (254 nm, 366 nm) 
 
2.1.4 General buffers 
LB medium (for 1 L):  
10 g Trypton 
5 g Yeast extract  
5 g NaCl  
To prepare LB-agar plates add 15 g top agar to 1 L of LB medium. Autoclave. 
6x SDS loading buffer: 
0.35 M Tris/HCl pH 6.8  
0.12 mg/ml Bromphenol blue 
10% (w/v) SDS  
30% (v/v) Glycerol 
50 mM DTT 
20x SSC (for 2 L): 
350 g NaCl  
176 g Sodium Citrate 
Adjust to pH 7.0 with NaOH. 
50x TAE (for 1 L): 
242 g Tris  
57.1 ml Glacial Acetic Acid  
100 ml 0.5M EDTA, pH 8.0. 
0.5 M EDTA (pH 8.0, for 1 L): 
86.1 g EDTA  
Adjust to pH 8.0 with NaOH before adding dH2O to 1 L. 
10x TBE (for 5 L): 
275 g Boric Acid  
46.5 g EDTA  
540 g Tris. 
10x TBS (for 1 L): 
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24.2 g Tris  
80 g NaCl  
2 g KCl. Adjust pH to 7.6 with HCl. 
1x TBST (for 1 L): 
100 ml 10x TBS  
2 ml 10% (v/v) Tween-20 
10% (v/v) Tween 20 (for 50 ml): 
5 ml Tween 20 
45 ml H2O 
50 μl 0.5 M EDTA, pH 8.0 
1x TE: 
10 mM Tris/HCl pH 7.5 
1 mM EDTA pH 8.0 
5x Western blot transfer buffer (for 1 L): 
72 g Glycine 
15 g Tris 
1x Western blot transfer buffer (for 1 L): 
200 ml 5x Western blot transfer buffer 
200 ml Methanol 
600 ml dH2O 
10x TGS (for 1 L): 
30.2 g Tris  
148 g Glycine 
10 g SDS 
PBS (phosphate-buffered saline): 
137 mM NaCl 
2.7 mM KCl 
4.3 mM Na2HPO2·2H2O 
1.4 mM KH2PO4 
20x SSC (for 2 L): 
350 g NaCl  
176 g Sodium Citrate  
Adjust to pH 7.0 with NaOH. 
Denaturation buffer for Southern blot: 
0.5 M NaOH 
1.5 M NaCl 
Neutralization buffer for Southern blot: 
0.5 M Tris/HCl, pH 7.4 
1.5 M NaCl 
Hybridization buffer for Southern blot (for 150 ml): 
15 g Dextransulphate (Amersham Biosciences, Cat. No. 17-0340-01)  
resolve Dextransulphate in dH2O  in a final volume of 30 ml at 80°C on a stirrer 
72 ml Formamide (Fluka, Cat. No. 47670) 
36 ml 20x SSC 
1.5 ml 1 M Tris/HCl, pH 7.5 
15 ml 10% (w/v) SDS 
3 ml 50x Denhardt’s solution (Invitrogen, Cat. No. 750018) 
Proteinase K lysis buffer: 
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10 mM NaCl  
10 mM Tris/HCl pH 7.5  
10 mM EDTA  
0.5% (w/v) N-Lauroylsarcosine  
0.2 mg/ml Proteinase K freshly added. 
ES cells lysis buffer: 
10 mM NaCl 
10 mM Tris/HCl pH 7.5 
10 mM EDTA pH 8.0 
1 mg/ml Proteinase K freshly added. 
Tail lysis buffer: 
100 mM Tris/HCl pH 8.5  
5 mM EDTA  
0.2% (w/v) SDS  
200 mM NaCl 
200 μg/ml Proteinase K and 0.5 mg/ml RNase A (Fluka, Cat. No. 83832) freshly 
added. 
 
Oocyte lysis buffer: 
10 mM Tris/HCl pH7.8 
17 μM SDS    
150 μg/ml Proteinase K freshly added. 
 
 
2.1.5 Enzymes 
DNase (RNase-free) Qiagen 
Proteinase K (PCR grade) Roche 
Restriction enzymes NEB or Fermentas 
RNase A (molecular biology grade) Sigma 
Taq polymerase Fermentas, Invitrogen 
 
2.1.6 Antibodies 
Table 4: Primary antibodies used in this work 
 
PRIMARY 
ANTIBODY 
ORIGIN PROVIDER DILUTION WB DILUTION IF 
PC4 (SA2249) Rabbit Eurogentec 1:500 1:400 
-tubulin Mouse Sigma 1:20000  
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Polymerase II (N-20,sc-
899) 
Rabbit Santa Cruz 1:1000  
p53 (sc-6243) Rabbit Santa Cruz 1:1000  
p53 (phosphoS15) 
(ab1431) 
Rabbit abcam 1:1000  
NC2 (4G7) Rat E. Kremmer 1:10  
 
 
Table 5: Secondary antibodies used in this work 
 
SECONDARY 
ANTIBODY 
PROVIDER DILUTION WB DILUTION IF 
Anti Rabbit Promega 1:5000  
Anti Rat Promega 1:4000  
Anti Mouse Promega 1:5000  
Anti-Rabbit-Cy3 Dianova  1:500 
Anti-rabbit Rhodamine 
Red-X 
Jackson 
ImmunoResearch 
 1:100 
 
 
2.1.7 List of plasmids 
Table 6: Plasmids used in this work 
 
PLASMID ID 
PARENTAL 
PLASMID 
DESCRIPTION 
CLONED 
BY 
USED FOR 
pWR1 pBluescriptSKII 
mPC4 exon 1-intron 1 
(587bp) 
Wera Roth 
Preparation for 
probe A used 
for Southern 
blot 
pWR3 pBluescriptSKII mPC4 intron 3 (541bp) Wera Roth 
Preparation for 
probe C used 
for Southern 
blot 
pWR5 pBluescriptSKII 
mPC4 intron 5 downstream 
(500bp) 
Wera Roth 
Preparation for 
probe B used 
for Southern 
blot 
pWR11 pBluescriptSKII+ 
PC4 conditional targeting 
construct 
Gene Bridges 
Generation of 
PC4 conditional  
knockout mice 
pWR-12 pEGFP-C1 EGFP vector Clonetech Rescue of PC4 
knockout in 
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mouse ES cells 
pWR-23 pEGFP-C1 human PC4 1-127 Wera Roth 
Rescue of PC4 
knockout in 
mouse ES cells  
pNL-4 pMSCV Cassette A 
Vigo 
Heissmeyer 
Knockdown of 
PC4 in MEFs 
pNL-5 pMSCV Cre recombinase gene 
Vigo 
Heissmeyer 
Knockdown of 
PC4 in MEFs 
pNL-6 pEco-pac gag/pol/env  insertion 
Vigo 
Heissmeyer 
Knockdown of 
PC4 in MEFs 
 
2.1.8 List of oligonucleotides 
Table 7: Oligonucleotides used in this work 
 
OLIGO ID SEQUENCE 5’–> 3’ GENERAL USE 
oWR1 
CGGGATCCATCACATTGAATGCCAGTTT
GG 
PCR cloning for generation of Southern 
blot probe A  
oWR2 
CGGAATTCTAACTCACATTGAGGGGACC
AG 
PCR cloning for generation of Southern 
blot probe A  
oWR5 
CGGGATCCATTCCTCAAGAGCAGAGGCT
GT 
PCR cloning for generation of Southern 
blot probe C 
oWR6 
CCATCGATGGTTAGGACACCTGGCCTTG
TC 
PCR cloning for generation of Southern 
blot probe C 
oWR9 
CGGGATCCATGAGATCTGCCGTCTGCTA
CC 
PCR cloning for generation of Southern 
blot probe B 
oWR10 
CGGAATTCTAGGAGAATCATCTTGCCTG
CT 
PCR cloning for generation of Southern 
blot probe B 
siRNA-PC4-NL 
AAGACAGGUGAGACUUCGAGA (target 
sequence) 
Knockdown of human PC4 in HeLa and 
A549 cells 
siRNA-PC4-WR 
GCAAAGUGCUAAUUGAUAUU (target 
sequence) 
Knockdown of human PC4 in HeLa cells 
siRNA-PC4-TK 
ACAGAGCAGCAGCAGCAGA (target 
sequence) 
Knockdown of human PC4 in HeLa and 
A549 cells 
mouse 
scrambled 
siPC4 
AAGCCUGGUGAGACUUCUAGA (target 
sequence) 
“scrambled” non-silencing control siRNA 
for knocking down PC4 in human cells 
scrambled 
siPC4 
GCATAGTAGCAATAGAGTT 
“scrambled” non-silencing control siRNA 
for knocking down PC4 in human cells 
oWR77 TGTCAGTGTTCGGGACTTCA 
Genotyping conditional PC4 knockout 
mice offspring with PCR 
oWR78 TGACTAGGGGAGGAGTGGAA 
Genotyping conditional PC4 knockout 
mice offspring with PCR 
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oWR79 CAACCAAGTAAGGCCAATCC 
Genotyping conditional PC4 knockout 
mice offspring  
oWR80 GCCGCATAACTTCGTATAGCA 
Genotyping conditional PC4 knockout 
mice offspring with PCR  
oWR81 GCTTTTGCTGCCTTCAGATT 
Genotyping conditional PC4 knockout 
mice offspring with PCR 
oWR82 TTTGGGCTGCATTCTTAATTC 
Genotyping conditional PC4 knockout 
mice offspring with PCR 
oWR83 TGTGGCTTGAGCTTCTGAAA 
Genotyping conditional PC4 knockout 
mice offspring with PCR 
oNL1 GCCTAATCTGCCTAGGAACTAG 
Genotyping conditional PC4 knockout 
mice offspring with PCR 
oNL2 CGCATAACCAGTGAAACAGCAT Genotyping Cre transgene 
oNL3 GAAAGTCGAGTAGGCGTGTACG Genotyping Cre transgene 
oNL7 GACAAGCGTTAGTAGGCACAT Genotyping FLP transgene 
oNL8 GAGAAGAACGGCATAGTGCGT Genotyping FLP transgene 
oNL36 TTCAAGGCAAGGCAGAGAAT 
Genotyping of PC4
+/-
 mice embryos  
with nested PCR  
oNL37 CCCCCTGAGGTAGTTGGATT 
Genotyping of PC4
+/-
 mice embryos  
with nested PCR 
oNL38 ACTGGGCAAAGCACCAATAC 
Genotyping of PC4
+/-
 mice embryos  
with nested PCR 
mPC4F-101 TGATTCGGACAGCGAAGTTG Mouse qRT-PCR (for gene PC4) 
mPC4R-289 TTGAAGTCCCGAACACTGAC Mouse qRT-PCR (for gene PC4) 
mP53F1 GTCACAGCACATGACGGAGG Mouse qRT-PCR (for gene p53) 
mp53R1 TCTTCCAGATGCTCGGGATAC Mouse qRT-PCR (for gene p53) 
mP21F1 CCTGGTGATGTCCGACCTG Mouse qRT-PCR (for gene p21) 
mP21R1 CCATGAGCGCATCGCAATC Mouse qRT-PCR (for gene p21) 
mBaxF1 TGAAGACAGGGGCCTTTTTG Mouse qRT-PCR (for gene Bax) 
mBaxR1 AATTCGCCGGAGACACTCG Mouse qRT-PCR (for gene Bax) 
m-Actin-F GACGGCCAGGTCATCACTATTG Mouse qRT-PCR (for gene -Actin) 
m -Actin-R TACGGATGTCAACGTCACACTTCA Mouse qRT-PCR (for gene -Actin) 
m18s-R GCAGCAACTTTAATATACGCTATTGG Mouse qRT-PCR (for gene 18S) 
m18s-F GAGGCCCCGTAATTGGAATGAG Mouse qRT-PCR (for gene 18S) 
m5S-F GCCATACCACCCTGAACG Mouse qRT-PCR (for gene 5S) 
m5S-R AGCCTACAGCACCCGGTATT Mouse qRT-PCR (for gene 5S) 
m5.8s-F CTCTTAGCGGTGGATCACTC Mouse qRT-PCR (for gene 5.8S) 
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m5.8s-R GATGATCAATGTGTCCTGCAA Mouse qRT-PCR (for gene 5.8S) 
m28s-F2 CAGGGGAATCCGACTGTTTA Mouse qRT-PCR (for gene 28S) 
m28s-R2 ATGACGAGGCATTTGGCTAC Mouse qRT-PCR (for gene 28S) 
U6 snRNA-F GCTCGCTTCGGCAGCACATATAC Mouse qRT-PCR (for gene U6 snRNA) 
U6 snRNA-R TATCGAACGCTTCACGAATTTGCG Mouse qRT-PCR (for gene U6 snRNA) 
7SKRNA-F GACATCTGTCACCCCATTGA Mouse qRT-PCR (for gene 7SK) 
7SKRNA-R GCGCAGCTACTCGTATACCC Mouse qRT-PCR (for gene 7SK) 
mCcne1-F GTGGCTCCGACCTTTCAGTC Mouse qRT-PCR (for gene Ccne1) 
mCcne1-R CACAGTCTTGTCAATCTTGGCA Mouse qRT-PCR (for gene Ccne1) 
mCcna2-F GCCTTCACCATTCATGTGGAT Mouse qRT-PCR (for gene Ccna2) 
mCcna2-R TTGCTGCGGGTAAAGAGACAG Mouse qRT-PCR (for gene Ccna2) 
mCcnb1-F AAGGTGCCTGTGTGTGAACC Mouse qRT-PCR (for gene Ccnb1) 
mCcnb1-R GTCAGCCCCATCATCTGCG Mouse qRT-PCR (for gene Ccnb1) 
mCcnd1-F GCGTACCCTGACACCAATCTC Mouse qRT-PCR (for gene Ccnd1) 
mCcnd1-R CTCCTCTTCGCACTTCTGCTC Mouse qRT-PCR (for gene Ccnd1) 
mCDK2-F CCTGCTTATCAATGCAGAGGG Mouse qRT-PCR (for gene CDK2) 
mCDK2-R TGCGGGTCACCATTTCAGC Mouse qRT-PCR (for gene CDK2) 
mOct4-F TGAGAACCTTCAGGAGATATGCAA Mouse qRT-PCR (for gene Oct4) 
mOct4-R CTCAATGCTAGTTCGCTTTCTCTTC Mouse qRT-PCR (for gene Oct4) 
mNanog-F TCTTCCTGGTCCCCACAGTTT Mouse qRT-PCR (for gene Nanog) 
mNanog-R GCAAGAATAGTTCTCGGGATGAA Mouse qRT-PCR (for gene Nanog) 
mDppa3-F GACCCAATGAAGGACCCTGAA Mouse qRT-PCR (for gene Dppa3) 
mDppa3-R GCTTGACACCGGGGTTTAG Mouse qRT-PCR (for gene Dppa3) 
mFgf17-F GCTGCCTAACCTTACCCTGTG Mouse qRT-PCR (for gene Fgf17) 
mFgf17-R CCTGGTCCCTCACGTACTG Mouse qRT-PCR (for gene Fgf17) 
mRbp1-F CTGAGCAATGAGAATTTCGAGGA Mouse qRT-PCR  (for gene Rbp1) 
mRbp1-R GCGGTCGTCTATGCCTGTC Mouse qRT-PCR (for gene Rbp1) 
mGng3-F GCACTATGAGTATTGGTCAAGCA Mouse qRT-PCR (for gene Gng3) 
mGng3-R GTGGGCATCACAGTATGTCATC Mouse qRT-PCR (for gene Gng3) 
mSfmbt2-F AAGATAACCGGCTCAGCAAATG Mouse qRT-PCR (for gene Sfmbt2) 
mSfmbt2-R TCTCTTCCAAATAGTCTCCCCAG Mouse qRT-PCR (for gene Sfmbt2) 
mRragd-F CTGTTTGACGTGGTCAGTAAGAT Mouse qRT-PCR (for gene Rragd) 
mRragd-R GTTGAGTCCTTGTCATACGGG Mouse qRT-PCR (for gene Rragd) 
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mTdrd12-F GGTGCTGAAGATTGAAGATCCA Mouse qRT-PCR (for gene Tdrd12) 
mTdrd12-R CGTCCTGACACATGCTGTTATAG Mouse qRT-PCR (for gene Tdrd12) 
mNeurod1-F ATGACCAAATCATACAGCGAGAG Mouse qRT-PCR (for gene Neurod1) 
mNeurod1-R TCTGCCTCGTGTTCCTCGT Mouse qRT-PCR (for gene Neurod1) 
mDdit4l-F CGGCCAGCATTTCAGAGTTG Mouse qRT-PCR (for gene Ddit4l) 
mDdit4l-R CAGGGACCAAGACCTTAGAGC Mouse qRT-PCR (for gene Ddit4l) 
mRb1-F TGCATCTTTATCGCAGCAGTT Mouse qRT-PCR (for gene Rb1) 
mRb1-R GTTCACACGTCCGTTCTAATTTG Mouse qRT-PCR (for gene Rb1) 
mPerp-F ATCGCCTTCGACATCATCGC Mouse qRT-PCR (for gene Perp) 
mPerp-R CCCCATGCGTACTCCATGAG Mouse qRT-PCR (for gene Perp) 
mPlk2-F CCTGCGGACTATCACCTACCA Mouse qRT-PCR (for gene Plk2) 
mPlk2-R CTGCCCATCTTCAGAAGGCT Mouse qRT-PCR (for gene Plk2) 
mPhlda1-F GGGCTACTGCTCATACCGC Mouse qRT-PCR (for gene Phlda1) 
mPhlda1-R AAAAGTGCAATTCCTTCAGCTTG Mouse qRT-PCR (for gene Phlda1) 
mFgf5-F CAGATCTACCCGGATGGCAAAG Mouse qRT-PCR for EBs (for gene Fgf5) 
mFgf5-R GCGGACGCATAGGTATTATAGCTG Mouse qRT-PCR for EBs (for gene Fgf5) 
mOtx2-F AGGAGCTGATGCGCCACCTC 
Mouse qRT-PCR for EBs (for gene 
Otx2) 
mOtx2-R GTAGCCCAGGGAGGGATGCA 
Mouse qRT-PCR for EBs (for gene 
Otx2) 
mNestin-F ACCTCAAGATGTCCCTTAGTCTGG 
Mouse qRT-PCR for EBs (for gene 
Nestin) 
mNestin-R GGTGCTGGTCCTCTGGTATCC 
Mouse qRT-PCR for EBs (for gene 
Nestin) 
mT-F TGAGGAGATTACAGCCCTTAAA Mouse qRT-PCR for EBs (for gene T) 
mT-R GGTTCCTTAGAGCTGGGTAC Mouse qRT-PCR for EBs (for gene T) 
mFgf8-F TCATTGTGGAGACCGATACTT Mouse qRT-PCR for EBs (for gene Fgf8) 
mFgf8-R CAGCACGATCTCTGTGAATAC Mouse qRT-PCR for EBs (for gene Fgf8) 
mEvx1-F ACAGGGAGAACTACGTTTCAA 
Mouse qRT-PCR for EBs (for gene 
Evx1) 
mEvx1-R GTGGCTCATCATGTAGGTGTA 
Mouse qRT-PCR for EBs (for gene 
Evx1) 
mWnt3-F GGGGCGTATTCAAGTAGCTG 
Mouse qRT-PCR for EBs (for gene 
Wnt3) 
mWnt3-R GTAGGGACCTCCCATTGGAT 
Mouse qRT-PCR for EBs (for gene 
Wnt3) 
mHnf4-F TGACAATGAATATGCCTGCCTCAA 
Mouse qRT-PCR for EBs (for gene 
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Hnf4) 
mHnf4-R CAAAGCGGCCCCGAGAGT Mouse qRT-PCR for EBs (for gene 
Hnf4) 
mSox17-F CCATTTAGTGAAGAAACTGAAATATGGC 
Mouse qRT-PCR for EBs (for gene 
Sox17) 
mSox17-R ATTCTCTTGATAGATACTTTGGGAGGAGT 
Mouse qRT-PCR for EBs (for gene 
Sox17) 
mGata4-F CCTGGAAGACACCCCAATCTC 
Mouse qRT-PCR for EBs (for gene 
Gata4) 
mGata4-R AGGTAGTGTCCCGTCCCATCT 
Mouse qRT-PCR for EBs (for gene 
Gata4) 
mGluR6-F GCTGTTCAGTCCATCTGCAA 
Mouse RT-PCR for EBs (for gene 
GluR6) 
mGluR6-R TCCACATCAAGAGCGAAGAG 
Mouse RT-PCR for EBs (for gene 
GluR6) 
mHNF3-F AGAAGCAACTGGCACTGAAGGA Mouse RT-PCR for EBs (for gene 
HNF3) 
mHNF3-R GTAGTGCATGACCTGTTCGTAG Mouse RT-PCR for EBs (for gene 
HNF3) 
m-Cardiac 
myosin-F 
GGCACAGAAGATGCTGACAA 
Mouse RT-PCR for EBs (for gene -
Cardiac myosin) 
m-Cardiac 
myosin-R 
CGAACATGTGGTGGTTGAAG 
Mouse RT-PCR for EBs (for gene -
Cardiac myosin) 
mH1-F CTCAAGGAGACCTTTGCTCA Mouse RT-PCR for EBs (for gene H1) 
mH1-R AGTCCCCATGGAGTCAAAGA Mouse RT-PCR for EBs (for gene H1) 
m-Fetoprotein-
F 
AGGAGGAGTGCTTCCAGACA 
Mouse RT-PCR for EBs (for gene -
Fetoprotein) 
m-Fetoprotein-
R 
TGCGTGAATTATGCAGAAGC 
Mouse RT-PCR for EBs (for gene -
Fetoprotein) 
 
The oligos used as RT-PCR and qRT-PCR are described as “m (mouse) gene name-F or R (F: forward 
primer, R: reverse primer)”. 
 
2.2 Methods 
2.2.1 Molecular Biology 
2.2.1.1 Genomic DNA extraction 
From 96-well plates: Genomic DNA was extracted from 96-well plates on which 
transfected TBV2 ES cells were grown to confluency. Cells were washed twice with 
100 μl PBS and incubated in 50 μl proteinase K lysis buffer overnight at 55°C in a 
Methods                                                                                                                        38 
 

humid chamber. On the next day, 100 μl cold NaCl/EtOH mixture (150 μl of 5 M NaCl 
was added in 10 ml EtOH) was added drop-wise to each well. To remove the buffer, 
the plate was gently inverted and drained on a paper towel. The cells were washed 
three times with 200 μl of 70% (v/v) EtOH. The DNA was air-dried at room temperature 
and resuspended in 50 μl H2O.  
Genomic DNA was subjected to restriction enzyme digestion. For each reaction, 50 μl 
of genomic DNA was used in a 60 μl total volume with the following components: 
1 mM                  Spermidine 
1 mM                  DTT 
100 μg/ml           BSA (NEB) 
50 μg/ml             RNase A 
1x                       Reaction buffer (NEB) 
50 U XbaI (20 U/μl, NEB), or KpnI (50 U/μl, NEB) or EcoRV (20 U/μl, NEB) 
 
Digestion was carried out overnight at 37°C. The plates were stored at -20°C or 
directly used for Southern blot analysis.  
From expanded candidate clone cells: Genomic DNA was extracted from expanded 
candidate ES clones to confirm their genotype. Cells were grown on gelatin-coated 6-
cm cell culture dish until confluence was reached and then trypsinized and pelleted. 
The pellets were washed with PBS, and the cells were resuspended in 250 μl of ES 
cell lysis buffer and incubated overnight at 56°C. Lysates were mixed with 800 μl 
Phenol/Clorophorm/Isoamil alcohol (PCI, Roth). After centrifugation (Eppendorf 5418, 
13000 rpm, room temperature, 5 minutes), the aqueous phase was collected and DNA 
was precipitated by adding 40 μl of a 3 M Sodium Acetate solution and 800 μl of 100% 
EtOH. DNA was then pelleted, washed with 70% EtOH and resuspended in 50 μl 1x 
TE buffer. 25 μl genomic DNA was used for Southern blot analysis. 
From mouse tails: Genomic DNA was extracted from mouse tails collected from the 
offspring of PC4 conditional knockout chimeras. Tails (approximately 5-10 mm) were 
cut and placed in Eppendorf tubes and kept overnight at 56°C in 200 μl of tail lysis 
buffer (containing 200 μg/ml proteinase K and 0.5 mg/ml RNase A) with proper 
shaking (650-700 rpm in a thermomixer). Hair and cell debris were removed by 
centrifugation (Eppendorf 5418, 13000 rpm, room temperature, 5 minutes). The 
supernatant was transferred to a new Eppendorf tube and mixed with 160 μl of 
isopropanol to allow DNA precipitation. The precipitated DNA was collected by using a 
Pasteur Pipette, washed with of 70% EtOH, and air-dried at room temperature. The 
genomic DNA was dissolved in 100 μl to 200 μl H2O, and incubated for one to two 
hours at 37°C for complete resuspension. From this preparation, 25 μl of genomic 
DNA was used for Southern blot analysis, or 1 μl was used for PCR genotyping 
analysis. 
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2.2.1.2 Southern blot 
To identify the homologous recombinant ES cell clones for PC4 conditional knockout, 
and to confirm the genotype of mouse offspring (F1 generation), Southern blot 
analysis was applied. The genomic DNA from ES cells or tails was digested with 
restriction enzymes as above. DNA fragments were resolved on a 0.8% agarose gel in 
1x TAE buffer at 60 V for 8-10 hours or overnight at 20-25 V at room temperature. The 
gel was denatured by seating in two times in denaturation buffer for 15 minutes at 
room temperature. Then, the gel was neutralized two times by incubation in 
neutralization buffer for 15 minutes at room temperature. Subsequently, the gel was 
equilibrated in 20x SSC for 5-20 minutes at room temperature. 
Then DNA fragments were transferred from the gel to a nylon membrane (Hybond-N) 
(Amersham Biosciences, Cat. No. RPN 203N), was carried out for overnight as 
follows. Specifically, a glass pan was covered by a glass plate, which was “bridged” by 
one layer of cut-in-size Whatman paper (GB 002, gel blotting paper, Schleicher & 
Schüll, 580 x 600 mm, Ref. No. 10426694). Then the gel was placed upside down on 
the Whatman paper, and covered with a cut-in-size Hybond-N membrane together 
with four layers of Whatman paper, multiple layers of paper and an additional glass 
plate. Finally a weight of 1-1.5 kg was placed on (i.e. Sigma catalogue + 0.5L filled 
bottle) the top to facilitate the transferring. 
After transfer, the membrane was dried with two layers of Whatman paper and the 
DNA was cross-linked by using a Stratagene Stratalinker UV crosslinker (program: 
“automatic crosslink”), and baked in an oven for another two hours at 80°C. 
The cross-linked membrane was prehybridized for one to two hours at 42°C in 5-15 ml 
hybridization buffer with 100 μg/ml boiled Salmon sperm DNA (Sigma, Cat. No. 
D1626) in a hybridization oven with constant agitation. During this period, the specific 
hybridization probes were labeled with “Megaprime DNA Labeling System” from 
Amersham (Cat. No. RPN1606) according to the instructions. Usually, 20 ng of DNA 
were labeled with 50 μCi of [32P] dCTP for one hybridization reaction. The labeled 
probes were purified by using “MicroSpin G25 Columns” (Amersham, Cat. No. 
27532501), and counted in a -counter to determinate labeling efficiency. More 
specifically, three probes were used for the Southern blot experiments (the localization 
of these probes was shown in Figure 13A). The probe A and the probe B were 
obtained by digestion of the vector pWR1 and pWR5 with the restriction enzymes 
BamHI and EcoRI, respectively. In addition, the probe C was resulted from the 
digestion of the plasmid pWR3 with restriction enzymes BamHI and ClaI. The correct 
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fragments were gel-purified with gel extraction kit (Qiagen, Cat. No. 28704) and eluted 
in X μl H2O.  
For the hybridization step, the appropriate amount of fresh hybridization buffer with 
equal amounts of boiled salmon sperm DNA and labeled probe were added into the 
membrane. Hybridization was carried out at 42°C overnight in an oven. After 
hybridization, the membrane was washed two times for 15 minutes each with 2x SSC, 
0.1% (w/v) SDS at 65°C in a water bath. Then the membrane was dried on a layer of 
Whatman paper, and autoradiography was performed using X-ray film (Kodak BioMax 
MR Film, 24x30 cm) and intensifying screens for one to three days at -80°C. 
2.2.1.3 PCR for genotyping of mouse offspring 
Since the mouse offspring is heterozygous for the target gene, the PCR for genotyping 
should separate wild-type allele and mutant allele by different products. Three primers 
were designed for genotyping every mouse strain. One primer is common for both 
wild-type and mutant alleles, and the other two primers are specific for each allele.  
The PCR reaction as follows: 
Genomic tail DNA                                          1 μl 
dNTPs (2 mM)                                               1 μl 
10x Buffer                                                      1 μl 
MgCl2 (25 mM)                                           0.6 μl 
Taq polymerase (5 U/μl)                            0.1 μl 
Common primer (10 pmol/μl)                   0.75 μl 
Specific primer 1 (10 pmol/μl )                   0.5 μl 
Specific primer 2 (10 pmol/μl )                   0.5 μl 
H2O                                                          4.75 μl 
 
For PC4+/- mouse strain: the common primer is oWR83, and the specific primers are 
oWR79 and oWR81; 
For PC4Neo flox/+ (F1 generation of PC4 conditional KO mice) mouse strain:  
1. Neo cassette checking strategy: the common primer is oWR77, and the specific 
primers are oWR78 and oWR79; 
2. Single loxP site checking strategy: the common primer is oWR81, and the specific 
primers are oWR80 and oWR83; 
For PC4+/flox mouse strain: the common primer is oWR77, and the specific primers 
are oWR78 and oWR79; 
The localization of all the primers for genotyping is shown in Figure 7 
PCR program: 
1. 94°C     2 minutes 
2. 94°C   45 seconds 
3. 58°C   45 seconds 
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4. 72°C     1 minute   go to step 2, 32 cycles 
5. 72°C   10 minutes  
6. 4°C           
 
Figure 7: Localization of PCR primers in mouse genome for genotyping different 
mouse strains and embryonic stem cells. 
Blue arrow indicates loxP sites. Yellow box indicates FRT sites. 
 
2.2.1.4 Nested PCR for genotyping early embryos 
To genotype the preimplantation or postimplantation embryos obtained from PC4+/- 
mice intercrosses, nested PCR was performed. The single blastomere or blastocyst or 
embryonic tissue from the sections was transferred into the PCR tube, in which 3 μl of 
oocyte lysis buffer was added and covered by one drop of mineral oil. The samples 
were incubate at 37°C overnight, and heated at 95°C for 15 minutes to inactivate 
Proteinase K (Roche, Cat. No. 03115828001), then directly used for the first PCR 
reaction.  
The first round of PCR reaction was as following: 
Embryo lysis mixture                                      3 μl 
dNTPs (25 mM)                                           1.5 μl 
10x Buffer                                                    1.5 μl 
MgCl2 (25 mM)                                            0.9 μl 
Taq polymerase (5 U/μl)                         0.045 μl 
oWR83 (10 pmol/μl)                                    0.3 μl 
oNL37 (10 pmol/μl)                                   0.45 μl 
oNL38 (10 pmol/μl)                                     0.6 μl 
H2O                                                             6.7 μl 
 
The second round of PCR reaction was as following: 
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DNA product from the first round PCR           1 μl 
dNTPs (25 mM)                                           1.2 μl 
10x Buffer                                                    1.2 μl 
MgCl2 (25 mM)                                          0.72 μl 
Taq polymerase (5 U/μl)                           0.05 μl 
oWR80 (10 pmol/μl)                                    0.5 μl 
oNL1 (10 pmol/μl)                                          1 μl 
oNL36 (10 pmol/μl)                                     0.5 μl 
H2O                                                           5.83 μl 
 
PCR program: 
1. 95°C     2 minutes 
2. 94°C   30 seconds 
3. 58°C   30 seconds 
4. 72°C     1 minute   go to step 2, 25 cycles for the first round PCR or 35 cycles for the 
second round PCR 
5. 72°C     7 minutes  
6.   4°C          
 
2.2.1.5 Quantitative Reverse-Transcription PCR (qRT-PCR) and Reverse-
Transcription PCR (RT-PCR) 
Reverse Transcription (RT): Total RNA was extracted from wild-type (WT) and PC4 
knockout (KO) ES cell lines or from embryo bodies (EBs) using the Qiagen RNeasy 
Mini kit (Qiagen, Cat. No. 74106) according to the manufacturer's instruction. An on-
column DNase I digestion was performed using the RNase-free DNase Set (Qiagen, 
Cat. No. 79254) to eliminate residual amounts of genomic DNA. Total RNA was eluted 
in 30-50 μl 0.1% (v/v) Diethylpyrocarbonate-treated H2O (DEPC-H2O) and RNA was 
stored at -80°C or directly used for RT. Two microgram of total RNA was subjected to 
reverse transcription using the ThermoScript™ RT-PCR System (Invitrogen, Cat. No. 
11146-024). The random primers provided by the kit were used to synthesize the first 
cDNA strand. The reaction was carried out as following: samples were incubated at 
25°C for 10 minutes to allow primers annealing, reverse transcription was carried out 
at 50°C for 1 hour followed by a denaturation step at 85°C for 5 minutes. The cDNA 
was diluted into 80 μl and stored at -20°C or immediately used it for quantitative Real-
time PCR or normal PCR.  
For Real-time PCR (qRT-PCR), the “Power SYBR GREEN PCR Master Mix” was 
used (Applied Biosystem, Cat. No. 4309155). Each reaction was carried out with 0.8 μl 
cDNA and 0.4 μM of forward and reverse primers (all the sequences are list in table 7). 
Primers were designed with a melting temperature (Tm) of 60°C. Primers of -Actin 
gene were included as a reference control. Samples obtained from reverse 
transcription reactions carried out without reverse transcriptase were used as negative 
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control. PCR reactions were performed in a StepOne™ Real-Time PCR System from 
Applied Biosystem. 
For standard PCR reaction (RT-PCR), 1.6 μl cDNA was used as a template, and 1 
μM of the gene specific primer pairs was used in a total reaction volume of 15 μl. 
During PCR reaction, the annealing temperature was 56°C, and 35 cycles of 
amplification were run. Reaction products were subsequently maintained at 4°C until 
they were analyzed by 2% (w/v) agarose gel in 1x TAE buffer.  
2.2.1.6 Microarrays 
For microarrays analysis, total RNA was prepared from 5x106 cells of PC4 wild-type 
(WT) and knockout (KO) ES cells using the Qiagen RNeasy Minikit (Qiagen) with the 
on column DNAase I (RNase-Free DNase Set, Qiagen, Cat. No. 79254) digestion 
according to the manufacturer's instructions. RNA samples (10 μg) were hybridized to 
GeneChip® mouse gene 1.0 ST arrays by the approved Affymetrix service provider 
KFB (Regensburg). Pre-processing of data, i.e. data acquisition and determination of 
up- and down-regulated genes, was also performed by KFB.  
2.2.1.7 Bioinformatic analysis 
Array data were analyzed further using Bibliosphere from Genomatix 
(www.genomatix.de) in order to create a hypothetical network amongst the target 
genes based on co–citation in literature databases (Scherf et al. 2005).  Networks 
were generated using microarray target genes and transcription factors that were co–
cited together with the corresponding gene at the “sentence level”, i.e. genes that were 
found cited in the same sentence in literature databases. Furthermore, gene ontology 
(GO) analysis was performed using MGI Gene Ontology Term Finder 
(http://proto.informatics.jax.org/prototypes/GOTools/web-docs/MGI_Term_Finder.html). 
In addition, a hierarchical clustering analysis was performed using MultiExperiment 
Viewer software (MeV) (http://www.tm4.org) (Eisen et al. 1998). 
2.2.2 Cell Biology   
2.2.2.1 Culture of human tumor cell lines and related methods 
2.2.2.1.1 Cell lines 
A549           Human lung adenocarcinoma epithelial cell line, adherent 
HeLa           Human epithelial cell line, cervical carcinoma, adherent 
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HEK293T    Human embryonic kidney cell line, adherent 
2.2.2.1.2 Growth conditions 
A549 and HeLa adherent cell lines were grown in Dulbecco’s modified Eagle medium 
(DMEM plus 4500mg/ml glucose, L-Glutamine, without pyruvate; Invitrogen, Cat. No. 
11971-025) supplemented with 10% (v/v) FBS (Invitrogen, Cat. No. 10270-106), L-
Glutamine (Invitrogen, Cat. No. 25030024) and 1% (v/v) Penicillin-Streptomycin 
(Invitrogen, Cat. No.15140-122). Cells were grown in culture dishes ranging from 15 
and 10 cm down to 6 and 12 well plates (Nunc, Cat. No. 157150, 150350, 140675, 
150628) in a tissue culture incubator under 5% CO2 and at 37°C. Confluent cells were 
detached from the plates by using 0.25% trypsin (Invitrogen, Cat. No. 25050-030) and 
seeded to a new plate in the ratio of 1:4. 
2.2.2.1.3 Freezing and thawing conditions 
Cells were grown to 90% confluence in 10 or 15-cm dishes, trypsinized and 
resuspended in 0.5-1ml of cold freezing medium containing 90% serum and 10% 
dimethyl-sulfoxide (DMSO) (Sigma, Cat. No. D2650). Subsequently, cells were 
transferred to cryovials (Nunc) and placed for 24 hours at -80°C by using Mr. Frosty 
freezing container (Nalgene Mr. Frosty, Cat. No. C1562) before stored in liquid 
nitrogen. For thawing, frozen aliquots were quickly hand warmed, resuspended in 10 
ml of pre-warmed DMEM medium (10% FBS), pelleted to remove residual amount of 
DMSO and resuspended in fresh growth medium and seeded on an appropriately 
sized cell culture dish.  
2.2.2.1.4 siRNA transfection in HeLa, A549 cells 
The day before transfection 1.3-1.5x105 cells were seeded in a volume of 4 ml per 6-
cm-plate. For siRNAs transfection, the following components in every plate were 
mixed as the following table.  
 
25 nM final siRNA 
concentration 
50 nM final siRNA 
concentration 
100 nM final siRNA 
concentration 
DMEM plain medium 
(Invitrogen, Cat. No. 
41965-039) 
100 μl 100 μl 100 μl 
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The siRNAs used in this work are: control siRNAs= non_si_AF488 (Qiagen, Cat. No. 
1022563), non target siRNA (Dharmacon, Cat. No. D-001810-01-05), scrambled 
siPC4, mouse scrambled siPC4; Target siRNA= siRNA-PC4-NL, siRNA-PC4-WR and 
siRNA-PC4-TK (all the target sequences were listed in table 7). All the siRNAs used in 
HeLa and A549 cells could yield 70-80% knockdown in protein level at the 25 nM. The 
components were mixed by vortexing and incubated for 10 minutes at room 
temperature to allow the formation of transfection complexes. The complexes were 
drop-wise added onto the cells. Then the plate was gently swirled to ensure uniform 
distribution of the transfection complexes. Transfection efficiency was monitored by 
using the non-silencing control siRNA from Qiagen “non_si_AF488” (25 nM final 
concentration on the plate) at 12-20 hours after transfection. Two days after 
transfection the cells were expanded if necessary. The cells were harvested by adding 
4 ml of 0.5 mM EDTA/PBS (500 μl 0.5 M EDTA was added into 500 ml PBS, pH 8.0) 
to the plate and incubation for 20-30 minutes at room temperature. Then the cell 
solution was centrifuged (Eppendorf 5415R, 13000 rpm 4°C, 5 minutes), the 
supernatant was removed and the pellet was stored at -80°C for further analysis. 
2.2.2.2 Culture of mouse embryonic fibroblasts (MEFs) and related 
methods  
2.2.2.2.1 Preparation of MEFs  
Timed matings of CD1-M-TKNEOR mice (Stewart et al. 1987) (From RCC) (for neo 
resistant MEFs preparation) and the C3H mice (for wild-type MEFs preparation)were 
set up. At E13.5, the pregnant female was sacrificed and the uterus was taken out. 
Then the uterus was washed with sterile PBS to remove blood. The embryos were 
isolated from the placenta and yolk sac. The head, heart and fetal liver were removed 
from the embryos. The left white tissues from 2 embryos were transferred into one 
sterile Erlenmeyer beaker (containing a magnetic stirring bar and glass pearls) 
(diameter 2.85-3.3 mm, Roth Art, Cat. No. A557.1) with 10 ml 0.25% trypsin 
(Invitrogen, Cat. No. 25050-030). The beaker was incubated at 37°C for 15 minutes on 
a stirrer to disaggregate the tissue. The trypsinization was stopped by adding 10 ml of 
fibroblast medium, then centrifuged (Multifuge 3SR+, Heraeus, 1000 rpm, 5 minutes, 
room temperature). The cell pellet was resuspended in 20 ml fibroblast medium and 
20 μM siRNA 5 μl 10 μl 20 μl 
HiPerFect (Qiagen, 
Cat. No.  301704) 
20 μl 20 μl 20 μl 
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10 ml cell suspension was transferred in a 10-cm culture plate. When the plate was 
confluent, cells were expanded on a 15-cm plate. The passage of these cells was 
annotated as passage one. When the plate reached confluent, the MEFs were frozen 
down with freezing medium. 
Fibroblast medium (for 600 ml): 
 
DMEM high glucose (Invitrogen, Cat. No. 41965-039)                                      500 ml 
Pen/Str/Glu (Invitrogen, Cat. No. 10378-016)                                                        6 ml 
MEM None Essential Amino Acids (100x) (Invitrogen, Cat. No.11140-068)          6 ml 
FBS (Invitrogen, Cat. No. 10270106)                                                                   90 ml 
2-Mercaptoethanol (Invitrogen, Cat No. 31350-010)                                           1.2 ml 
 
Freezing medium for MEFs (for 10 ml): 
 
Fibroblast medium                                                                                                 8 ml 
FBS (Invitrogen, Cat No.10270106)                                                                      1 ml 
DMSO (Sigma, Cat. No. D2650)                                                                           1 ml 
 
2.2.2.2.2 Knocking down PC4 in MEFs with retroviral transduction 
To knock down PC4 in MEFs, MEFs were generated from PC4flox/- embryos obtained 
by intercrossing PC4+/- and PC4flox/+ mice. Then they were infected initially with 
ecotropic retroviruses. The ecotropic retroviruses were freshly prepared from 
HEK293T cells by cotransfecting pNL-4 (mock plasmid) or pNL-5 (Cre expression 
plasmid) together with pNL-6 (packaging protein expression plasmid) with the calcium 
phosphate or FuGENE 6 (Roche, Cat. No. 11814443001) reagent. The HEK293T cells 
were seeded such that 60% confluence was reached at 24 hours before transfection. 
Following the handbook of FuGENE 6 transfection reagent, HEK293T cells were 
cotransfected with above plasmids for producing retrovirus. After 48 hours, the 
retrovirus packed with target gene was produced into the culture medium. A 45 μm 
sterile filter was used to isolate the retrovirus from the culture medium supernatant. 
The filtered culture medium together with 5 μg/ml polybrene (Sigma, Cat. No. H9268) 
was used to infect MEFs (PC4
flox/-). The MEFs were already seeded at 1105 cells per 
well in a six-well plate. MEFs were grown for 48 hours and then selected for 7 days by 
adding 2 μg/ml puromycin. Then the cells were harvested and total RNA and/or whole 
extract was prepared for later analysis. 
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2.2.2.2.3 Preparation of feeder cells from MEFs 
MEFs were inactivated by mitomycin C treatment and -irradiated to provide a matrix 
for ES cell growth. 
Mitomycin C treatment: 
Confluent MEFs were treated with 10 μg/ml mitomycin C (Sigma, Cat. No. M0503) in 
DMEM plus 15% FBS culture medium for 2-3 hours at 37°C in an incubator at 5% 
CO2. After that, the dishes were washed extensively with several changes of PBS. The 
cells were harvested by trypsinization and centrifugation (Multifuge 3SR+, Heraeus, 
1000 rpm, 5 minutes, room temperature) and diluted into appropriate density. One 
confluent 15-cm plate of MEFs cells generated approximately the following numbers of 
feeder plates: 
           5x 10-cm plates (10 ml each) 
           10x 6-cm plates (5 ml each) 
           40x 3.5-cm plates (2 ml each) 
           18x 4-well plates or 3x 24 well plates (0.5 ml/well) 
             3x 96-well plates (0.2 ml/well) 
 
-Irradiation treatment: 
The confluent cells were exposed to 3,000-10,000 rads of -irradiation and then 
harvested by trypsinization and expanded into culture plates as above. 
2.2.2.3 Culture of mouse embryonic stem (ES) cells and related methods  
2.2.2.3.1 Embryonic stem cell culture (TBV2) 
The TBV2 ES cell line was derived from a 129/Ola strain, created in the Institute of 
Experimental Genetics (IEG) of Helmholtz-Zentrum München. It was grown on 
Mitomycin C inactivated MEFs feeder cells with ES growth medium. Routinely cells 
were splitted every 2-3 days at a ratio of 1:3 with daily replenishment of the culture 
medium. ES colonies were washed twice with PBS and then treated shortly with 0.25 
% trypsin (Invitrogen, Cat. No. 25050-030) at 37°C, until the cells were detached from 
the dish. The dissociated clones were used for splitting, transfection and freezing. 
During freezing, the cell pellets were resuspended into ES growth medium, then slowly 
added 2x freezing medium. All the ES cell vials should be transferred in liquid N2 as 
soon as frozen. 
TBV2 ES cell growth medium (for 600 ml): 
 
DMEM (Invitrogen, Cat. No. 41966-029 )                                                         500 ml 
FBS (PAA, Cat. No. 2602-p242901 Lot.P242901ES)                                        90 ml 
Pen/Str/Glu (Invitrogen, Cat. No. 10378-016)                                                      6 ml 
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MEM None Essential Amino Acids (100x) (Invitrogen, Cat. No.11140-068)        6 ml 
2-mercaptoethanol (Invitrogen, Cat. No. 31350-010)                                        1.2 ml 
LIF (CHEMICON, Cat. No. ESG1107,10
7 
units/ml)                                             90 μl 
 
2x freezing medium for TBV2 ES cells (for 10 ml): 
 
ES cell growth medium                                                                                         3 ml 
FBS (PAA, Cat. No. 2602-p242901 Lot.P242901ES)                                           5 ml 
DMSO (Sigma, Cat. No. D2650)                                                                           2 ml 
 
2.2.2.3.2 Generation of ES cell lines containing PC4 conditional knockout 
allele 
For the transfection of the PC4 targeting construct (refer to figure 13), an aliquot of 
TBV2 ES cells at the 10th passage was thawed and plated on a 6-cm plate. Cells were 
passaged in total 2 times before collecting enough cells for the electroporation. For 
electroporation, 0.9x107 cells in 0.8 ml PBS were transferred into one 2 mm cuvette, 
and 30 μg linearized target DNA or mock DNA was added. The electroporation 
conditions were 500 μF, 0.23 kV with a Gene Pulser II (Bio-Rad) electroporator. 
Transfected cells were resuspended in 10 ml TBV2 ES cell growth medium, 9 ml of 
which were distributed equally onto 3x 10-cm feeder (prepared with M-TK NEOR 
MEFs) plates. The remaining 1 ml was resuspended in 10 ml growth medium and 
divided into 2x 10-cm plates, which were used as control plates. The leftover in the 
cuvette (about 10 μl) was also transferred into another 6-cm plate as controls. The 
non-transfected cells were also kept as control. Three days after transfection, cells 
were placed under G418 selection (Geneticin G-418 sulphate, 200 μg/ml, Invitrogen, 
Cat. No. 11811-023). Selection against HSV-tk containing random integrants started at 
day 4 after transfection by supplementing the medium with 0.5 μg/ml gancyclovir 
(Sigma, Cat. No. G2536). One of the control plates containing transfected cells was 
also treated as just described, while the other two (one with tranfected cells and one 
with non transfected cells) were under G418 selection only. The comparison of these 
last two control plates allowed monitoring of selection specificity. The ratio of double 
selected colonies versus G418 selected colonies was defined as Ganciclovir 
enrichment, i.e. the theoretical enrichment of homologous recombinant versus random 
integrants while using ganciclovir. Ganciclovir killed 30% of the colonies that would 
have undergone G418 selection. At 14 days after transfection, 312 double resistant 
colonies were picked, trypsinized in round-bottom 96-well plates with 45 μl cold 0.05% 
trypsin-EDTA (Invitrogen, Cat. No. 25300-096). The U-bottom 96-well was incubated 
in 37°C for 5 minutes then 150 μl ES growth medium was added and transferred into 
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At day 3 after transfection, start G418 selection  
At day 14 after transfection, pick double resistant 
colonies and plate them in 96-well plates 
another 96-well feeder plate. About 4 days later, the clones were big enough to be 
frozen down. After washing with PBS, the cells were trypsinized in 35 μl 0.25% trypsin 
(Invitrogen, Cat. No. 25050-030), and then 65 μl of pre-warmed ES medium was 
added to stop the reaction. 65 μl of the cell mixture were transferred into a new 96 well 
plate (without MEFs), and an equal volume of 2x freezing medium was added. Plates 
were quickly closed and sealed with parafilm and embedded in several layers of 
cellulose paper sheets and stored at -80°C. The remaining 35 μl cells were added to 
150 μl growth medium in the original 96-well plate for DNA extraction. Once the 
Southern blot analysis was finished, the candidate ES cell clones were thawed from 
the frozen 96-well plates. The candidate ES cell clones were frozen in early passage 
and also some DNA extraction of these cells were kept to confirm the genotype. For 
blastocysts injection, the earlier passage candidate ES cell clones were thawed and 
plated in a 6-cm dish containing feeders, and 2 days later splitted 1:3 in order to be 
injected the following day. The injection process was carried out in IEG of Helmholtz-
Zentrum München. A schematic view (Figure 8) of the steps followed from the 
electroporation of PC4 targeting construct to the end of the selection process is given 
below. 
 
 

 
 
 
 
 
 
 
 
Figure 8: Scheme view of the generation of ES cell lines containing PC4 
conditional alleles. 
Freeze DNA preparation for Southern blot analysis 
2/3 
TBV2 ES cells (from 
129/Ola strain) 
Targeting vector (30 μg) 
Transfeced cells+ G418 
Transfeced cells+ G418+ gancyclovir 
Transfeced cells without selection Candidate clones 
selection 
1/3
Controls 
At day 4 after transfection, start gancyclovir selection 
Untransfeced cells without 
selection 
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2.2.2.3.3 PC4 wild-type (WT) and knockout (KO) ES cells derivation from 
blastocysts 
The E1.5 embryos from PC4+/- mice intercrosses were collected and cultured in vitro 
until E3.5. Zona pellucida was removed by pipetting up and down in Acid (Acid 
Tyrode's, Sigma, Cat. No. T1788), then the single blastocyst was transferred into a 48-
well plate containing a monolayer of confluent mitomycin C-inactivated MEF feeder 
cells in ES growth medium. Blastocysts were allowed to attach to the MEF feeder 
layer, which usually takes 2 days. After attachment, medium was changed. About 6 
days later, the inner cell mass was expanded to a ring-like morphology. The expanded 
blastocysts were washed with PBS, and 100 μl 0.25% trypsin (Invitrogen, Cat. No. 
25050-030) were added to the well. After 15 seconds, the trypsin was aspirated. This 
procedure reduced stickiness of the cells and allowed easier detachment. To 
mechanically detach an expanded blastocyst and surrounding MEFs, a 20 μl pipette 
and 10 μl pipette tip were used. Under a microscope, 10 μl of 0.25% trypsin (Invitrogen, 
Cat. No. 25050-030) was added into the expanded clones and several circles with the 
pipette tip around the blastocyst  were made to remove surrounding MEFs and 
separate the blastocyst (on the top of some MEFs) from the rest of the feeder layer. 
The clones were transferred into a drop of 10 μl 0.25% trypsin (Invitrogen, Cat. No. 
25050-030). After 5 minutes trypsinization, the clones were dissociated into individual 
cells and small cell clumps by pipetting up and down approximately ten times with a 10 
μl pipette tip. The cell suspension was transferred into a 48-well plate with feeders in 
ES cell medium. Several days after trypsinization, compact cell colonies with typical 
ES cell colony morphology were detected in some of the wells. The culture procedures 
of these ES cells were based on the standard method for TBV2 except the FBS was 
specific and MEFs were prepared from CH3 mice (none resistance for drug selection).  
 
ES cell growth medium for PC4 WT and KO ES cells (for 600 ml): 
DMEM low glucose (PAA, Cat. No. E15-005)                                                   500 ml 
FBS (Invitrogen, Cat. No.10270106, Lot 40G8251K)                                          90 ml 
Pen/Str/Glu (Invitrogen, Cat. No.10378-016)                                                        6 ml 
MEM None Essential Amino Acids (100x) (Invitrogen, Cat. No. 11140-068)        6 ml 
2-Mercaptoethanol (Invitrogen, Cat. No. 31350-010)                                         1.2 ml 
LIF (bacterial recombination protein purified by ourselves) 
(added freshly)                                                                                              600 μl 
 
2x freezing medium for PC4 WT and KO ES cells (for 10 ml): 
ES cell growth medium for PC4 WT and KO ES cells                                          6 ml 
FBS (Invitrogen, Cat. No.10270106, Lot 40G8251K)                                           2 ml 
DMSO (Sigma, Cat. No. D2650)                                                                           2 ml 
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2.2.2.3.4 Rescue of PC4 KO ES cells 
In the rescue experiments, PC4 WT and KO ES cell lines were used, and Apal I was 
used to linearize pWR12 and pWR23 for transfecting these cells. The electroporation 
conditions were 500 μF, 0.25 kV, in a 4 mm cuvette with gene Pulser II (Bio-Rad) 
electroporator. The cell number for one transfection was 4x106, and the DNA amount 
for each transfection was about 20 μg. After electroporation, the transfected ES cells 
were transferred into a MEFs coated 10-cm plate for culturing. One day later, G418 
was added to a final concentration of 300 μg/ml into the transfected and untransfected 
(control) ES cells for selecting resistant clones. After about 5 days selection, almost all 
untransfected cells were dead. Resistant ES cells were used for cell growth analysis.
More specifically,the resistant ES cell colonies (green in fluorescent microscope) 
were picked with mouth glass pipette and transferred in a new culture dish. After 
trypsinization, the colonies were splitted into single cell suspension, and then equal 
number of cells were seeded in 6-well plates and counted every 24 hours till day 4. 
2.2.2.3.5 Karyotyping of ES cells 
Actively growing PC4 WT and KO ES cell lines (24 hours after 1:5 passage on feeder 
plates) were cultured in the presence of Nocodazol (3 μg/ml) for 4 hours, after removal 
of the MEFs by plating them on gelatin-coated (PBS/0.1% gelatin, Sigma, Cat. No. 
G1393) culture dish for a minimum of 5 minutes at 37°C. Then 50 ng/ml colcemid 
(Sigma, Cat. No. D7385) was added and cultured for another 2 hours. Chromosome 
spread of the cells for karyotyping analysis was obtained as follows. The cells were 
harvested by centrifugation (Multifuge 3SR+, Heraeus, 1000 rpm, 5 minutes, room 
temperature). The cell suspension was flicked by drop-wise adding 1 ml 0.56% (w/v) 
KCl. Another 3 ml 0.56% (w/v) KCl was slowly added to the cells.  After 10 minutes 
incubation at 37°C in water bath, cells were pelleted by centrifugation (Multifuge 3SR+, 
Heraeus, 1000 rpm, 5 minutes, room temperature). The cells were fixed by adding FIX 
solution (3 volume methanol: 1 volume acetic acid) drop by drop while flicking the 
tubes. Then the cells were incubated at room temperature for 30 minutes, and pelleted 
by centrifugation (Multifuge 3SR+, Heraeus, 1000 rpm, 5 minutes, room temperature). 
The cells were resuspended in 4 ml FIX solution. This step was repeated before 
resuspending the cells in 200 μl FIX solution. The cell suspension was dropped onto a 
glass slide from a 10 cm distance. After the slides were air dried at room temperature, 
the slides were stained with DAPI solution and scanned with 40x objective for good 
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spreads. The chromosome spreads were analyzed on a microscope using 100x oil 
immersion objectives and 1000x magnification. 
2.2.2.3.6 In vitro differentiation of embryonic stem cells 
For in vitro differentiation, ES cells of PC4 WT and KO were feeder-depleted by being 
replated onto gelatin-coated dishes for 45 minutes. This step was repeated once more. 
Non-adherent cells were recovered and seeded onto bacterial grade (without 
adherence) dishes in ES cell growth medium in the absence of LIF for 4 days. After 
the formation of embryonic bodies (EBs), EBs were treated with 0.5 μM retinoic acid 
(RA) for 4 days in the bacterial grade dishes and reseeded onto new tissue culture 
dishes for 8-12 days. Differentiated ES cells were used for RNA isolation and RT-PCR 
(or qRT-PCR) analysis. 
2.2.2.3.7 Cell cycle and apoptosis analysis with Flow Cytometer 
Cell cycle analysis: PC4 WT and KO ES cells were resuspended in 1 ml PBS at a 
density of 3x106/ml after feeder depletion. The single-cell suspensions were kept on 
ice until they were run on the flow cytometer. 900 μl DAPI (4,6-diamidino-2-
phenylindole) solution (10 g/ml DAPI and 0.1% Nonidet P-40 detergent in a Tris 
buffered saline) was added to 100 μl cell suspension for staining. The tube was mixed 
thoroughly for cell cycle analysis with Flow Cytometer (Partec CyflowR space).
Apoptosis analysis: ES cells were collected as above, and washed twice with PBS. 
5x105 cells were resuspended in 100 μl of 1x Annexin V Binding Buffer (BD 
Pharmingen™, Component No. 51-66121E) with 2 μl FITC Annexin V (BD 
Pharmingen™, Component No. 51-65874X) and 2 μl Propidium Iodide (PI) (BD 
Pharmingen™, Component No. 51-66211E). The cells were gently vortexed and 
incubated for 15 minutes at room temperature in the dark. 400 μl of 1x Annexin V 
Binding Buffer was added to each tube and analyzed by flow cytometry within 1 hour.
2.2.3 Mouse experiments 
2.2.3.1 Mouse keeping 
Mice were kept in the mouse facilities of Helmholtz-Zentrum München. Chimeras 
generated after blastocyst injection of PC4 homologous recombinant ES cells were 
mated with C57BL/6J wild-type mice in order to produce germ-line transmitted 
offspring. The F1 generation was mated with Cre deleter mice (C57BL/6J background) 
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for generating the PC4+/- mouse strain. The mouse strain PC4+/- was back-crossed to 
wild-type C57BL/6J mice for maintenance and further analysis. 
 
2.2.3.2 Dissection of E7.5 to E9.5 mouse embryos 
Timed matings between PC4+/- mice were set up. The day of the plug corresponds to 
day 0.5 of embryonic development. At the day of dissection, the female was sacrificed 
by cervical dislocation. The reproductive organs were dissected and the uterus 
containing the mouse embryos were removed and put in ice-cold PBS. The embryos 
including the placenta were released by rupture of the uterus muscle with two forceps. 
Between E6.5-9.5, the embryos are fully surrounded by the deciduas. At E7.5 the 
deciduas containing the embryos are pear-shaped. In order to reveal the small 
embryos, the deciduas were dissected by holding them at their broader end with a 
watchmaker #5 forceps using a dissection microscope. The embryos were shelled out 
by piercing the deciduas at the very tip of the “pear” and by pushing carefully to the 
direction of the holding forceps. After the embryos were released, the ectoplacental 
tissue and red blood cells was carefully removed with forceps and the embryos were 
transferred with a plastic Pasteur pipette. At E8.5 and E9.5, the deciduas are still fully 
surrounding the mouse embryo. After the decidua was carefully removed, the embryo 
was prepared by rupture and removal of the yolk sac membrane. The yolk sac was 
collected for genotyping. 
2.2.3.3 Histological analysis of early embryos 
Timed matings were conducted with interbreeding between PC4+/- mice. Females with 
copulation plugs were considered to be at embryonic development day 0.5 (E0.5) of 
gestation. Deciduas were isolated in ice-cold PBS at E5.5, E6.5, and E7.5, fixed 
overnight in 4% (w/v) paraformaldehyde (PFA) buffered with PBS overnight at 4°C. 
After rinsing three times with PBS, the fixed deciduas were incubated with 10% (w/v) 
sucrose buffered with PBS for 6 hours at 4°C, then with 25% (w/v) sucrose overnight 
at 4°C and washed with PBS. The deciduas were then dehydrated in an ethanol series 
(70%-95%-100% EtOH) and imbedded in paraffin for sagittal sections. Paraffin blocks 
were trimmed and serially sectioned at 5-7 μm. All the tissue sections were collected 
and fully extended on a SuperFrost/Plus slide (Fisher Scientific, Cat. No. 1255015). 
The slides were kept in an oven overnight at 40°C. At the following day, all the embryo 
sections were deparaffinized with Xylene (2 times 5 minutes each) and rehydrated in 
an ethanol series (100%-95%-80% EtOH). Then the sections were immerged in tap 
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water for 4 minutes, before they were stained with hematoxylin (Sigma, Cat. No. 
GHS216) for 3 minutes. After rinsing with tap water for 4 minutes, the slides were 
submerged into 70% EtOH (v/v) for 4 minutes and rinsed with water. After that, the 
slides were microscopically inspected. One slide for each embryo was kept for 
mechanically isolating embryonic tissues out of deciduas to achieve its genotype with 
PCR strategy. The remaining slides were stained with eosin solution (Sigma, Cat. No. 
HT110116) for 1 minute, and dehydrated from 95% (v/v) EtOH to 100% EtOH. Finally, 
the slides were immerged in Xylene for 15 minutes, then covered with coverslips using 
Permount mounting medium (Fisher Scientific, Cat. No. SP15-500) for microscopic 
evaluation. 
2.2.3.4 Superovulation 
Since large numbers of oocytes and preimplantation embryos are required for early 
phenotype analysis and ES cell derivation, gonadotropins were administered to 
females prior to mating for inducing superovulation. The efficient induction of 
superovulation in mice depends on age and weight of female mice, dose of 
gonadotropins, and time of administration. For C57BL/6J strain, it was empirically 
determined that 8 to 10-week-old females produced sufficient amounts of 
preimplantation embryos for subsequent analysis. Light cycle in mouse house of 
Muenster is 6 a.m. to 6 p.m., so 10 IU PMSG (pregnant mare serum gonadotropin, 
Calbiochem, Cat. No. 367222) was administered intraperitoneally between 4 to 5p.m. 
Then, 48 hours later, 10 IU hCG (human chorionic gonadotropin, Calbiochem, Cat. No. 
230734) was administered intraperitoneally to the females, and then females were 
mated with males. 
2.2.3.5 Collection of morulas and blastocysts 
Morulas (E2.5) and blastocysts (E3.5) were located in the uterus of pregnant female 
mice. After superovulation, the pregnant mice were killed and the uterus was taken out 
for collecting embryos. All the isolated uteri were rinsed 2-3 times before flushed. Then 
the uterus was cut across the cervix, and ovary was removed. In a plastic tissue 
culture dish, a 30-guage needle was inserted into the base of each horn to flush with 
0.5 ml M2 medium (Sigma, Cat. No. M7167) with 4 mg/ml BSA (Sigma, Cat. No. 
A3311). Because there may be some morulas left in oviduct, the oviduct was isolated 
and smashed to release all the embryos. The embryos were picked up and rinsed 
through several drops of fresh M2 medium containing 4 mg/ml BSA, then analyzed. 
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2.2.3.6 Immunofluorescence staining of morulas and blastocysts 
Morulas (E2.5) and blastocysts (E3.5) were isolated from C56BL/6 female mice, which 
were mated with C56BL/6 male mice. The embryos were fixed in 1.3% PFA in 0.5x 
PBS (1:2 dilution of PBS with distilled water), incubated at room temperature for one 
hour, and transferred into a 4-well plate in PVP/PBS (1 mg/ml PVP40 in PBS) buffer at 
4°C. After permeabilized with 0.5% Triton X-100 in PVP/PBS buffer for one hour at 
room temperature and washed two times with PVP/PBS, the embryos were ready for 
immunostaining. Incubation with the primary antibody (polyclonal rabbit-anti-PC4, 
1:400 dilution was used for the immunostaining) was carried out in 100 μl PVP/PBS for 
one hour at 37°C in a humid dark chamber. To control the primary antibody specify, 
incubation with PBS (negative control) was included. After this, the embryos were 
washed with at least 3 times for 10 minutes each in PVP/PBS. Incubation with the 
secondary antibody (Goat-anti-Rabbit-Cy3 IgG) (Dianova, Jackson immnuoresearch 
Europe ltd, Cat. No. 111-165-144) conjugated to the fluorescent dye was performed as 
above except the incubation time was only 30 minutes. After washed with PVP/PBS 
for 3 times, the embryos were mounted with Vectashield mounting medium (Vector 
Laboratories, Cat. No. H1200) on 76x26 mm cover glass. The analysis of the embryos 
was carried out with a confocal microscope (Zeiss).  
2.2.3.7 E1.5 embryos isolation from PC4+/- mice intercrosses for in vitro 
culture 
Superovulated female PC4+/- mice were mated with male PC4+/- mice. At E1.5, the 
oviducts without ovary and fat were isolated from the female mice. Then all the 
oviducts were transferred into M2 medium (Sigma, Cat. No. M7167) in a 35-mm Petri 
dish covered with mineral oil (Sigma, Cat. No. M5310). The oviducts were flushed with 
M2 medium by thin glass pipettes. The embryos were collected and washed through 
several drops of fresh M2 medium to rinse off the debris. The embryos were 
transferred into a microdrop of KSOM medium in the culture dish, which was 
equilibrated for at least 2 hours in an incubator. The embryos were cultured in vitro 
until E2.5 for deriving ES cells. 
 
KSOM medium: 
 
EDTA (disodium salt)                                                                          0.01 mM 
NaCl                                                                                                       95 mM 
KCl                                                                                                        2.5 mM 
CaCl2                                                                                                   1.71 mM 
KH2PO4                                                                                               0.35 mM 
MgSO4                                                                                                  0.2 mM 
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Na lactate (Sigma, Cat. No. L7900)                                                       10 mM 
Na pyruvate (Sigma, Cat. No. P4562)                                                  0.2 mM 
Glucose (MP Biomedicals, Cat. No. 194672)                                       0.2 mM 
Phenol red (0.5%, Sigma, Cat. No.P0290)                                          100 l/L 
NaHCO3 (MP Biomedicals, Cat. No.194553)                                         25 mM 
MEM EAA (50x, Invitrogen, Cat. No.11130-077)                                       1x 
MEM NEAA (100x, Invitrogen, Cat. No.11140-068)                                   1x 
Pen/Strep/Glu (100x, Invitrogen, Cat. No.10378-016)                                1x 
BSA (sigma, Cat. No. A3311)                                                         1 mg/ml 
  
2.2.3.8 In vitro fertilization of mouse oocytes and immunofluorescence 
staining 
To determine the localization of PC4 in zygote stage, in vitro fertilization was 
performed with wild-type mice. F1 generation mice (obtained from matings of 
C57BL/6J with CBA wild-type mice) were used as sperm and oocytes donors. Mature 
oocytes were collected 14 hours post human chorionic gonadotropin injection as 
outlined in 2.2.3.4. Sperm isolation and in vitro fertilization (IVF) procedures were 
performed as following. In briefly, the sperm was isolated from cauda epididimus of 
donor males and capacitated in pre-gassed HTF buffer for 1.5 hours. Isolated oocytes 
in cumulus cell mass were placed into 100 μl drop of HTF buffer with capacitated 
sperm and incubated in CO2 incubator for 3, 5, or 8 hours. For longer incubation time 
the oocytes were incubated with sperm in HTF medium for 8 hours and then 
transferred into the drop of pre-gasses and pre-warmed M16 medium (Sigma, Cat. No. 
M7292) and incubated further for 2, 4 or 10 hours. After the removal of zona pellucida 
by treatment with Acidic Tyrode’s solution, fertilized oocytes were fixed for 20 minutes 
in 3.7% (w/v) PFA in PBS, and permeabilized with 0.2% (v/v) Triton X-100 in PBS for 
10 minutes at room temperature. The fixed zygotes were blocked overnight at 4°C in 
1% (w/v) BSA (Equitech-Bio, Cat. No. BAC62-0050) and 0.1% (v/v) Triton X-100 in 
PBS. After blocking, the embryos were incubated in the same solution with anti-PC4 
rabbit polyclonal antibody at room temperature for 1 hour, followed by several washes 
and incubation for 1 hour with anti-rabbit secondary antibodies coupled with 
Rhodamine Red-X (Jackson ImmunoResearch Laboratories Inc.). Then, after washing, 
the zygotes were placed on slides and mounted with a small drop of Vectashield 
mounting medium (Vector Laboratories, Cat. No. H1200). At least 20 zygotes were 
analyzed. The slides were analyzed on Zeiss Axiovert 200 M inverted microscope 
equipped with the fluorescence module and B/W digital camera for imaging. The 
images were captured, pseudocoloured and merged using AxioVision software 
(Zeiss). 
HTF buffer: 
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NaCl (Sigma, Cat. No. S-5886)                                             101.6 mM 
KCl (Sigma, Cat. No. P-5405)                                                 4.69 mM 
MgSO47H2O (Sigma, Cat. No. M-1880)                                   0.2 mM 
KH2PO4 (Sigma, Cat. No. P5655)                                           0.37 mM 
CaCl2 (Sigma, Cat. No. C-7902)                                              2.04 mM 
NaHCO3 (Sigma, Cat. No. S-5761)                                             25 mM 
Glucose (Sigma, Cat. No. G-6152)                                          2.78 mM 
Na-pyruvate (Sigma, Cat. No. P-4562)                                    0.33 mM 
Na-lactate (Sigma, Cat. No. L-1375)                                        21.4 mM 
Penicillin (Sigma, Cat. No. P-7794)                                         0.075 g/L 
Streptomycin (Sigma, Cat. No. S-9137)                                    0.05 g/L 
Phenolred (1%) (Sigma, Cat. No. P-0290)                                0.2 ml/L 
BSA (Equitech-Bio, Cat. No. BAC62-0050)                               4 mg/ml 
             
The buffer was gassed for 5 minutes with 5% CO2, 5% O2 balanced with N2 before 
supplementing it with BSA. Medium was stored at 4°C for no longer than 2 weeks, and 
regassed before used. 
 
2.2.4 Biochemistry  
2.2.4.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Proteins were separated on a SDS-PAGE gel using the mini-gel system from Bio-Rad. 
Depending of the size of the protein, 12-15% 170:1 acrylamide/bisacrylamide gels 
were used. For electrophoresis, proteins were mixed 1:6 with 6x loading buffer, heat 
denatured at 95°C and loaded onto the gel. Proteins were separated applying a 
current of 25 mA for the mini-gels and the running buffer was 1x TGS. For molecular 
weight determination, prestained marker (Bio-Rad, Cat. No. 161-0375) was run in 
parallel. Following electrophoresis, proteins were subjected to Western blotting. 
Components for different percentages of SDS-PAGE: 
                                                            12%                 15%        stacking gel 
GelA (Roth, Cat. No. 3037.1)             4 ml                   5 ml               1.7 ml 
GelB (Roth, Cat. No. 3039.1)        0.35 ml              0.44 ml               0.7 ml 
1.5 M Tris/HCl (pH 8.8 )                  2.5 ml                2.5 ml     
1 M Tris/HCl (pH 6.8 )                                                                      1.25 ml 
H2O                                                    3 ml                   2 ml                6.2 ml 
10% SDS                                        0.1 ml                0.1 ml                0.1 ml 
30% APS                                          23 μl                  23 μl                  35 μl 
TEMED                                               6 μl                    6 μl                    6 μl 
2.2.4.2 Whole-cell extracts preparation 
For cell pellets: Cell pellets were resuspended in 200-300 μl of 0.2% NP-40 lysis 
buffer, and incubated on ice for 5 minutes. Then, three to five freeze-thaw cycles were 
performed to complete lysis. Debris was removed by centrifugation (Eppendorf 5415R, 
13000 rpm, 4°C, 10 minutes). The supernatant were stored at -80°C. 
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0.2% NP40 lysis buffer: 
50 mM Tris/HCl, pH 8.0  
150 mM NaCl   
0.2% (v/v) NP40    
1 mM EDTA, pH 8.0   
Prior to use, add protease inhibitors to a final concentration of 
2 μg/ml Leupeptin   
2 μg/ml Aprotinin   
2 μg/ml Pepstatin   
1 mM PMSF   
For organs: A piece of organ was homogenized in 0.1% (w/v) NP-40, 150 mM NaCl, 
50 mM Tris (pH 7.5), 1mM EDTA, 1mM DTT with complete protease inhibitors (Roche,
Cat. No. 1697498001) by electronic homogenizer. Then the tube was incubated on ice 
for 30 minutes. Insoluble material was removed by centrifugation (Eppendorf 5415R, 
13000 rpm, 4°C, 10 minutes). Equal protein content was used for SDS-PAGE and 
Western blot analysis. 
Measurement of protein concentration: Total protein concentration was determined 
using the Bradford assay (Bio-Rad protein assay) by detecting absorbance at 595 nm. 
A standard curve was made using serial dilution of BSA (100-250-500-750-1000 
μg/ml) and protein concentration of the sample was calculated according to the 
standard curve. 
2.2.4.3 Western blot 
Proteins separated by SDS-PAGE were transferred to a PVDF membrane (Bio-Rad, 
Cat. No. 162-0177) using a Semi-Dry Transfer Cell (Bio-Rad, Trans-BlotR SD), paper 
soaked in 1x transfer buffer and run for 50 minutes at 15 V (mini-gels). After transfer, 
the membrane was shortly stained with a Ponceau S solution to make the transferred 
marker visible. The membrane was then incubated for 1-12 hours in 1x TBS containing 
5% (w/v) milk powder to reduce unspecific background binding. After blocking, the 
membrane was incubated for 1-12 hours with appropriate dilutions of the primary 
antibodies in 1x TBST containing 1% milk powder. To remove excess antibody, the 
membrane was washed 3 times for 15 minutes with TBST. Secondary antibodies 
(1:10,000 dilution) were applied for 1 hour in TBST containing 1% (w/v) milk powder 
and after 3 times washes in 1x TBST 15 minutes each and a final rinse in dH2O, the 
antibodies were detected using the enhanced chemiluminescence detection system 
(Western Lightning, Perkin Elmer, Cat. No. NEL105) according to the manufacturer’s 
instructions and exposed on BioMax MR Film (Kodak, Cat. No. 8736936). 
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3. RESULTS 
3.1 PC4 knockdown in HeLa and A549 cells  
In order to validate the physiological function of PC4, messenger RNA was knocked 
down by RNA interference in HeLa and A549 cells. We used several PC4-specific 
siRNAs, which are named as following: siRNA-PC4-NL (target sense in human PC4 
cDNA is 177-197) (Figure 9), siRNA-PC4-TK [(target sense in human PC4 cDNA is 
213-233, taken from (Das et al. 2006) (Figure 9)], siRNA-PC4-WR (target sense in 
human PC4 cDNA is 292-311) (Figure 9) and several non-sequence-specific control 
siRNAs which are named as following: non-targeting siRNA (from Dharmacon), 
scrambled siRNA (target sequence was listed in the table 7)and FITC-conjugated 
negative control siRNA AF488 (non_si_AF488, Qiagen). The efficiency of PC4 mRNA 
knockdown was usually 80% in A549 and HeLa cells. This is exemplified in Western 
blot analysis for siRNA-PC4-NL and siRNA-PC4-TK in A549 (Figure 10A left panel) 
and in HeLa cells (Figure 10B left panel) at day3 and day5 after transfection.  
Cell proliferation rates were measured by counting viable cells at different time points 
after PC4 knockdown. As shown in Figure 10A (right panel), A549 cells proliferated 
normally upon application of non-targeting siRNA, scrambled siPC4. But sequence-
specific siRNA-PC4-NL and siRNA-PC4-TK performed differently in these two cell 
lines. Only siRNA-PC4-TK reduced proliferation of A549 cells, whereas none of the 
siRNA had an effect on cell growth of HeLa cells. Lack of inhibition of proliferation was 
evident from further independent PC4-specific siRNA pool (Dharmacon). The siRNA 
pool knocked down PC4 significantly but did not interfere with cell proliferation (by 
Sanghamitra Singhal and Thomas Albert, unpublished data). Hence, reduced 
proliferation of A549 cells upon knocking down PC4 is most likely due to the off-target 
effects of the siRNA-PC4-TK, which contains repeated sequence (CAG) (Figure 9). 
Another PC4-specific siRNA (siRNA-PC4-WR) (Figure 9) was tested in comparison 
with two other control siRNAs: non_si_AF488 and mouse scrambled siPC4 in HeLa 
cells. The knockdown efficiency of siRNA-PC4-WR and siRNA-PC4-NL were similar 
(Figure 10C, left panel) without effect on cell proliferation. 
To investigate the effect of PC4 knockdown on global gene expression, we carried out 
gene profiling analysis with microarrays (Affymetrix GeneChip ‘Human Genome U133 
Plus 2.0 Array’). A mixture PC4-specific siRNAs (siRNA-PC4-NL and WR) transfected 
cells was used and a mouse scrambled siPC4 served as control. The effects on 
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endogenous PC4 levels were tested in Western blots. As shown in Figure 10C, about 
15% of PC4 was found after knockdown in HeLa cells. From four best-quality arrays, 
we identified 110 up-regulated genes and 12 down-regulated genes (more than 2 fold 
changes were considered and listed in table 9-10 in appendix) in response to the PC4 
knockdown. Compared with previously published genes identified from microarrays in 
HeLa cells (Das et al. 2006), only two common genes were found: RTRF and DSG2. 
Taken together, all these results suggest that PC4 is not essential for human tumor 
cells or the residual levels of PC4 persisting after transient knockdown maintain the 
normal growth of tumor cells. To circumvent this difficulty, a knockout approach was 
proposed. 
 
 
 
Figure 9: Target sequences of different siRNAs specific for PC4 mRNA in human 
cells. 
Different target sequences of diverse siRNAs are indicated in different colored boxes in the 
alignment of human and mouse PC4 cDNA sequences. 
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Figure 10: Effect of PC4 knockdown in A549 and HeLa cells. 
(A) Western blot analysis of endogenous PC4 protein levels in A549 cells after siRNA 
transfection (left panel). Knocking down PC4 did not decrease A549 cell proliferation (right 
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panel). -tubulin was used as a loading control. The numbers of cells were counted at different 
time points. Day1: cells were seeded, days 2, 3, 4, 5, and 7: days after transfection of siRNA. 
(B) Western blot analysis of endogenous PC4 protein levels in HeLa cells after siRNA 
transfection at different time points (left panel). Knocking down PC4 did not decrease HeLa cell 
proliferation (right panel). Cells were counted as shown in (A). (C) Microarray analysis of gene 
expression upon PC4 knockdown by siRNA. Western blot analysis of endogenous PC4 protein 
levels in siRNA-transfected HeLa cells used for microarray analysis (left panel). The samples 
shown in red were those analyzed by microarrays. NC2 was used as a loading control. The 
number of deregulated genes in response to PC4 knockdown is listed in a table (right panel). 
Only those genes whose expressions were more than double or less than half of control levels 
were considered.  
3.2 Generation of PC4 conditional knockout mice 
3.2.1 Organization of PC4 genomic locus 
The murine PC4 gene consists of 5 exons on chromosome 15 encoding 127 amino 
acids (aa). The N-terminal part of PC4 contains a SEAC motif, which is encoded by 
exon 2 and exon 3. Exon 3 also encodes the lysine-rich motif (aa 23-41). The 
evolutionary conserved C-terminal domain (CTD) for ssDNA binding is encoded by 
exon 4 and exon 5 (aa 66-101). A schematic summary of the PC4 gene structure is 
shown in Figure 13A. PC4 is widely expressed in different tissues and cell lines in 
mouse and human as shown by northern blots (Figure 11, from Dr. Wera Roth). 
3.2.2 Generation of constitutive knockout mice for PC4 
To characterize the in vivo function of PC4, a loss-of-function study was carried out 
using a knockout mouse approach. Given that PC4 homolog (SUB1) in yeast was non-
essential, we initially chose to eliminate gene in a non-conditional manner. A 
constitutive knockout mutant of PC4 was first generated by Gertraud Stelzer in our lab. 
A region comprising intron 3 to exon 5 was deleted which resulted in mice with a null 
allele (Figure 12A). After homologous recombination (Figure 12B), positive ES cells 
were injected into blastocysts to obtain chimeric mice. A single heterozygous mouse 
colony was established. These mice were viable and fertile. In contrast, live offspring 
lacking both PC4 alleles were never obtained (Figure 12C).  
Examination of the embryos at different developmental stages suggested that 
homozygous embryos died at the preimplantation stage, as knockout blastocysts were 
obtained at a ratio far lower than that expected according to Mendelian inheritance 
(Figure 12C). Because the analysis of preimplantation stage embryos was difficult and 
without suitably established techniques at the time, further the analysis of this classical 
PC4 knockout was not pursued in the lab.  
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Figure 11: Northern blot analysis of PC4 in different mouse tissues and cell lines. 
Total RNAs (30 μg) were isolated from mouse organs and different cell lines, and then 
analyzed by northern blotting using 
32
P-labeled human PC4-cDNA. MCF-7 and TH7D: human 
breast adenocarcinoma cell line; P19: pluripotent murine embryonic carcinoma cell line; RA: 
retinoic acid, induces ES cell differentiation; Rac65: P19 EC-derived mutant cell line resistant to 
the differentiation-inducing activity of RA; F9: mouse embryonic carcinoma cell line; E2: 
estradiol, induces MCF-7 proliferation.  
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Figure 12: Constitutive gene knockout of PC4 (performed by Gertraud Stelzer). 
(A) Genomic targeting of PC4 null allele. Exons 3 to 5 of PC4 were replaced by the neo-
resistance cassette, which was flanked by two homologous arms for ES homologous 
recombination. (B) Southern blot analysis for identification of homologously recombined ES 
clones. (C) Summary of different embryonic stages for homologous null PC4 mice.  
3.2.3 Conditional knockout of the PC4 gene 
We used a conditional knockout approach to circumvent early embryonic lethality. In 
this approach, exon 4, which encodes the PC4-CTD, was flanked with two loxP sites. 
Deletion of exon4 eliminates all known functions of PC4 and abrogates binding to both 
dsDNA and ssDNA. Because the PC4-CTD is essential for ssDNA binding as well as 
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for the cofactor function of PC4, a loss-of-function allele was expected when Cre 
recombinase was present. A neo cassette flanked by two Flippase Recognition Target 
(FRT) sites was introduced into intron 4 (Figure 13A). As a consequence, the neo 
cassette can be removed from the mutant allele via recombination with FLP 
recombinase before conducting the Cre-mediated deletion of exon 4 in a tissue or cell 
lineage of interest.  
3.2.4 Homologous recombination (HR) in ES cells  
Double-selected TBV2 ES cell clones were analyzed in Southern blot to identify ES 
cell clones with that underwent distinct homologous recombination. To distinguish wild-
type and mutant alleles 3 probes were used for the screening (Figure 13A). Probe A 
and probe B, which targeted upstream and downstream of the mutant allele, 
respectively, were used to distinguish homologous recombination from the random 
integration. Probe C was used to check the presence of the single loxP site so as to 
exclude cells with the mutation during recombination.  
Restriction enzymes were selected in a manner that allowed to generate specific 
mutant and wild-type genomic patterns on Southern blots. For example, the digestion 
of the target vector with KpnI and hybridization against probe A yielded a 7.8 kb 
fragment in the mutated allele versus a 9.2 kb fragment in the wild-type allele. The 
Xbal digestion yielded a 4.3 kb fragment using probe B in the mutant allele and a 6.5 
kb fragment in the wild-type allele. An EcoRV digestion site was inserted between the 
loxP sites in the targeting allele. As a consequence, a 4.8 kb fragment in the mutant 
and a 10.5 kb fragment in the wild-type allele were detected with probe C.  
Among 312 ES cell clones that survived antibiotics selection and were picked, 179 
were successfully screened by Southern blot, and four clones were positive for 
homologous recombination on all events. These candidate clones were expanded and 
again confirmed by Southern blot. An example for screening of homologous 
recombination (HR) is shown in Figure 13B.  
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Figure 13: Construction of knockout mice and confirmation of targeting event. 
(A) Organization of PC4 domains. Genomic regions encoding various domains of the protein 
are represented with different colors. Homologous recombination results in the insertion of the 
targeting vector, which included an FRT-flanked neomycin cassette (Neo) and exon 4 flanked 
by loxP sites. KpnI, XbaI, and EcoRV: enzymes used for Southern blot analysis. ClaI was used 
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for linearization. The yellow arrows indicate the loxP sites. The mt (-) allele shows the genomic 
organization after exon 4 deletion by Cre-recombinase. The upstream (probe A) and 
downstream (probe B) probes used for Southern analysis are indicated in red and grey, 
respectively. The internal probe C, is indicated in orange. (B) Southern blot analysis of genomic 
DNA from double-selected clones (6E3, 6F9) after digestion with KpnI, XbaI, EcoRV and 
hybridization with the probe A, probe B, and probe C, respectively. These fragments distinguish 
between the targeted event and the wild-type allele. (C) PCR genotyping of F1 generation. 
Upper panel checks the existence of the neo cassette (primer used: oWR77, oWR78, oWR79, 
see method section 2.2.1.3), and lower panel checks whether the single loxP side is inserted 
upstream of exon 4 (primer used: oWR80, oWR81, oWR83, see methods section 2.2.1.3). Both 
methods yielded the same results. Numbers from 1-18 in the figure indicate the mouse 
identification number. (D) Southern blot analysis of tail genomic DNA from the F1 generation to 
confirm the genotype. (E) PCR genotyping for heterozygous mice (+/-) (primers used: oWR79, 
oWR83, oWR81, see methods section 2.2.1.3). Numbers from 418-427 indicate the mouse 
identification number. (F) Southern blot analysis of heterozygous mouse (+/-).  
 
 
 
 
Figure 14: Chimerism percentage for PC4 conditional knockout chimeras.  
The three photos on the left show three male chimeras and the three photos on the right show 
the pairs of corresponding chimera and C57BL/6J female mice. Mouse ET42_6E3 exhibited 
germ line transmission. Mouse ET44_6F9 and ET49_6F9 were sterile. ET42, ET44, ET49 in 
indicate the chimeras’ identification numbers. 6F3 and 6F9 indicate the homologous 
recombination ES cell clones used for microinjection. The percentage in each picture 
represents the estimated chimerism judged by fur color. 
3.2.5 Heterozygous PC4 knockout mice 
Three out of four positive ES HR clones carrying the mutated allele were injected into 
mouse blastocysts to generate chimeric mice by the staff at the Institute for 
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Developmental Genetics, Helmholtz-Zentrum München. After microinjection 
blastocysts were transferred into the uterus of pseudopregnant foster mice. Of the 14 
pups born from two ES lines, three male chimeric mice were identified that showed 
chimerism of estimated 80%-95% as judged by coat colors (Figure 14). Chimeric mice 
were mated with wild-type C57BL/6J mice for germ line transmission. The ES cell line 
TBV2 stems from 129/Ola mice that have chinchilla-colored fur, while the C57BL/6J 
are black. Hence, the offspring derived from the ES cell clones have brown coat color, 
if the recombinant ES cells went into the germ line in the previous generation. From 
these crossings, one of the chimeras (ET42_6E3), showed 100% germ line 
transmission because all of its pups (F1) were brown, and the other two chimeric mice 
are sterile.  
Eighteen of the F1 offspring were genotyped using PCR and Southern blotting on DNA 
extracted from their tails (see methods section 2.2.1-3). The PCRs were run with 3 
primers targeting the neo cassette and the single loxP site of the mutant allele, as 
shown in Figure 13C and confirmed that all F1 mice carried the mutant allele. As the 
PCR strategy we used did not reveal homologous recombination, Southern blot was 
used to confirm the mouse genotypes. As shown in Figure 13D, it is clear that the F1 
mice (PC4
Neo flox/+) contained one mutant allele at the target locus. PC4 is expressed in 
many if not all tissues tested (Figure 11). Since the constitutive knockout mouse strain 
was lost because of unsuccessful recovery from frozen embryos, a heterozygous 
mouse line (termed PC4+/-), which contained one wild-type PC4 allele (‘+’) and one 
mutated PC4 allele lacking both exon4 and the neo cassette (‘-’), was generated via 
ubiquitous Cre recombinase-mediated excision [F1 mice were mated with Cre-deleter 
mice (CMV-Cre) (Schwenk et al. 1995; Rodriguez et al. 2000)] in order to investigate 
its general physiological function. The heterozygote state was confirmed by PCR and 
Southern blot analyses (Figure 13E-F). Since the first generation of PC4+/- mice 
contains the Cre transgene initially, the heterozygous mice were back-crossed with 
C57BL/6J mice to exclude this gene. After the PC4+/- mouse strain (without Cre 
transgene) was established, it was maintained by crossing with wild-type C57BL/6J 
mice. All mice used for further phenotypic analyses used in this work are on a 
C57BL/6J background (at least 5 generation crossed back with C57BL/6J mice). 
The conditional knockout mice can be used to investigate tissue-specific roles of PC4. 
This requires mouse strains that express Cre recombinase from a tissue-specific 
promoter. Initially, the neo cassette had to be removed via mating with mice that 
express FLP recombinase in all tissues (Rodriguez et al. 2000). Figure 15A shows the 
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genomic organization of the PC4+/flox strain. The genotype was confirmed by Southern 
blot analysis with EcoRV digestion and PCR analysis (Figure 15B-C). 
 
 
 
 
Figure 15: Construction of PC4+/flox mouse strain and confirmation of genotype. 
(A) Genome organization of the mt (flox) allele. The F1 generation was mated with FLP 
recombinase transgenic mice, and the neo resistant cassette was removed. (B) PCR 
genotyping for PC4
+/flox
 mouse strain (primers used: oWR77, oWR78, oWR79, see methods 
section 2.2.1.3). 401-407 indicates the mouse identification number. (C) Southern blot 
confirmation of PC4
+/flox
 mouse strain. Genomic DNA was digested by EcoRV and analyzed 
with the probe C.  
3.3 Phenotypic analysis of heterozygous and homozygous PC4 knockout 
mice 
Although these heterozygous mice were viable, fertile, and indistinguishable from their 
wild-type siblings in growth rates and litter sizes, no homozygous PC4 (PC4-/-) 
offspring resulted from crossing PC4+/- mice with one another. 
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3.3.1 Heterozygous (PC4+/-) and hypomorphic PC4 (PC4Neo flox/-) mice 
contain reduced protein 
To study protein levels in PC4+/+ and PC4+/- mice, spleen extracts (see methods 
section 2.2.4.2) taken from heterozygous and wild-type mice were analyzed by 
Western blot analysis. Extracts from PC4+/+ spleens had higher PC4 protein levels 
than PC4+/- (Figure 16). Furthermore, there are reports (Frank et al. 2002; Hu et al. 
2004) indicating that hypomorphic alleles (containing the neo allele) can decrease the 
mRNA levels of target genes. So we tested whether tissues from the PC4 
hypomorphic (PC4Neo flox/-) mutant mice (obtained by cross PC4Neo flox/+ with PC4+/-) 
contain less protein. As demonstrated in the western blot shown in Figure 16, the 
amount of PC4 in the hypomorphic (PC4Neo flox/-) mice was markedly less than that in 
either the PC4+/- or PC4+/+ mice. Although the PC4+/- and PC4Neo flox/- mice had less 
PC4 protein, they were viable and showed no obvious abnormalities. 
 
 
 
 
Figure 16: Analysis of PC4 protein levels in spleen of PC4+/-, PC4Neo flox/- and 
PC4+/+ mice.  
(A) Western analysis of whole spleen lysates of heterozygous (PC4
+/-
), hypomorphic (PC4
Neo 
flox/-
) and wild-type (PC4
+/+
) mice. Lysates (9 g, 36 g) were analyzed with polyclonal 
antibodies directed against PC4 and RNA Polymerase II. (B) Western blot analysis of spleen 
lysates from other three different genotype mice versus A. 
3.3.2 Loss of PC4 causes embryonic lethality in postimplantation stage   
Intercrosses of PC4+/- mice (Figure 17A) never resulted in viable PC4-/- mice. To 
determine the precise time point of embryonic death, embryos from different stages of 
development were collected for PCR genotyping and phenotype analysis. At E9.0, 
only embryonic debris genotyped to be homozygous for the knockout allele could be  
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Figure 17: Analysis of PC4-deficient embryos. 
(A) Genotype analysis of PC4
-/-
 newborns and embryos in different development stages (B) 
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Morphology of PC4
+/+ 
versus PC4
-/-
 embryos at E7.5. (C) PCR genotyping of E7.5 embryos 
shown in panel B (upper panel: PCR genotyping with primers oWR83, oWR79, oWR81, see 
methods section 2.2.1.3; lower panel: nested PCR genotyping with primers oNL1, oNL36, 
oNL37, oNL38, oWR80, oWR83, see methods section 2.2.1.4) (D) Morphology of PC4
+/+ 
versus 
PC4
-/-
 embryos at E8.5. The PC4 deficient embryo is much smaller and disorganized than its 
wild-type littermate. (E) PCR genotyping of E7.5 embryos shown in panel D (upper panel: PCR 
genotyping with primers oWR83, oWR79, oWR81, see methods section 2.2.1.3; lower panel: 
nested PCR genotyping with primers oNL1, oNL36, oNL37, oNL38, oWR80, oWR83, see 
methods section 2.2.1.4). 
 
collected from small deciduas, while wild-type and heterozygous embryos were 
isolated from normal-sized deciduas. This suggests that PC4-/- embryos died before 
E9.0. At E7.5, the PC4-/- embryos reached normal Mendelian frequencies, but were 
dramatically smaller than wild-type embryos and did not contain normal structures 
(Figure 17B). At E8.5, the PC4-/- embryos were collected that were developmentally 
retarded, having a smaller size and abnormal morphology (Figure 17D), whereas the 
wild-type and PC4+/- embryos formed a visible embryonic axis, a defined head, somites, 
and other embryonic structures. Although the E8.5 mutant embryos exhibited some 
variation in size, even the largest mutant embryo was much smaller than its littermate 
control. All of the disorganized embryos seemed to be in the process of resorption. 
Intact deciduas of E5.5-E7.5 embryos were subjected to histological sectioning to 
better understand the defects present in the PC4-/- embryos. At E5.5, wild-type, 
heterozygous, and PC4-/- embryos showed similarities in size and structures (Figure 
18A). At E6.5, normal embryos underwent a process of rapid cell division and 
elongation to form the egg cylinder (Figure 18B, left). A clear boundary was seen 
between embryonic and extraembryonic portions and wild-type embryos exhibited a 
well-organized ectoderm, endoderm, and primitive streak region. In contrast, the 
mutant embryos showed various defects. The less severe mutant (Figure 18B middle) 
had no detectable primitive streak and thin embryonic endoderm and ectoderm. 
However, the more severe mutant PC4
-/- embryo (Figure 18B right) was much smaller 
and underdeveloped, and no defined structures could be identified. At E7.5, wild-type 
embryos had a well defined mesodermal layer between the endoderm and ectoderm, 
and the amnion was clearly visible (Figure 18C left), the PC4-/- embryos 
morphologically lacked a distinguishable extraembryonic portion and an ectoplacental 
cone. There was two-layered, round egg cylinder embryonic tissue, which was about 
half the size of the wild-type embryo (Figure 18C right). Embryonic endoderm and 
ectoderm were visible, but the mesoderm cell layer seems to be absent in these 
mutants. From these results, we conclude that PC4-/- embryos survived through the 
blastula stages and exhibited normal implantation, but arrested at around E7.5. Thus, 
PC4 appears to be essential for embryonic development beyond E7.5 in mouse. 
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Figure 18: Histological sections of embryos between E5.5 to E7.5.  
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(A) Hematoxylin and eosin staining of sagittal sections of E5.5 PC4
+/+
, PC4
+/-
, and PC4
-/-
 
embryos. (B) Hematoxylin and eosin staining of sagittal sections of E6.5 PC4
+/+
 and PC4
-/-
 
embryos. Wild-type embryos have initiated the formation of a primitive streak and show an 
elongated egg cylinder, however, the knockout embryos (middle) show underdeveloped 
embryonic endoderm and ectoderm or are smaller. (C) Hematoxylin and eosin staining of 
sagittal sections of E7.5 PC4
+/+
 and PC4
-/-
 embryos. The wild-type embryo has well-defined 
embryonic and extra-embryonic structures. A layer of mesodermal cells is visible between the 
ectoderm and endoderm. The PC4
-/-
 embryo has only a two-layered, rounded egg cylinder and 
no extra-embryonic ectoderm, endoderm, or mesoderm. (D) Genotype analyses (primers used: 
oNL1, oNL36, oNL37, oNL38, oWR80, oWR83, nested PCR, see methods section 2.2.1.4) of 
all embryos shown in A, B, C. Arrows indicate the corresponding structures of the embryo. 
Numbers are the embryo identification numbers used for genotyping analyses. ecp, 
ectoplacental cone; eec, embryonic ectoderm; een, embryonic endoderm; ems, embryonic 
mesoderm; ps, primitive streak; xec, extra-embryonic ectoderm; xen, extra-embryonic 
endoderm; xms, extra-embryonic mesoderm. 
3.3.3 PC4-/- embryos exhibited normal preimplantation development 
To evaluate the effects of PC4 knockout on preimplantation development, embryos at 
the blastocyst stages were derived from PC4+/- mice crosses and genotyped. In this 
stage, homozygous blastocysts achieved normal Mendelian frequencies (Figure 17A). 
Furthermore, a time-lapse experiment was performed on preimplantation embryos for 
morphological analysis. Embryos at the two-cell stage were flushed from oviducts at 
E1.5 and cultured on a microscope stage with time-lapse image recording. After 
finishing the observation, each embryo was genotyped by nested PCR (Figure 19D). It 
was found that PC4-/- embryos cleaved normally from the two-cell to the eight-cell 
stage (Figure 19A-B), then compacted quickly and cavitated normally to form regular 
blastocysts at E3.5 (Figure 19C). Compared with wild-type preimplantation embryos, 
PC4-/- embryos did not differ in morphology, size, or total cell numbers during 
development. Hence, these observations clearly indicated that the knockout of PC4 
did not compromise embryo development at the preimplantation stage. 
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Figure 19: Preimplantation development of PC4-deficient embryos. 
(A) Morphology of two- to four-cell stage embryos isolated from oviducts. (B) Morphology of 
eight-cell stage embryos after one day culture in vitro. (C) Blastocyst-stage embryos at E3.5. (D) 
Nested PCR genotyping analysis of preimplantation embryos shown in A-C (primers used: 
oNL1, oNL36, oNL37, oNL38, oWR80, oWR83, nested PCR, see methods section 2.2.1.4). 
Red arrows and numbers indicate homozygous embryos; blue lines and numbers indicate wild-
type embryos.  
3.4 PC4 expression in mouse preimplantation embryos  
PC4, as a general positive transcription cofactor, is very active during preimplantation 
development, when the expression of a vast number of genes is initiated during 
activation of the zygotic genome around the two-cell stage. Eventually, differential 
gene expression results in differentiation of cell lineages for the three germ layers 
(trophoblast, hypoblast, and epiblast). Due to the lack of data concerning the pattern of 
PC4 expression at early embryonic stages, in vitro fertilization oocytes were studied 
for the presence of PC4 using immunostainning with a specific PC4 polyclone antibody 
(Figure 20). In unfertilized eggs, PC4 is diffusely localized in the cytoplasm and is 
excluded from  
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Figure 20: Immunodetection of PC4 in fertilized oocyte.  
Unfertilized oocytes and in vitro fertilized zygotes as well as two-cell stage embryos were 
histochemically stained to detect nuclear localization of PC4 during preimplantation 
development. Heterochromatic DNA was visualized by DAPI (blue) staining. PC4 was detected 
by primary polyclonal antibody from rabbit with Rhodamine Red-X-conjugated anti-rabbit 
secondary antibodies (red or green). Red arrows indicate the structures of zygotes.  
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Figure 21: Distribution of PC4 in mouse morula and blastocyst.  
(A) Localization of PC4 at the 8-cell, morula stage. (B) Localization of PC4 at the blastocyst 
stage. PC4 was detected by primary polyclonal antibody and Cy3-conjugated secondary 
antibody (red) 
 
the condensed metaphase chromosomes. After fertilization, in addition to its 
cytoplasmic localization, PC4 enters into the two maternal and paternal pronuclei. 
Interestingly, the factor accumulates at the nucleoli few hours after fertilization [till 5 
hours after in vitro fertilization (5h IVF)]. At 8hIVF, PC4 is then localized in the nucleus 
and highly overlapped with DAPI staining (heterochromatin). At the two cell stage, PC4 
signals become more pronounced. At the morula (Figure 21A) and blastocyst (Figure 
21B) stages, PC4 is concentrated in nucleus versus the cytoplasm. The nuclear 
localization is unrelated to DAPI staining, indicating that PC4 was localized with 
euchromatin instead of heterochromatin at the morula and blastocyst stages. The 
dynamic localization of PC4 might indicate a role in early embryo development. 
3.5 Generation and phenotypic analysis of PC4 knockout (KO) ES cells  
3.5.1 Reduced proliferation rates of PC4 KO ES cells 
Based on the observation that PC4 knockout blastocysts are viable and 
morphologically normal, we hypothesized that ES cells could be generated from them. 
PC4 KO ES cells could serve as a model to dissect the molecular functions of PC4. 
Beyond it, ES cells have the inherent capacity to develop into different cell types in 
vitro. Hence, they could be used as a differentiation model to study the role of PC4 in it. 
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Cell proliferation and differentiation events are closely involved in the processes of 
early embryogenesis. In vivo, the cell population initially doubles every 24 hours, and 
doubling time decreases to 12 hours close to the onset of gastrulation. ES cell lines 
were established following the procedure described below. After plating the 
blastocysts on inactivated mouse embryonic fibroblasts (MEFs) with ES cell culture 
medium, the outgrowth of ICM of the embryos were formed around 7 days later. The 
ES cell like colonies that were derived from the outgrowth were detected after several 
weeks (see methods section 2.2.2.3.3). Since the PC4 knockout embryos grew so 
slowly and were very sensitive to the environment, it took around one year to establish 
the two homozygous PC4 null ES cell lines. When compared at high magnification 
(200x), both WT and KO cell lines showed the same typical morphology of ES cell 
colonies (Figure 22A). However, at lower magnification (40x), colony densities of PC4 
KO
 ES cells were reduced compared to wild-type ES cells. As expected, PC4 KO ES 
cells did not contain detectable levels of PC4 as determined by Western blotting 
(Figure 22B). Deletion of the wild-type allele was also confirmed in PC4 KO ES cells 
by using PCR analysis (Figure 22B). Growth rates of KO cell lines were significantly 
below the one of the wild-type cell lines (Figure 22C). The doubling time of PC4 null 
ES cells was 34 hours, while wide-type ES cells had a doubling time of approximately 
15 hours. These observations suggest that PC4 is necessary for normal cell 
proliferation rates. 
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Figure 22: Morphology and growth curves of PC4 wild-type (WT) and knockout 
(KO) ES cells. 
(A) Morphology of wild-type (WT) and knockout (KO) ES cells at 40x and 200x magnification. 
(B) PCR genotyping and western blot analysis of different WT versus KO ES cell lines. ES cell 
lysates were analyzed with polyclonal antibodies against PC4 and a mouse monoclonal 
antibody against -tubulin (as a loading control). (C) Cell growth curves. WT and KO ES cells 
were seeded in culture dishes, and the cell numbers were determined at the indicated times 
thereafter. Data are means ± SD from three independent experiments. 3B1, H2, 2D, 2E and F7 
in this figure indicate clone numbers of the ES cell lines. These clone numbers are used 
thereafter.  
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3.5.2 The reduced proliferation in PC4 KO ES cells is not due to an 
increase in apoptosis 
Because the depletion of PC4 in ES cells resulted in a significantly lower growth rate, 
the question arose whether this might have been due to cell loss via apoptosis. To 
investigate this possibility, we performed an apoptosis assay. The apoptotic program is 
characterized by certain morphological changes, including one of the earliest features, 
loss of plasma membrane integrity. In apoptotic cells, the membrane phospholipid 
phosphatidylserine (PS) is translocated from the inner to the outer leaflet of the plasma 
membrane, thereby exposing PS to the external cellular environment. Annexin V is a 
35-36 kDa Ca
2+-dependent phospholipid-binding protein that has a high affinity for PS, 
and can bind to cells with exposed PS. Conjugated to FITC, Annexin V serves as a 
sensitive probe for flow cytometry analysis of cells that are undergoing apoptosis at 
the early stage. Another fluorescent agent, propidium iodide (PI), is excluded by viable 
cells with intact membranes, whereas the membranes of dead and damaged cells are 
permeable to PI. Therefore, using flow cytometry analysis, FITC Annexin V- and PI-
negative cells represent viable, non-apoptotic cells, FITC Annexin V-positive and PI-
negative cells represent early apoptotic cells, FITC Annexin V- and PI-positive cells 
represent end stage apoptotic cells or early necrotic cells, and PI-positive cells 
represent the late necrotic or dead cells. We analyzed two WT and two KO ES cell 
populations for apoptosis. As shown in Figures 23, the percentages of viable cells, 
pre-apoptotic cells, late apoptotic or early necrotic cells, and late necrotic or dead 
cells, did not differ significantly between the WT and KO ES cell lines. Thus, the loss of 
PC4 did not induce apoptosis, and apoptosis cannot be considered an explanation for 
the proliferation defective phenotype observed in PC4 KO ES cells.
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Figure 23: Flow cytometry analysis to determine the number of apoptotic cells 
induced by PC4 deletion 
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(A) Representative dot plots from flow cytometry. The WT and KO ES cells were stained with 
FITC Annexin V in conjunction with propidium iodide (PI) (‘FL3 PJ’ channel) for Fluorescence-
activated cell sorting (FACS) analysis. (B) Percentages of apoptotic cells (as assayed by 
Annexin V expression), dead or late necrotic cells (as assayed by PI-positive cells), late 
apoptotic or early necrotic cells (as assayed by both Annexin V- and PI-positive cells), viable 
cells (as assayed by both Annexin V- and PI-negative cells). Error bars represent SD and 
means are of three independent experiments with two biological samples. WT and KO ES cell 
lines used here were F7, 2D, H2, 3B1. 
3.5.3 Human PC4 partially rescues the slow growth phenotype seen in 
PC4 KO ES cells 
To ascertain whether the low growth rate of PC4 KO ES cells could be rescued by 
ectopic expression of PC4, a plasmid vector with human PC4 cDNA was transiently 
transfected back into the KO ES cells. The human PC4 full length DNA, which is highly 
conserved in mouse, was fused with an EGFP-coding sequence at its N-terminal end 
to visualize the transfection efficiency (Figure 24A). The resulting fusion protein was 
assumed to be functional as it replaced endogenous PC4 in both human and mouse 
cell lines in DNA damage recognition (Mortusewicz et al. 2008). After electroporation 
of the linearized EGFP-mock and EGFP-PC4 vectors, approximately 30% of the ES 
cells were transfected, based on EGFP expression. We also confirmed the fusion 
protein expression in KO ES cells by Western blot (Figure 24B). After neomycin 
selection for five days, the growth rates of the transfected WT and KO ES cells were 
evaluated. The growth rate of KO
 cells transfected with EGFP-PC4 was higher than 
that of the mock-transfected KO cells; however, it was still lower than that of the mock-
transfected WT ES cells (Figure 24C). The doubling time changed from 35 hours in 
KO to 28 hours in the rescue situation. These results demonstrated that PC4 did play 
a role in cell proliferation regulation. Further proof for the crucial role of PC4 in cell 
proliferation came from conditional knockdown experiments (Xiaoli Li, Jianming Xu, 
Sanghamitta Singhal, Thomas Albert unpublished observation). Together data 
suggested that the KO ES cell lines contained no artificial genetic mutation that 
caused the observed proliferation defect, and re-expression of human PC4 in mouse 
cells partially rescued the reduced proliferation phenotype observed following PC4 
depletion. 
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Figure 24:  Human PC4 partially rescues the slow growth of KO ES cells 
(A) Arrangement of EGFP-PC4 fusion expression vector. PC4 is from human cDNA that 
encodes 127 amino acids. (B) Western blot analysis of transfected WT (F7) and KO (3B1) ES 
cell whole lysates prepared after 10 days following transfection and selection. ES cell lysates 
were analyzed with polyclonal antibodies against PC4 and a mouse monoclonal antibody 
against -tubulin. (C) Viable cells were counted at various time points (0-4 days) after 
transfection with mock and EGFP-PC4 vectors. 
3.5.4 Tetraploidy was occasionally observed in ES cells lacking PC4 
Cell cycle arrest might be another explanation for the reduced cell proliferation seen in 
PC4 KO ES cells. To examine this possibility, we analyzed the cell cycle progression 
in three WT and two KO ES cell lines by flow cytometry. All the WT ES cells showed 
the expected, normal cycle progression (Figure 25A): about 28% of the cells were in 
G1 phase, 60% in S phase, and 12% in G2/M phase. One of the KO ES cell lines also 
exhibited a normal cell cycle, whereas the other proceeded through S-phase without 
an intervening mitosis, and became tetraploidy (Figure 25A). The tetraploid cell 
population in G1 is difficult to distinguish from the G2 phase of the normal cell 
population. Furthermore, the observed tetraploidy in PC4 KO ES cells was 
documented by karyotype analysis. As shown in Figure 25B, many metaphase plates 
of the KO ES cells contained nearly double the number of chromosomes. However, it 
was reported that hypoeuploid and hypereuploid metaphases could be found 
throughout the period of ES cell culture (Rebuzzini et al. 2008). From passage 6 to 34, 
the frequency of tetraploid cells in metaphase ES cells is about 1-2.2% (Rebuzzini et 
al. 2008). To exclude that the tetraploidy observed was due to high passage culturing, 
we used early passages of ES cells (less than 20 passages) with the same conditions 
for both WT and KO ES cells. Our data reveal that the WT and PC4 KO ES cells have 
a similar frequency of hypoeuploid chromosomes, about 7% and 10%, respectively. 
On the other hand, the proportions of cells with 40 chromosomes in the WT and PC4 
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Figure 25: Lack of PC4 could induce tetraploidy in ES cells. 
(A) Cell cycle analysis of WT and KO ES cell lines. F7 and 1A are WT ES cell lines. H2 and 
3B1 are KO ES cell lines. (B) Metaphase chromosomes of diploid and tetraploid cells. (C) The 
frequency of chromosome number distribution in WT (F7) and KO (3B1) ES cells. 
KO ES cells were notably different (66% versus. 32%, respectively). The percentage 
of KO ES cells with 70-80 chromosomes was 27%, which was remarkably higher than 
the 1% in the WT ES cells (Figure 25C). Furthermore, the tetraploid frequency was 
also much higher than that found in high passage ES cells, which suggested that the 
tetraploidy was a consequence of the loss of PC4. But the tetraploidy was not seen in 
short term knockdown experiments (Xiaoli Li, Jianming Xu, Sanghamitra Singhal, 
Thomas Albert unpublished observation). From these results, we conclude that loss of 
PC4 in ES cells may promote tetraploidy in the cells as a survival mechanism. 
3.5.5 PC4 is important for embryonic stem cell differentiation  
To explore the potential role of PC4 in differentiation we used embryoid body (EB) in 
vitro differentiation assay and in vivo teratoma formation assays. Two WT and two 
PC4 KO ES cell lines were used for EB differentiation. We observed that PC4 KO ES 
cells formed EBs, but they were slightly smaller than those differentiated from the WT 
ES cells (Figure 26A), which is due to their slower growth rate. After 16 days 
differentiation, we observed many beating cardiomyocytes (around 10%) in the culture 
dishes of WT cells in vitro. In contrast, the KO ES cells generated only few 
cardiomyocytes (about 1%). 
To investigate the genetic defects in PC4 KO ES cells, we monitored transcripts of 
well-documented markers of the three embryonic germ layers. Initially, we utilized end-
point RT-PCR analysis to monitor gene expression (Figure 26B). Undifferentiated ES 
cells highly expressed the Oct4 pluripotency marker, whereas differentiated WT and 
KO ES cells also expressed Oct4, but at lower levels, possibly due to contamination 
from remaining undifferentiated ES cells. While undifferentiated WT and KO ES cells 
did not express the three layer-specific markers: GluR6, hepatocyte nuclear factor 3 
(HNF3), -fetoprotein, H1, and -cardiac myosin, all except the mesoderm marker 
H1, were expressed in differentiated WT and KO ES cells; H1 was not detected in 
differentiated KO ES cells. We used H1 (hematopoietic lineage marker) and -
cardiac myosin (cardiomyocyte lineage markers) as markers because mesoderm cells 
can develop into cardiomyocytic and hematopoietic cell lineages incipiently. Consistent 
with our observation of beating cardiomyocytes in the differentiated PC4 KO ES cells, 
-cardiac myosin, which functions to control cardiac contractility, was detected in these 
cells. Because the differentiated PC4 KO ES cells did not express H1, we 
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hypothesize that PC4 might play a role in the differentiation of hematopoietic cells 
during embryogenesis. 
Because the traditional RT-PCR did not detect quantitative differences between KO 
and WT EBs, we analyzed further samples with more differentiation markers [(taken 
from (Landry et al. 2008)] using quantitative real-time PCR. During the differentiation 
time course (8 days and 16 days), Nestin, a marker of neural stem cell progenitors 
derived from the primitive ectoderm, was elvated in KO compared with WT EBs at day 
8, whereas it dropped to wild-type level at day 16. This indicated that loss of PC4 
induced the ES cells to differentiate into neural cells early on. However, we did find 
significantly lower expression of the primitive ectoderm markers Fgf5 and Otx2 in the 
KO compared with the WT differentiated ES cells during the entire differentiation time 
course (Figure 27), indicating connections between PC4 and the differentiation of 
primitive ectoderm. As markers of endoderm differentiation, we observed 
overexpression of Sox17, Gata4, and Hnf4 in KO differentiated ES cells compared to 
WT during the entire period, implying that depletion of PC4 may moderately favor 
endoderm differentiation. In other words, PC4 might normally play a role in repressing 
endoderm differentiation. Although the mesoderm markers T and Fgf8 were 
significantly underexpressed in PC4 KO EBs compared to WT (Figure 27), especially 
at day 8, two other mesoderm markers, Evx1 and Wnt3, were highly expressed in the 
early PC4 KO EBs. At a later stage, when both genes were upregulated in WT 
differentiated cells, their levels in KO were still lower than in WT. In summary, the 
qPCR results clearly indicated that PC4 was involved in certain processes related to 
the differentiation of all three germ layers, although some differentiation markers were 
not affected by its loss.  
To evaluate the effects of PC4 KO on the differentiation of ES cells in vivo, we carried 
out a teratoma formation assay by transplanting PC4 KO ES cells into ‘severe 
combined immunodeficient’ (SCID) mice. Four weeks after subcutaneous injection, 
PC4 KO ES cells formed teratomas in 5/5 injected mice. In hematoxylin and eosin 
stained teratoma sections (Figure 28) we found tissues from all three germ layers, 
such as neural cells and keratinized epithelium (ectoderm), muscle and osteroid island 
cells (mesoderm), and columnar epithelium and pancreatic follicles (endoderm). We 
did not yet detect any cell types missing from the teratoma sections due to the PC4 
depletion. This may be due to the fact that there are more than 200 different cell types 
in mouse, and the number of tissues that can be morphologically identified in 
teratomas is very limited. Nevertheless, the gene expression studies on differentiated 
cells strongly suggest that PC4 was closely involved in cellular differentiation 
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Figure 26: Differentiation of WT and KO ES cells in vitro. 
(A) Morphology of WT embryoid bodies (EBs) (upper left) and PC4 KO EBs (lower left) (Both 
KO ES cell lines showed the same results, and the representative photos are from F7 and 3B1 
cell lines). (B) RT-PCR analysis showing expression of layer-specific markers in differentiated 
WT and KO ES cells (Both KO ES cell lines showed the same results and the representative 
gels are from F7 and 3B1). -Actin was used as a loading control. 
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Figure 27: Quantitative PCR analysis of gene expression in PC4 WT and KO 
differentiated ES cells.  
Relative expression of developmental markers during the time course of embryoid body 
differentiation (all the sequences of primers used here are listed in table 7). The expression of 
many markers of ectoderm, mesoderm, and endoderm tissue lineages were decreased or 
increased during differentiation. The mRNA levels of the various markers in 8 days 
differentiated WT ES cells were set to one, and ß-Actin expression was used as an internal 
control. Error bars represented ±SD. WT and KO ES cell lines used here were F7, 2D, H2, 3B1. 
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Figure 28: In vivo, teratoma formation assay following injections of PC4 KO ES 
cells into SCID mice. 
Four weeks after the injections, teratomas were sectioned and stained with hematoxylin and 
eosin. The micrograph shows a teratoma containing ectoderm: neural cells and keratinized 
epithelium; mesoderm: muscle and osteroid islands; and endoderm: columnar epithelium and 
pancreatic follicles. 
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3.5.6 Gene expression profiling analysis in ES cells upon loss of PC4  
3.5.6.1 Microarray data analysis  
Currently, there is very limited data available regarding the target genes of PC4. The 
number and identity is expected to provide insight into the mechanism of gene control 
by PC4. It may further explain the mechanism underlying the proliferation defect in 
PC4 KO cells. Gene expression profiling was conducted with a mouse gene 1.0ST 
array (Affymetrix) representing 28853 genes (offering whole-transcript coverage). Total 
RNA was isolated from 2 independent WT and 2 independent KO ES cell lines and 
equal amount of total RNA was analyzed by KFB (Center of Excellence for 
Fluorescent Bioanalytics, Regensburg, Germany). Eight independent arrays were 
used for the WT ES and KO ES cells. Only those genes whose expressions in all KO 
ES cells were significantly (p < 0.05) more than double or less than half of that in the 
WT ES cells, were considered to be ‘differentially expressed’ between WT and KO 
cells. We found 80 genes that fulfilled these criteria. Among them, 54 genes were 
upregulated and 26 were down regulated. The latter include 4 microRNAs genes. 
Unsupervised cluster analyses of the expression patterns of the differentially 
expressed genes are shown in Figure 29A. The candidate PC4-regulated genes were 
also classified based on the biological process annotations according to the Gene 
Ontology (GO) terms (Figure 29B). Although many genes were associated with more 
than one biological process, the GO analysis gave us some clues about the PC4-
regulated networks. The biological processes that were deregulated include 
proliferation, cell death, development (differentiation), cell communication, cell 
metabolism, cell cycle, and transcription. As the p values (observed frequency vs. 
genome frequency) for these processes were less than 0.05, the differences observed 
are significant at the whole genome level. Hence, PC4 may directly or indirectly 
modulate these physiological processes. 
We further analyzed the differentially expressed genes using Bibliosphere 
(www.genomatix.de), a bioinformatics tool developed recently to facilitate literature-
based array data analysis. This software sorts the genes according to their co-citation 
in the NCBI database to identify gene-gene relationships. Of the 80 differentially 
expressed genes we had identified, 68 of them were annotated in the Bibliosphere 
database. For example, transcription factors were listed with their co-cited candidate 
target genes. As shown in table 8, it is intriguing that out of the 37 genes co-cited with 
one of the transcription factors, Nfkb1, Stat3, Trp53, Jun, or Fos, 21 of them were co-
cited with Nfkb1, and all had binding sites for it in their promoter regions. Seventeen of  
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Figure 29: Biological features of above two fold regulated genes in microarrays. 
(A) Hierarchical clustering of the gene expression profiling data obtained by microarray analysis 
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of PC4 KO ES cells versus WT ES cells. Hybridizing samples are listed to on the top and the 
target genes are listed to the right. wt1 and wt3 are from two independent WT cell lines: F7 and 
2D. wt2 and wt4 is the duplicate of wt1 and wt3, respectively. Likewise, ko1 and ko3 are from 
two independent KO cell lines: 3B1 and H2. Ko2 and ko4 is the duplicate of ko1 and ko3, 
respectively. (B) GO (Gene Ontology) analysis of the differentially expressed genes using 
the filter of biological processes. 
 
 
 
Table 8: Microarray target genes that were co-cited together with transcription 
factors. 
Differentially expressed genes and presence of transcription factors binding sites were shown 
here. 
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Figure 30: Bibliosphere-predicted regulatory network based on differentially 
expressed genes revealed by microarray.  
Blue box: differentially expressed genes identified from microarray; white box: transcription 
factors; green line: transcription factor binging site match in target promoter; filled arrowhead: 
activation; blocked arrowhead: inhibition; red connection ball: connection annotated by 
molecular connection experts; blue connection ball: connection annotated by Genomatix 
experts; green box: BioCyc pathways. Co-citation filter used: GFG level B3, meaning that two 
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genes were co-cited in the same sentence as ‘gene...function word . . . gene’. 
 
 
the 37 genes were co-cited with and bind to STAT3, and 13 genes were similarly 
related to Trp53, and 11 of them to Fos and Jun. These data suggest that PC4 might 
regulate its target genes by forming complexes with certain transcription factors, such 
as Nfkb1. An Nfkb1-regulated network (Figure 30) was generated by the Bibliosphere 
pathway software, demonstrating its central role in these biological processes, and 
which might be connected to the phenotype we observed in the PC4 KO ES cells. 
3.5.6.2 Validation of PC4-dependent genes 
It is well known that PC4 functions as a co-activator for Pol II transcription. It was 
further reported that human PC4 (Wang and Roeder 1998) and SUB1 (the yeast 
homolog of PC4) (Rosonina et al. 2009; Tavenet et al. 2009) binds to Pol III genes. 
Moreover, SUB1 activates Pol III genes. So far, SUB1 was not found at the Pol I-
transcribed ribosomal DNA promoter. Therefore, we anticipated that the loss of PC4 
might also have an impact on the expression of Pol III-transcribed genes. Because a 
role in Pol III is not disclosed by gene expression profiling on microarrays, we 
analyzed endogenous expression of Pol III- and Pol I-transcripts using quantitative 
PCR (qRT-PCR) on total RNA from PC4 KO ES and WT cells (Figure 31). ß-Actin was 
used as an internal control. Pol I transcripts, included 5.8S, 18S, and 28S rRNAs, 
together with the Pol III-dependent transcripts, 5S rRNA, 7SKRNA and U6snRNA were 
examined. The results show that PC4 does not affect Pol I-transcribed ribosomal 
rRNAs. In contrast, expression of Pol III-dependent genes is upregulated about 1.5 
fold. Hence, loss of PC4 does not alter Pol I transcription. The increase of Pol III 
transcription level, however, could be indirect, i. e. a consequence of an altered 
number of grams in the cell.  
In addition, it was reported that p53 was a potential target gene of PC4 (Banerjee et al. 
2004; Batta and Kundu 2007). Therefore, we analyzed the expression of p53, and p53 
target genes with qRT-PCR upon loss of PC4. It is shown that the expression of p53 
and its target gene Bax is unaffected by the PC4 knockout. However, p21 expression 
in KO ES cells is 2.27 times that in WT cells. All these results suggest that loss of PC4 
may consequently upregulate p21 expression, but can not regulate the expression of 
p53 or its target gene Bax. 
Considering the low growth rate phenotype of PC4 KO cells, at the beginning, we 
hypothesized that cell cycle-related genes might also be influenced in these cells. The 
cell cycle, G1, S, G2, and M phases, is crucial for cell proliferation and growth, as well 
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as for cell division after DNA damage. Progression of a cell through the cell cycle is 
promoted by a number of cyclin-dependent kinase (CDK) complexes with specific 
regulatory proteins called cyclins (Schwartz and Shah 2005). Cyclin D isoforms (D1-
D3) (Pontano et al. 2008) interacting with CDK2,-4, and -6 drive a cell to progress 
through the G1 phase. Cyclin E/CDK2 directs the G1/S phase transition and the cyclin 
A (ccna2)/CDK2 complex controls S phase progression. In addition, cyclin A (ccna2) 
complexed with CDK1 (cdc2) is important in the G2/M phase transition. Compared 
with WT ES cells, depletion of PC4 in KO ES cells led to slightly reduced expressions 
of cyclin E1 (ccne1), cyclin D1 (ccnd1), and CDK2, but not of cyclin A (ccna2). This 
was confirmed on microarrays.  
To validate the microarray results, we listed differentially expressed genes as potential 
target genes. Seven of the genes that were upregulated and seven of those that were 
downregulated in the KO ES cells, all reported to be involved in regulation of cell 
proliferation and differentiation, were verified by qRT-PCR from two independent WT 
and two KO ES cell lines. Results showed that the corresponding transcripts were 
markedly increased by at least 100% or decreased by at least 50% in the KO ES cells 
compared to the WT, thus confirming the accuracy of our microarray data. Of the 
upregulated genes, Ddit4l was upregulated more than 4-fold in the knockout ES cells. 
Ddit4l was reported to negatively regulate the mTOR (mammalian target of rapamycin) 
pathway, which plays an essential role in cell growth control (Corradetti et al. 2005). 
Likewise, other up-regulated genes, Perp, p21, Rb1, Plk2 and Phlda1 function in cell 
proliferation, cell apoptosis and cell death processes (Burns et al. 2003; Hossain et al. 
2003; Young and Longmore 2004; Singaravelu et al. 2009). Furthermore, over-
expressing of Neurod1, which is reported to facilitate the differentiation of ES cells 
towards endocrine and insulin-producing cells (Marchand et al. 2009), could also slow 
down the proliferation of pluripotent ES cells. Among the downregulated genes, 
Sfmbt2 was dramatically repressed in PC4 KO ES cells to only 10% of the expression 
level in WT ES cells. Tdrd12 was decreased by 80%, and Gng3, Rbp1, Rragd, Fgf17, 
and Dppa3 were each reduced by around 60% in PC4 KO ES cells. Dppa3 null 
embryos were shown to rarely reach the blastocyst stage (Payer et al. 2003), so 
downregulation of Dppa3 in vivo may result in the early embryo lethality of PC4 
knockout mice. Two other pluripotent genes, Nanog and Oct4, shown to be unchanged 
in microarray analyses, were shown by qPCR to be slightly upregulated (increased 
about 50% and 40%, respectively) in KO ES cells. These data suggest that PC4 
regulates proliferation by altering the expression of other genes involved in 
proliferation. 
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Figure 31: Quantitative PCR analysis of candidate genes in WT and KO ES cells 
validates the microarray data.  
(A) Relative Pol I- and Pol III-transcribed gene expression in KO ES cells. (B) Relative 
expression of cell cycle-related genes, p53 and its target genes, and pluripotent genes in KO 
ES cells. (C) Validation of the expression of PC4 potential target genes by qRT-PCR analysis. 
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For the qRT-PCR analyses (all the sequences of primers used here are listed in table 7), gene 
expression in KO ES cells was normalized to that in WT ES cells, which was arbitrarily set to 
one. WT cell lines used in this experiment were 2D, F7 and KO cell lines used here were H2 
and 3B1. -Actin was used as an internal control gene. Error bars indicated ±SD. 
  
3.5.7 Loss of PC4 does not affect p53 activation 
It has been reported that PC4 mediate gene activation by the tumor suppressor p53. 
Furthermore, the PC4 gene is p53 target gene and p53 itself drives PC4 expression 
(Banerjee et al. 2004; Batta and Kundu 2007; Kishore et al. 2007). Mechanistically 
PC4 triggers p53 recruitment to its target genes by inducing a bent. (Batta and Kundu 
2007). Here we asked whether PC4 is critical for p53 expression and activation of the 
factor by genotoxic signals and subsequent activation of target genes. We analyzed 
protein levels and mRNA in PC4 KO and WT ES cells following their treatment with the 
p53-inducing agent doxorubicin. Four hours after the treatment, we found that the 
levels of p53 protein were highly increased in both WT and KO ES cells (Figure 32A). 
In KO ES cells, p53 was induced in a dose-dependent manner, while in WT ES cells 
p53 was induced independently of doxorubicin concentration. In the presence of 
doxorubicin, p53 was phosphorylated at Ser15 in both WT and KO ES cells, which is 
crucial for arresting the cell cycle and a sensor for DNA damage (Siliciano et al. 1997). 
The phosphorylation impairs the ability of Mdm2 to bind p53, promoting both the 
accumulation and functional activation of p53 in response to DNA damage. We also 
analyzed the mRNA levels of p53 target genes. Bax, p21, and Mdm2 were all induced 
in the PC4 KO ES cells. This was also true for p21 that was already upregulated in 
non-treated PC4 KO ES cells, and that was still markedly upregulated by doxorubicin 
treatment. In addition, doxorubicin led to a slightly higher expression of p21 in PC4 KO 
cells than in WT cells (Figure 32B). Bax, a pro-apoptotic member of the Bcl-2 family, 
has p53 binding sites in its promoter; thus, direct activation by p53 could provide a link 
with the apoptotic machinery (Miyashita and Reed 1995). However, the p53 target 
gene Bax was upregulated to a slightly lesser extent in KO ES cells than in WT cells 
following such treatment, suggesting that PC4 might play a role of in of Bax activation 
in ES cells. Another p53 target gene Mdm2 was similarly overexpressed in both KO 
ES cells and WT ES cells upon doxorubicin treatment, indicating that PC4 deletion did 
not affect Mdm2 activation. 
It was reported that p53 activation induces ES cell differentiation by suppressing 
Nanog expression (Lin et al. 2005). Nanog, a homeodomain protein expressed, as is 
Oct4, exclusively in ES cells, is required to maintain renewal and the undifferentiated 
state of ES cells. As expected, we found that Nanog mRNA was massively  
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Figure 32: p53-dependent gene expression can be activated in absence of PC4. 
(A) Upregulation of p53 protein levels at different concentrations of doxorubicin. p53 and -
tubulin expression are shown following 0.5 M and 1 M doxorubicin treatment for 4 hours 
(Whole cell lysates were prepared as methods section 2.2.4.2 and the representative Western 
blots from F7 and 3B1 cell lines are shown.). (B) mRNA levels of p53 target genes under 
different treatments in WT (F7) and PC4 KO (3B1) ES cells. The quantitative PCR (all the 
sequences of primers used here are listed in table 7) was normalized with ß-Actin, and the 
mRNA levels in untreated WT ES cells were set to one. 
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downregulated in both WT and KO ES cells after p53 activation, without any effect on 
Oct4 mRNA. However, the downregulation of Nanog was more severe in PC4 KO ES 
cells than in WT cells in response to doxorubicin (Figure 32B). In conclusion, these 
results indicate that, although PC4 is not required for p53 activation, PC4 is important 
for maintaining embryonic stem cell homeostasis and it might be involved in the DNA 
damage response. 
3.6 Down-regulation of PC4 in MEFs induced a similar proliferation 
phenotype as PC4 KO ES cells 
To extend our findings of PC4 in differentiation cells, we further investigated PC4 
function in mouse embryonic fibroblasts (MEFs). PC4 protein is present in MEFs, but 
only at a level of about 10-20% of that detected in ES cells (Figure 33A). To explore 
the function of PC4 in MEFs, we preformed knockdown experiments by transient Cre 
expression in PC4flox/- MEFs. We used Cre recombinase plasmids to transfect the 
MEFs and to induce genome deletion, and one week of drug selection to concentrate 
the transfected cells. Then we evaluated the numbers of surviving cells from the mock 
and Cre transfection. As shown in Figure 33B, we seeded the same number of cells 
for transfection at Day -1, then transfected (Day 1) and selected until Day 9. The 
number of surviving cells was much lower in the Cre-transfected MEFs than in the 
mock-transfected cells (Figure 33B), indicating reduced proliferation of the PC4-
depleted MEFs, as we observed for the PC4 KO ES cells. Therefore, we assume that 
PC4 is important for cell growth in general in different types of cells. 
At the molecular level, we tried to elucidate whether the PC4 target genes affected by 
the loss of PC4 in ES cells were also targets in other cell types, or whether they were 
targets only in ES cells. When PC4 was downregulated to about 5% of that in WT 
MEFs, 5S rRNA, 7SK, and U6 snRNA transcriptions were reduced about 50-60% 
(Figure 33C), contrary to the results found in ES cells. However, 5.8S rRNA, 28S 
rRNA, and 18S rRNA transcriptions were not significantly affected (increased or 
decreased about 10-20%) by the depletion, which is in agreement with the results from 
ES cells. Therefore, PC4 seems to regulate Pol III- rather than Pol I-dependent gene 
expression in vivo. Hence, in various cell types, PC4 is involved in regulation of Pol III 
transcription.  
Because of the low transfection efficiency and reduced proliferation of PC4 knockdown 
MEFs, it was impossible to get enough material to repeat all experiments performed in 
the ES cells, but we did test a few potential target genes in PC4 knockdown MEFs. We 
found that p21 and Ddit4l were consistently upregulated and Sfmbt2 was 
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downregulated in MEFs and ES cells upon PC4 depletion, but the changes were less 
in MEFs than is ES cells. However, Rragd, which was reduced in PC4 KO ES cells, 
was increased about 50% upon PC4 knockdown in MEFs. Furthermore, Rb1 was 
decreased by only about 20% in knockdown MEFs, whereas it was increased by 130% 
upon PC4 knockout in ES cells. These data indicate that PC4 regulates its potential 
target genes in different ways during cell differentiation in vivo. 
 
 
Figure 33: Phenotype analysis of MEFs upon PC4 knockdown. 
(A) Western blot analysis of endogenous PC4 protein levels in WT MEFs compared with those 
in WT (F7), heterozygous (clone number of this cell line is 2D2), and PC4 KO (3B1) ES cells. 
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(B) Lower growth of MEFs when PC4 was downregulated. Day -1: flox/- MEFs seeded for 
transfection; Day 9: MEFs cultured after drug selection. (C) Analysis of the mRNA levels of 
each gene in mock and Cre-induced MEFs. The quantitative PCRs were normalized with ß-
Actin and relative gene expression was normalized to mock transfected WT MEFs (set to one) 
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4. DISCUSSION 
4.1 PC4 is required for embryogenesis  
The classical PC4 knockout mouse generated by Gertraud Stelzer in our lab showed 
embryonic lethality as early as the preimplantation stage, indicating that PC4 is 
essential for mouse embryonic development. However, not all physiological processes 
could be assessed by this constitutive gene inactivation strategy, and this mouse 
strain could not be recovered from frozen embryos. Therefore, the new conditional 
knockout model provided a powerful tool to gain insights into the biological roles of 
PC4. Although the constitutive knockout mouse already showed lethality in 
preimplantation embryos, it was still of great significance to identify whether PC4 null 
embryos could survive in the new PC4 knockout mouse strain. The fact that 
homozygous PC4
-/- mutants died in utero around E7.0, confirmed that PC4 is essential 
for early stage embryogenesis. Compared with constitutive knockout mice, in which 
both exons 3 and 4 were deleted, the new “constitutive” exon 4 knockout mice 
exhibited a less severe embryonic lethality phenotype. This might possibly have been 
explained by the different targeting strategies; however, the early embryo lethality 
phenotype was present using both targeting strategies. As PC4-/- embryos were 
smaller and disorganized at E6.5 when gastrulation (characterized by massive cell 
proliferation) starts, the major cause of embryonic lethality was possibly due to 
impaired proliferation. This brings up the question of whether the preimplantation 
mutant embryos could have developed normally. After viewing cultured two-cell stage 
embryos in vitro via time-lapse microscopy, we concluded that preimplantation 
embryos did not appear to suffer from the loss of PC4. The survival of embryos to the 
blastocyst stage was likely due to maternal PC4. However, as the embryos developed, 
cell proliferation and differentiation become more important, and the lack of PC4 did 
not support life. Surprisingly, PC4
+/- mutant mice did not exhibit developmental 
problems. Even though there was much less PC4 protein in hypomorphic mice, there 
were no differences in the viabilities of homozygous, heterozygous, and hypomorphic 
mice. This suggests that PC4 functions in a dose-independent way, and that small 
amounts of PC4 are sufficient.  
This study is the first to characterize the physiological roles of PC4 in a knockout 
model and there are, as yet, few knockout studies of other positive transcription 
cofactors. PC1 (PARP) and other transcription cofactors show little sequence 
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homology, which proved to be nonessential in vivo for most of the functions suggested 
by the in vitro studies, with knockout mice showing few defects in nucleotide excision 
and base excision-repair (Wang et al. 1995). Four genetic studies of the murine 
TRAP/Mediator (PC2) have shown that TRAP220, SRB7, Trap100, and Med23 
subunits are essential for embryogenesis but with quite different degrees of phenotypic 
severity. Trap220-/- embryos are viable up to E11.0, and the differentiation of primitive 
organs expected at this stage is apparent but incomplete (Ito et al. 2000; Zhu et al. 
2000). It also showed that TRAP220-/- primary embryonic fibroblasts impaired cell 
cycle regulation (Ito et al. 2000). In contrast, Srb7-/- embryos are viable only up to the 
blastocyst stage, through which maternal SRB7 remains (Tudor et al. 1999). Culturing 
of homozygous knockout blastocysts yielded no outgrowth, indicating that Srb7 was 
essential for ES cell viability. The phenotypic severity of the Trap100-/- embryos is 
intermediate between that of the Trap220 and Srb7 mutations, and the Trap100 and 
Trap220 double mutations augment the phenotypic severity (Ito et al. 2002). The 
present studies showed that Med23-/-  mice were embryonic lethal around 10.5 days of 
gestation (Wang et al. 2009). These indicate that TRAP/Mediator is essential for cell 
viability, but that a given mutant phenotype is variable and dependent upon the subunit 
composition of the residual TRAP/Mediator. Taken with our results, these data suggest 
PC4 is as important as other cofactors in mammals, although SUB1 is nonessential for 
the yeast growth in standard growth conditions.  
4.2 Distinct localization of PC4 during fertilization implies a role in 
maintenance of genome methylation  
In unfertilized eggs, PC4 was localized in the cytoplasm and excluded from condensed 
metaphase chromosomes. After fertilization, PC4 was mainly located in the two 
pronuclei, while cytoplasmic localization increased initially and then decreased 
significantly in late stage zygotes. From the 2-cell to the blastocyst stage, PC4 was 
mainly restricted to the nucleus. The dramatic change in the localization of PC4 
indicated that it must play a crucial role after fertilization and before the 2-cell stage. 
During this developmental phase, many molecular events occur, including zygotic 
genome activation (Hamatani et al. 2006) and drastic alterations in genome 
methylation status (Mayer et al. 2000b; Mayer et al. 2000a; Santos et al. 2002). The 
increased PC4 in pronuclei after fertilization was attributed to either the translation of 
maternal stored mRNA or translocation of cytoplasmic protein. As a transcription 
cofactor, PC4 is very active and involved in genome activation, which was borne out 
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by the large amounts of PC4 concentrated for rRNA preparation in nucleoli after 
fertilization. Although the intensity of PC4 expression was less in the 2-cell to 
blastocyst stages compared with that found in zygotes, it was preferentially localized to 
euchromatin rather than heterochromatin to activate transcription. Similar to the PC4 
localization pattern we observed during fertilization, PGC7/Stella/Dppa3, a maternal 
factor essential for early development, translocates from the cytoplasm to pronuclei to 
protect the maternal genome from demethylation (Nakamura et al. 2007). Does PC4 
play a similar role or co-function in genome demethylation in early embryogenesis? If 
PC4 were involved in maintenance of methylation after fertilization, it would be 
interesting to determine whether it is associated with epigenetic regulation. To address 
this issue it might be useful to explore the methylation status of histone H3K9 (H3K9) 
(Santos et al. 2005), or to compare the sequences of maternally imprinted, paternally 
imprinted, and non-imprinted genes in PC4 null zygotes with those in wide-type 
zygotes. From our microarray data on PC4 knockout ES cells showing that Dppa3 was 
decreased, we expect that demethylation was increased in many target genes.  
4.3 PC4 is important for the embryonic stem cell growth 
To improve our understanding of the functions of PC4 in early embryonic development 
and ES cell differentiation, we tried to generate knockout ES cells. Because the 
heterozygous knockout mice was viable and no obvious phenotype was observed, we 
established PC4 KO ES cells from blastocysts obtained from PC4+/- mice intercrosses. 
Blastocysts from different genotypes were cultured on feeder layers of MEFs, and 
outgrowths were observed after 5 days in vitro culture. The morphologies of 
outgrowths from knockout and wild-type blastocysts were similar, and inner cell 
masses (ICM) developed in both genotypes. Although the ES cell-like colonies in the 
outgrowths grew and proliferated much more slowly from knockout blastocysts than 
from wild-types, the PC4 KO ES cells still survived and were suitable for in vitro culture. 
Taken together, these observations provided strong evidence that PC4 was important 
for ES cell proliferation. Together with the observed formation of morphologically 
normal blastocysts, this experiment suggests that the differentiation of ES cell 
equivalents in vivo was not initially disturbed, but the amplification of this population 
was partially compromised, thereby resulting in inhibition of in vitro proliferation of 
ICM-derived ES cells. Because the ES cells were similar to epiblasts at the blastocyst 
stage, we suggest that the PC4 null embryos died around gastrulation in vivo due to a 
repressed proliferation of PC4 knockout ES cells in the ICM, which could decrease 
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expansion in preimplantation embryos. Once the embryos are implanted, gastrulation 
becomes stronger and faster proliferation is required. The slow proliferation speed of 
epiblasts cannot provide enough cells for differentiation and organogenesis, which 
leads directly to embryonic death. Furthermore, the constant presence of maternal 
PC4 protein and other possible factors provided by the developing trophectoderm 
and/or maternal tissues in the in vivo situation might have temporarily compensated for 
the loss of PC4 until gastrulation. 
4.4 Does PC4 have similar proliferation phenotypes in primary cells as in 
somatic cells? 
Because ES cell lines are a unique system and are pluripotent compared with other 
somatic cell lines, it is meaningful to examine whether PC4 functions similarly in other 
cell types. The first candidate was mouse embryonic fibroblasts (MEFs), a primary 
mouse cell line. Although MEFs have lower PC4 protein levels than ES cells do, it 
seems this protein is very important for cell growth, because dramatically slower 
proliferation occurred after PC4 was knocked down. These data suggest that the effect 
of PC4 in proliferation is same. As MEFs are derived from late stage embryos (E13.5) 
and ES cells are from preimplantation embryos, one might suspect that PC4 functions 
differently in distinct developmental stages, especially because proliferation is so 
important in early embryonic stages. Moreover, the large amounts of PC4 exist in early 
developmental stages may suggest that it is more important for embryogenesis than 
for organogenesis.  
Do carcinoma cell lines show similar phenotypes when PC4 is knocked down?  We 
used a siRNA strategy for knocking down PC4 in vivo, and found that HeLa cells did 
not show any inhibition of proliferation with two different siRNAs targeting endogenous 
PC4. In contrast, A549 cells exhibited opposite effects following two different siRNA: 
one had no effect and the other reduced proliferation. HeLa cells contain no detectable 
p53 protein due to the degradation of endogenous E6 protein, whereas A549 cells 
express p53. Could it be that p53 was influenced to affect cell growth when PC4 was 
knocked down? This is one possibility, and another might be off-target effects of the 
siRNA-PC4-TK, recently reported by Das et al (Das et al. 2006). To clarify this issue, 
we have already tried a new siRNA pool targeting human PC4 consisting of a mixture 
of four siRNAs. The results showed that A549 cells did not proliferate slowly when 
PC4 was downregulated by this pool of siRNAs. Current ongoing research clearly 
answered the question of whether siRNA-PC4-TK has side effects. Taken together, 
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our results in carcinoma cell lines demonstrate that PC4 knock down did not alter 
proliferation, contrary to what happened in ES cells and MEFs. The reason for this 
difference appears to be incomplete deletion of PC4 carried out with siRNA in these 
cells. This abundant protein can apparently function very well even though only small 
amounts are left, which bodes well for the viability of hypomorphic PC4 knockout mice. 
Furthermore, PC4 might be substituted by other factors in somatic cell lines to rescue 
the deficiencies induced by PC4 knockdown.  
 
4.5 Mechanisms underlying reduced proliferation upon loss of PC4  
4.5.1 Loss of PC4 induced abnormal cell cycle, which inhibited cell 
proliferation. 
All of the PC4 knockout ES cells derived from blastocysts showed similar 
morphologies and were slower to proliferate than wild-type ES cells. To understand 
how this phenotype arose, we performed cell cycle analyses. Surprisingly, one of the 
two PC4 knockout ES cell lines exhibited tetraploidy in about 30% of the cells, which is 
quite high compared with that found in wild-type ES cells. Polyploidy (e.g., tetraploidy, 
octaploidy) is observed in a large variety of both plant and animal cells during normal 
development or under stress, while aneuploidy is never detected in normal cells. 
Tetraploidy or aneuploidy can be induced by several signals and is prevalent in 
different forms of cancer cell lines. Because the PC4 KO ES cells proliferated with 
tetraploidy, we wondered whether the tetraploidy was a protective mechanism against 
stress, or rather a maladaptive response. Numerous studies have shown that normal 
diploid cells can be induced to undergo polyploidization via endomitosis. For example, 
hypertension can induce vascular smooth muscle cells and cardiac myocytes to 
become polyploid (Chobanian et al. 1984; Hixon et al. 2000). In these cases, 
polyploidy is believed to be a protective mechanism to prevent cellular proliferation. 
Similarly, based on the phenotype of PC4-depleted ES cells, we hypothesized that 
tetraploidy inhibits proliferation to compensate for mutations introduced by the 
knockout of PC4. In addition to tetraploidy, there might be other unknown pathways to 
coordinate this abnormal cell status.  
Does PC4 regulate cyclin complexes to influence the cell cycle? It is reported that 
tetraploidy can be induced by the aberrant expression of proteins regulating the G2/M 
transition (Cyclin-B1, Aurora-A, Forkhead transcription factor, M3) (Hauf et al. 2003; 
Shin et al. 2003), or by mitotic spindle checkpoint proteins (BUBR1, Mad2, Aurora-B, 
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Survivin) (Barr et al. 2004; Meraldi et al. 2004), leading to abortive cytokinesis. Our 
qRT-PCR study showed that CyclinE1 and Cdk2 were slightly downregulated upon 
PC4 depletion, Ccna2 and ccnd1 were unaffected, and p21 was highly upregulated. It 
is reported that p21 plays an important role in regulating mitotic cell cycles and 
induces polyploidy together with p27 (Ullah et al. 2009). p27 is primarily responsible 
for preventing the cell from premature entrance into S-phase, a role that is common to 
mitotic cells and endocycles. p21 can facilitate this role and helps to prevent 
premature entrance into M-phase. The upregulation of p21 is responsible for DNA 
damage and maintenance of polyploidy cells, and is also involved in preventing 
polyploid cells from undergoing apoptosis through suppression of the checkpoint 
pathway. p21 is identified as a Cdk2 inhibitor, so the over-expression of p21 may also 
inhibit the activity of the Cdk2-CyclinE complex. As the Cdk2-CyclinE complex is 
constitutively active throughout the cell cycle in mouse ES cells, the diminished Cdk 
activity resulting from p21 inhibition may delay progression from G1 to S phase, thus 
lengthening overall generation times. Taken together, our experiments and those of 
others suggest that when PC4 is knocked out, cell cycle regulators are positively or 
negatively affected. PC4 takes part in many regulatory steps to maintain an orderly cell 
cycle. Once this balance is upset by the depletion of PC4, cells are under stress and 
try to adapt to their environment by adjusting the cell cycles. 
4.5.2 Deletion of PC4 did not affect the expression of GTFs, but affected 
the transcription of cell growth- and death-related genes. 
Based on the microarray data, deletion of PC4, a positive transcription cofactor, did 
not change the expressions of general transcription factors. The expressions of 
transcription factors that interact with PC4 in the basal transcription machinery, such 
as TFIIH and TFIIA, were not changed in PC4 knockout ES cells. These results 
indicate that the physiological deficit in PC4 did not correlate with those of other 
transcription factors, perhaps because the cofactor activities of PC4 may be 
substituted by other similar factors. 
At the molecular level, many negatively regulated genes (e.g., Rb1) were expressed at 
higher levels upon PC4 deletion. Many genes related to cell death were also 
deregulated. Although the level of apoptosis in knockout ES cells was not different 
than that in wild-type cells, cell proliferation was inhibited upon deregulation of many 
genes involved in cellular growth processes, such as cell communication and 
metabolism. Many target gene promoters contain similar transcription factors: NFKB1, 
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STAT3, p53, Jun, and Fos, which are involved in the mitogen-activated protein kinase 
(MAPK) signaling pathway. The MAPKs are a group of serine/threonine protein 
kinases that are activated in response to a variety of extracellular stimuli and mediate 
signal transduction from the cell surface to the nucleus. In combination with several 
other signaling pathways, they can differentially alter the phosphorylation status of 
numerous proteins, including transcription factors, cytoskeletal proteins, kinases, and 
other enzymes, and greatly influence gene expression, metabolism, cell division, cell 
morphology, and cell survival. Therefore, we hypothesize that the mechanism 
underlying reduced proliferation following the loss of PC4, is that a large number of 
genes involved in the MAPK pathway were deregulated in their ability to modulate cell 
proliferation and metabolism.  
4.5.3 P21 might be the key factor regulated by PC4 in the control of cell 
proliferation 
Gene expression profiling showed that some miRNAs were downregulated when PC4 
was depleted in ES cells. Could be these miRNAs involved in cell proliferation? Recent 
work from Robert Blelloch’s laboratory described a role for mouse ES cell-specific 
miRNAs in establishing rapid cell cycles (Wang et al. 2008). The miRNAs they 
screened suppressed many key regulators of the G1/S transition to enable rapid 
proliferation in mouse ES cells. One miRNA, miR-20a, rescued the proliferation 
defects of Dgcr8-/- ES cells. Similarly, miR-20a was remarkably downregulated (1.63 
fold downregulation) in our PC4 KO ES cells. Likewise, two other miRNAs, miR-17 and 
miR-467a, were also downregulated (1.75 and 2.87 fold decrease individually). 
Furthermore, p21 was identified as a potential target of all three miRNAs by the 
computational program, Targetscan. In addition, qRT-PCR confirmed that p21 
transcription was enhanced in knockout cells (2.3 fold upregulation). Therefore, we 
hypothesized that PC4 might suppress p21 protein expression by enhancing the 
expression of miRNAs. Alternatively, PC4 may also directly regulate p21 transcription 
by binding its promoter, a claim that is confirmed by a chromatin immunoprecipitation 
(ChIP) assay (performed by Jianming Xu, unpublished data). Furthermore, deletion of 
PC4 reduces the occupancy of Pol II and TBP in p21 promoter, which implies PC4 is 
involved in regulation of p21 activation. Other inhibitors that play roles in the 
Cdk2/Cyclin E regulatory pathway, such as Rb1 and Lats2, were also upregulated (2.5 
and 1.4 fold upregulation individually) in PC4 knockout ES cells. Therefore, when PC4 
was depleted, an increase in p21 together with other cell cycle inhibitors may delay 
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progression from G1 into S phase by restraining Cdk2/Cyclin E activity, thus 
lengthening overall generation times (Figure 34). Therefore, the rapid cell cycle in ES 
cells has been finally impaired and proliferation is reduced in vivo. One approach to 
confirm the key role of p21 in the PC4 regulation network is to knock down p21 in PC4 
knockout ES cells. If the deletion of p21 rescues the reduced proliferation, the 
mechanism underlying the PC4 physiology function could be elucidated. 
 
 
 
Figure 34: Proposed mechanism for PC4 regulation of G1 progression in mouse 
ES cells. 
Mouse PC4 knockout ES cells exhibit high miRNA levels including miR-17, miR-20a and miR-
467a, leading to elevated p21 protein level. Together with other upregulated Cdk2/Cyclin E 
pathway inhibitors (Lats2 and Rb1), the activity of Cdk2/Cyclin E is inhibited and progression 
from G1 to S phase is delayed, thus lengthening overall cell cycle time. 
4.6 PC4 is required for differentiation 
Because the differentiation of ES cells has been known to recapitulate changes in 
embryonic development, factors that have essential functions during early 
embryogenesis are also expected to be involved in the formation of embryoid bodies. 
Therefore, to characterize the role of PC4 in differentiation, we examined the potential 
of PC4 mutant cells to form embryoid bodies in vitro. Based on similar expressions of 
germ layer markers detected by RT-PCR, we concluded that the loss of PC4 did not 
influence the differentiation of ectoderm and endoderm tissues, but did affect 
mesoderm formation. In addition, pluripotency markers were still expressed in 
differentiated ES cells, probably due to incomplete differentiation in vitro. However, to 
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our surprise, qRT-PCR analysis in PC4 KO ES cells identified many ectoderm and 
mesoderm markers that were poorly expressed and some endoderm markers that 
were relatively overexpressed during embryoid body formation. Although RT-PCR and 
teratoma assays showed no effects of the knockout on differentiation, these results 
were probably due to the use of improper methodologies. The relatively low 
expression of ectoderm and mesoderm markers during knockout embryoid body 
formation in vitro and proper teratoma generation in vivo, indicate that PC4 plays a 
role in regulating differentiation and that the process was delayed somehow when PC4 
was depleted. Therefore, we conclude that the delayed differentiation and reduced 
proliferation in the inner cell mass might result in the early embryo lethality observed in 
the PC4 knockout mice. To further explore differentiation defects in PC4 knockout ES 
cells, a microarray analysis should be performed on embryoid bodies. In addition, the 
histological analysis of PC4 mutant embryos at E5.5, E6.5, and E7.5 provide enough 
evidence to confirm that the early embryonic lethality is partially due to germ layer 
defects. In agreement with in vitro differentiation data, at E6.5 the embryonic ectoderm 
layer was thinner or unformed and the embryonic endoderm was not affected. At E7.5, 
no mesoderm layer was formed in PC4 knockout embryos, confirming observations 
made in the embryoid body differentiation assays. Taken together, these data suggest 
that PC4 is required for embryonic ectoderm, mesoderm, and endoderm formation in 
early embryonic developmental stages.  
The gene profiling analysis also gave some clues to predict the function of PC4 in 
differentiation. From the microarray data, it is possible to conclude that the deletion of 
PC4 in ES cells may contribute to self-renewal and prevent the differentiation of 
specific cell lineages. This idea is supported by the upregulation of STAT3 (1.26 fold) 
and ID1 (1.53 fold) upon loss of PC4 in ES cells. Furthermore, STAT3 is the target 
gene of the miR-17 family of miRNAs, which are differentially expressed during early 
mouse embryo development and is involved in stem cell differentiation. Thus, the 
downregulation of the miR-17 family of miRNAs including miR-17 (1.75 fold), and miR-
20a (1.63 fold) triggered the possible self-renewal of their target genes, which are 
linked with STAT3 and bone morphogenetic protein (BMP) self-renewal pathways. The 
consequence of this is that the ES cells don’t differentiate well. However, the 
upregulation of Smad7 (1.56 fold), another target of the miR-17 family, antagonizes 
BMP signaling and induces differentiation. By contrast, downregulation of T (2.3 fold) 
limits mesoderm specification, which was confirmed by our embryoid body 
differentiation assays. Surprisingly, the gene Neurod1 is highly expressed in PC4 null 
ES cells, which indicates these cells can differentiate towards endocrine lineages 
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(Marchand et al. 2009) and neurons. This is also supported by our embryoid body 
differentiation assays, which showed that Nestin expression was fast and high in PC4 
knockout embryoid bodies. Taken together, our data and that of others suggest that 
the STAT3 and BMP signaling pathways were deregulated by PC4 in KO cells, which 
finally altered their fates. 
4.7 Human PC4 can functionally replace its mouse counterpart 
To rule out the possibility that the low growth phenotype of PC4 KO ES cells was 
attributed to the carry over of automatic genetic mutations during in vitro derivation, we 
rescued PC4 null ES cells by transfecting them with human EGFP-PC4 fusion protein. 
PC4-/- ES cells expressing the hPC4-EGFP fusion protein proliferated faster than 
vector-transfected PC4 null cells, showing that human PC4 (hPC4) can functionally 
replace mouse PC4 in mouse ES cell lines and suggesting that hPC4 can enter into 
the various murine PC4-containing complexes. This is in good agreement with the high 
homology between the mouse and human proteins. However, the proliferation of 
rescued PC4 KO ES cells was still slightly slower than that of the wild-type cells. This 
partial rescue might reflect the functional difference between the human fusion protein 
and the mouse protein. In addition, low transfection efficiency might be another reason 
for the partial rescue. The PC4 null ES cells also exhibited inhibited proliferation, which 
might have been due to deregulation of the network of growth signals. Even though a 
functional PC4 protein was reintroduced into the null ES cells, the low growth of the 
cells could not be completely reversed, possibly due to pre-established damage, such 
as epigenetic changes. In other words, PC4 is important for maintaining the 
homeostasis of the cells. Once this homeostasis is broken down, the cells are under 
stress and some permanent damages might occur to compensate for the abnormal 
status.  
4.8 PC4 and DNA damage  
4.8.1 Loss of PC4 doesn’t inhibit p53 activation in ES cells  
The tumor repressor p53 can be activated in response to stress, for example DNA 
damage, and cause cell cycle arrest, DNA repair, and apoptosis. It was reported that 
PC4 could activate p53 and facilitate its DNA binding ability. In addition, the activation 
of p53 by PC4 is dependent on their physical interaction, DNA binding, and 
posttranslational modifications. Furthermore, the expression of PC4 is also regulated 
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by p53, which means PC4 is a p53-responsive gene. As all the above results were 
gathered from somatic cell lines (e.g., A549, H1299), and there was previously no 
evidence to show whether p53 was activated while PC4 was downregulated, we 
addressed this issue with our PC4 null ES cells. Surprisingly, depletion of PC4 did not 
influence either the expression or the phosphorylation of p53. Additionally, 
transcription of the p53 target genes p21 and MDM2 were enhanced following p53 
induction due to genotoxic insult in PC4 KO ES cells. These results clearly indicated 
that PC4 was not functionally associated with p53, at least not in ES cells. This might 
be because pluripotent ES cells have their own specific players in p53 activation that 
are far different from those in somatic cells. Even though PC4 did not affect p53 
activation, PC4 appeared to weaken the expression of p53 and its target genes. In 
contrast to wild-type ES cells, the expressions of p53, p21, and Mdm2, but not Bax, 
were slightly increased in PC4 null ES cells. Actually, p21 was already upregulated in 
PC4 KO ES cells even before doxorubicin treatment. Therefore, it is possible that 
when PC4 is deleted, ES cells become more sensitive to stress signals, and to some 
degree, PC4 could be thought of as safeguarding the stable physiological situation of 
the cell for normal growth.  
For ES cells, maintaining self-renewal is very important, and is controlled by Oct4, 
Nanog, and other transcription factors. During embryonic stem cell differentiation, Oct4 
and Nanog expressions are downregulated; however, if cells constitutively express 
Nanog, differentiation is inhibited. If, for example, ES cells are exposed to a DNA 
damage-inducing drug, p53 binds to Nanog to suppress its expression, which induces 
differentiation. In our PC4-depleted ES cells, Nanog was largely downregulated upon 
doxorubicin treatment, similar to what happened in wild-type ES cells. But the level of 
Oct4 did not change so much in response to the DNA damage. Therefore, we predict 
that PC4 null ES cells are prone to differentiate upon p53 activation induced by DNA 
damage. 
4.8.2 PC4 is involved in DNA damage response from yeast to mammals 
Absence of the PC4 yeast homologue SUB1 renders the cells to undergo spontaneous 
and peroxide-induced hypermutability, suggesting the importance of PC4 expression 
under DNA-damaging conditions (Wang et al. 2004). If the HOG pathway fails, SUB1 
becomes important to ensure survivals under osmotic stress. This is because the cell 
turns to an alternative pathway that makes use of SUB1 to target Pol II to enhance the 
expression of the necessary osmoresponse genes (Rosonina et al. 2009). All these 
imply PC4 may play a role in response to stress signals probably due to its DNA repair 
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activity. In our study, we proved that PC4 can be recruitment to the DNA damage site 
independent of poly (ADP-ribosyl)ation and phosphorylation of H2AX, but it functions 
in the very early steps of the DNA damage response. Although knockdown of PC4 in 
HeLa cells didn’t show elevated DNA damage because of the low efficiency and short 
term of the knockdown treatment (data unpublished), it is expected that the repair 
function of PC4 is important for DNA damage response because it was observed to be 
recruited to the DNA damage sites. In our PC4 knockout ES cell model, we found 
slight enhancement of p53 dependent gene activation and increase of membrane 
damage (based on the observation), which implies PC4 might be important for sensing 
and signaling DNA damage. Probably the early embryo lethality of PC4 knockout 
embryos is due to the increasing of the DNA damage upon loss of PC4. Taken 
together, the DNA repair activity from yeast to mammals is consistent and important 
for normal cell growth and development of the mammals.  
4.9 PC4 regulates Pol III-dependent transcription in vivo 
Pol I and III are specialized for transcribing only non-coding RNAs, which contribute up 
to 80% of all nuclear transcription in rapidly growing cells. Moreover, tRNA, 18S, 5.8S, 
28S, and 5S rRNAs transcribed by Pol I and Pol III can comprise as much as 95% of 
the RNA content of a cell. Pol III regulates Pol II transcription by synthesizing 7SK, 
Alu, and B2 RNAs. In our PC4-deficient ES cells, Pol I-dependent transcription of 
rRNAs was not affected, whereas Pol III-dependent 5S rRNA, 7SK and U6snRNA 
transcriptions were enhanced, the latter indicating that PC4 might repress Pol III-
dependent transcription. Tumor suppressors are able to inhibit transcription by Pol I 
and Pol III. For example, while p53 represses Pol III transcription, the p53 substitution 
mutation R175H (the most common p53 mutation in tumors) converts p53 from a 
repressor to an activator of Pol III transcription (Chesnokov et al. 1996; Cairns and 
White 1998; Stein et al. 2002; Crighton et al. 2003; Gridasova and Henry 2005; Morton 
et al. 2007). As PC4 is a potential tumor repressor, Pol III transcription should be 
increased when PC4 is reduced, but this issue needs to be carefully tested again by 
checking the transcription levels of other non-coding RNAs in PC4 KO cells. In 
contrast to PC4 KO ES cells, PC4 knockdown MEFs exhibited downregulation of Pol 
III transcription and almost no change in Pol I transcription. One explanation for the 
different Pol III responses in ES cells and MEFs is that PC4 depletion directly inhibits 
Pol III-dependent transcription as does SUB1 in yeast, but the ES cells try to 
circumvent this defect, leading to the overregulation of Pol III-dependent transcription.  
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Can the inappropriate expressions of the products of Pol III transcription in PC4 KO 
ES cells and knockdown MEFs have detrimental consequences, such as the abnormal 
proliferation we observed? Maf1, an essential mediator of Pol III repression in 
response to starvation in Saccharomyces cerevisiae, can repress Pol I- and Pol III-
dependent tRNA and rRNA gene activity (Johnson et al. 2007), which causes 
anchorage-independent growth inhibition and cell morphology alternation. In view of 
this, one can hypothesize that the strikingly slower growth of PC4 KO ES cells and 
knockdown MEFs is due, in part, to the deregulation of Pol III. Although Manley’s 
group claimed that SUB1, the yeast homolog of PC4, positively regulates Pol III 
recruitment to its target genes, which is contradictory to the PC4 repression effects 
seen in our mouse ES cells but in agree with the effect in MEFs, the role of PC4 in 
transcription other than that of only Pol II was confirmed by our studies (Rosonina et 
al. 2009).  
4.10 Conclusions 
To summarize the possible mechanisms underlying the phenotype upon loss of in vivo, 
the following diagram can be drawn (Figure 35). In vivo, PC4 is critical for mouse early 
embryo development. Loss of PC4 results in early embryo lethality via decreasing cell 
proliferation and impairing differentiation. Based on the gene expression analysis, 
many mechanisms underlying reduced proliferation were proposed, including 
abnormal cell cycle, deregulation of MAPK pathway and Pol III transcription. 
Furthermore, increase of DNA damage upon PC4 depletion may also lead to failure in 
early development of PC4 knockout embryos.  
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Figure 35: Diagram of possible mechanisms underlying early embryo lethal 
phenotype of PC4 knockout mice. 
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6. APPENDIX 
6.1 List of abbreviations 
  
% percentage 
°C degree Celsius 
[32P]dCTP cytidine 5´-alpha 32P triphosphate 
aa amino acid 
bp base pair 
Cat. No. catalogue number 
cDNA complementary deoxyribonucleic acid 
CTD carboxy-terminal domain of RNA polymerase II  
C-terminal carboxy-terminal 
dH2O distilled water 
dNTP deoxynucleoside triphosphate 
DMEM Dulbecco’s Modified Eagle Medium 
DNA deoxyribonucleic acid 
ds double-stranded 
g gram  
mg milligram 
μg microgram 
HSV-tk herpes simplex virus thymidine kinase  
IF immunofluorescence 
ID identification number 
kDa kilo Dalton 
kb kilobase 
L liter 
ml milliliter 
μl microliter 
M molar 
mM millimolar 
mir microRNA 
mRNA messenger RNA 
N-terminal aminoterminal 
NaCl sodiumchloride 
PC4 positive transcription cofactor 4 
PC4-CTD carboxy-terminal domain of PC4 
PCR polymerase chain reaction 
RNA ribonucleic acid 
±SD standard diviation 
siRNA small interfering RNA 
ss single-stranded 
U unit 
V volt(s) 
kV kilovolt(s) 
μF      microfarad(s) 
WB Western blot 
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6.2 Microarray data 
Table 9: Genes more than two fold downregulated after PC4 knockdown in HeLa 
cells 
Gene symbol Gene Title 
Fold 
Change 
SUB1 SUB1 homolog (S. cerevisiae) 18.3  
SPINK5 serine peptidase inhibitor, Kazal type 5 3.6  
EIF4EBP2 Eukaryotic translation initiation factor 4E binding protein 2 2.6  
IFI44 interferon-induced protein 44 2.8  
C1S complement component 1, s subcomponent 2.6  
C3 complement component 3 2.6  
RP1-32F7.2 hypothetical protein FLJ37659 2.7  
KCNK3 potassium channel, subfamily K, member 3 2.7  
POPDC3 popeye domain containing 3 2.1  
GPNMB glycoprotein (transmembrane) nmb 3.3  
CA9 carbonic anhydrase IX 2.7  
LOC339745 hypothetical protein LOC339745 2.2  
TNFRSF11B 
tumor necrosis factor receptor superfamily, member 11b 
(osteoprotegerin) 
2.1  
 
Table 10: Genes more than two fold upregulated after PC4 knockdown in HeLa 
cells 
Gene symbol Gene Title 
Fold 
Change 
C19orf6 chromosome 19 open reading frame 6 23.0  
PTK9 PTK9 protein tyrosine kinase 9 13.4  
HSP90AB1 
heat shock protein 90kDa alpha (cytosolic), class B member 
1 
11.4  
SLC39A6 solute carrier family 39 (zinc transporter), member 6 9.5  
VPS35 vacuolar protein sorting 35 (yeast) 7.8  
CDCP1 CUB domain containing protein 1 7.7  
WDR1 WD repeat domain 1 6.4  
P4HB 
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-
hydroxylase), beta polypeptide 
6.1  
DAPK3 death-associated protein kinase 3 6.0  
HSP90B1 heat shock protein 90kDa beta (Grp94), member 1 5.9  
SPTBN1 spectrin, beta, non-erythrocytic 1 5.7  
FUS fusion (involved in t(12;16) in malignant liposarcoma) 5.5  
PTBP1 polypyrimidine tract binding protein 1 5.3  
GRK5 G protein-coupled receptor kinase 5 5.1  
INPP5A inositol polyphosphate-5-phosphatase, 40kDa 5.1  
RAD21 RAD21 homolog (S. pombe) 5.1  
LIX1L Lix1 homolog (mouse) like 5.0  
BUB1 
BUB1 budding uninhibited by benzimidazoles 1 homolog 
(yeast) 
4.8  
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PIP5K1A phosphatidylinositol-4-phosphate 5-kinase, type I, alpha 4.6  
WDR68 WD repeat domain 68 4.6  
PSPC1 paraspeckle component 1 4.4  
RXRB retinoid X receptor, beta 4.3  
PTPLB 
protein tyrosine phosphatase-like (proline instead of catalytic 
arginine), member b 
4.3  
MET met proto-oncogene (hepatocyte growth factor receptor) 4.3  
PITPNC1 Phosphatidylinositol transfer protein, cytoplasmic 1 4.1  
THBS1 thrombospondin 1 4.0  
NEK9 NIMA (never in mitosis gene a)- related kinase 9 3.8  
SYTL5 synaptotagmin-like 5 3.8  
SKP2 S-phase kinase-associated protein 2 (p45) 3.8  
CBFB core-binding factor, beta subunit 3.7  
HIPK2 Homeodomain interacting protein kinase 2 3.7  
TAGLN transgelin 3.6  
MATR3 matrin 3 3.6  
FAM60A family with sequence similarity 60, member A 3.6  
PTRF polymerase I and transcript release factor 3.6  
HRB HIV-1 Rev binding protein 3.6  
MAZ 
MYC-associated zinc finger protein (purine-binding 
transcription factor) 
3.6  
VIL2 villin 2 (ezrin) 3.5  
CARS cysteinyl-tRNA synthetase 3.5  
ABR active BCR-related gene 3.5  
FAM62B 
family with sequence similarity 62 (C2 domain containing) 
member B 
3.4  
SPFH1 SPFH domain family, member 1 3.4  
SP1 Sp1 transcription factor 3.4  
CASP2 
caspase 2, apoptosis-related cysteine peptidase (neural 
precursor cell expressed, developmentally down-regulated 2) 
3.4  
BHLHB2 basic helix-loop-helix domain containing, class B, 2 3.4  
RERE arginine-glutamic acid dipeptide (RE) repeats 3.4  
CDV3 CDV3 homolog (mouse) 3.4  
MGC23985 similar to AVLV472 3.3  
USP31 ubiquitin specific peptidase 31 3.3  
SPG7 
spastic paraplegia 7, paraplegin (pure and complicated 
autosomal recessive) 
3.2  
C9orf86 chromosome 9 open reading frame 86 3.2  
FXR1 fragile X mental retardation, autosomal homolog 1 3.2  
KIAA1458 KIAA1458 3.1  
TMPO thymopoietin 3.1  
FGFR1 
fibroblast growth factor receptor 1 (fms-related tyrosine 
kinase 2, Pfeiffer syndrome) 
3.0  
M6PR mannose-6-phosphate receptor (cation dependent) 2.9  
RSN 
restin (Reed-Steinberg cell-expressed intermediate filament-
associated protein) 
2.9  
BCL2L1 BCL2-like 1 2.9  
CAB39 calcium binding protein 39 2.7  
C3orf37 Chromosome 3 open reading frame 37 2.7  
WAC WW domain containing adaptor with coiled-coil 2.7  
RP6-213H19.1 
serine/threonine protein kinase MST4 /// serine/threonine 
protein kinase MST4 
2.7  
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CYCS cytochrome c, somatic 2.7  
MOBK1B MOB1, Mps One Binder kinase activator-like 1B (yeast) 2.6  
CALD1 caldesmon 1 2.6  
ARL2BP ADP-ribosylation factor-like 2 binding protein 2.6  
MRPL30 mitochondrial ribosomal protein L30 2.6  
MAPKAPK2 mitogen-activated protein kinase-activated protein kinase 2 2.6  
HERC4 hect domain and RLD 4 2.6  
GLUL glutamate-ammonia ligase (glutamine synthetase) 2.6  
CYB5R3 cytochrome b5 reductase 3 2.6  
RANBP2 RAN binding protein 2 2.5  
HIP1 huntingtin interacting protein 1 2.5  
DSG2 desmoglein 2 2.5  
LOC653890 similar to serine/threonine/tyrosine interacting protein 2.5  
MSRB3 methionine sulfoxide reductase B3 2.5  
TAF6L 
TAF6-like RNA polymerase II, p300/CBP-associated factor 
(PCAF)-associated factor, 65kDa 
2.4  
CLSPN claspin homolog (Xenopus laevis) 2.4  
TAF9B  
TAF9B RNA polymerase II, TATA box binding protein (TBP)-
associated factor, 31kDa /// similar to TBP-associated factor 
9L 
2.4  
RAB11FIP1 RAB11 family interacting protein 1 (class I) 2.4  
PDK4 pyruvate dehydrogenase kinase, isozyme 4 2.4  
CAV2 caveolin 2 2.4  
XTP3TPA XTP3-transactivated protein A 2.4  
SMAD3 SMAD, mothers against DPP homolog 3 (Drosophila) 2.4  
SLC10A3 
solute carrier family 10 (sodium/bile acid cotransporter 
family), member 3 
2.4  
GSTCD glutathione S-transferase, C-terminal domain containing 2.4  
CDC2L5 
cell division cycle 2-like 5 (cholinesterase-related cell division 
controller) 
2.4  
SFPQ 
Splicing factor proline/glutamine-rich (polypyrimidine tract 
binding protein associated) 
2.3  
C5orf22 chromosome 5 open reading frame 22 2.3  
SQLE squalene epoxidase 2.3  
FAM120A family with sequence similarity 120A 2.3  
C5orf13 chromosome 5 open reading frame 13 2.3  
CPNE3 copine III 2.3  
NFIB nuclear factor I/B 2.2  
MT1F metallothionein 1F (functional) 2.2  
RICTOR rapamycin-insensitive companion of mTOR 2.2  
ANKHD1 /// 
MASK-BP3 
ankyrin repeat and KH domain containing 1 /// MASK-4E-
BP3 alternate reading frame gene 
2.2  
ODZ2 odz, odd Oz/ten-m homolog 2 (Drosophila) 2.1  
HSPH1 heat shock 105kDa/110kDa protein 1 2.1  
C16orf35 chromosome 16 open reading frame 35 2.1  
UBE2M ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) 2.1  
SVH SVH protein 2.1  
RAP2A RAP2A, member of RAS oncogene family 2.1  
DDX3X DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked 2.1  
TMOD3 tropomodulin 3 (ubiquitous) 2.1  
C9orf19 chromosome 9 open reading frame 19 2.1  
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ARHGAP18 Rho GTPase activating protein 18 2.1  
AP1S3 adaptor-related protein complex 1, sigma 3 subunit 2.1  
NUSAP1 nucleolar and spindle associated protein 1 2.0  
ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 2.0  
                                                                                                                                    129 

CURRICULUM VITAE 
Personal data:    
Full Name Na Li 
Gender  Female 
Date of Birth  15.04.1979 
Nationality Chinese  
Marital Status  Married 
Dissertation: 
Since June 2005    (Jun. 2005-May. 2008) Laboratory of Prof. Dr. Michael Meisterernst,  
                                                                     Institute of Molecular Immunology, 
                                                                     Helmholtz-Zentrum München 
                               (Jun. 2008- present)     Laboratory of Prof. Dr. Michael Meisterernst,   
                                                                     Institute of Molecular Tumor Biology, 
                                                                     Medical Faculty of the WWU Münster  
                               Title of the thesis: Critical role of transcription cofactor PC4 in mammals 
University education: 
Sept. 1997- Jul. 2001    Bachelor’s education in biological science, School of Life science,  
                                      Northeast Normal University, China 
Sept. 2001- Sep. 2004  Master’s education in cell biology, Institute of Genetics and Cytology, 
                                      Northeast Normal University, China 
                                      Title of Master thesis: Modified heparin can inhibit P-selectin-mediated 
adhesion of leucocytes 
School education: 
Sept. 1985-Jul. 1991 Shiyan Elementary School of Xin Zheng in Henan Province, China 
Sept. 1991-Jul. 1994 Yuanling Junior High School of Xin Zheng in Henan Province, China 
Sept. 1994-Jul. 1997 The first Senior High School of Xin Zheng in Henan Province, China 
 
Munich, 11.01.2010 
